mechlorethamine has been researched along with Granuloma, Hodgkin in 1224 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was undertaken to systematically evaluate the agreement rates among single photon emission computed tomography using gallium-67 (Ga-67 SPECT), lymphangiography (LAG), and computed axial tomography (CT) scan findings for Hodgkin disease and to correlate radiologic findings with clinical outcome." | 9.09 | Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome. ( Allen, PK; Choe, JG; Cox, JD; Edmund, E; Ha, CS; Kong, JS; Oh, YK, 2000) |
| "In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine." | 9.08 | Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997) |
| "In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease." | 9.07 | Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study. ( Anderson, JR; Barcos, M; Burns, LJ; Cooper, MR; Gottlieb, AJ; Kirshner, JJ; Parker, B; Peterson, BA, 1993) |
| "Colorectal cancer surveillance should be considered for HL survivors who received Infradiaphragmatic radiotherapy and a high cumulative procarbazine dose." | 7.85 | Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. ( Aleman, BM; de Boer, JP; De Bruin, ML; Janus, CP; Kremer, LC; Krol, AD; Louwman, MW; Schaapveld, M; van der Maazen, RW; van Eggermond, AM; van Leerdam, ME; van Leeuwen, FE; Visser, O; Zijlstra, JM, 2017) |
| "Fifty-six patients with newly diagnosed Stage II-IV Hodgkin disease, ages 18-77 years, were randomized to receive GM-CSF (5 microg/kg subcutaneously) or placebo from Day 7 to Day 4 before each chemotherapy administration (6 cycles of a hybrid of mechlorethamine, vincristine, procarbazine, and prednisone with doxorubicin, bleomycin, vinblastine, and dacarbazine)." | 5.09 | Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease. ( Aglietta, M; Amadori, S; Botto, B; Cantonetti, M; Castoldi, GL; Dammacco, F; Fagioli, F; Ferrara, R; Levis, A; Montemurro, F; Racanelli, V; Teofili, L; Volta, C, 2000) |
| "This study was undertaken to systematically evaluate the agreement rates among single photon emission computed tomography using gallium-67 (Ga-67 SPECT), lymphangiography (LAG), and computed axial tomography (CT) scan findings for Hodgkin disease and to correlate radiologic findings with clinical outcome." | 5.09 | Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome. ( Allen, PK; Choe, JG; Cox, JD; Edmund, E; Ha, CS; Kong, JS; Oh, YK, 2000) |
| "In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine." | 5.08 | Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997) |
| "9 years, range, 1-15 years) received the AIEOP-MH 1983 Hodgkin disease protocol of low-dose radiation therapy (20-25 Gy), with three cycles of adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) for children with early-stage and favorable disease, and with alternating cycles of an eight non-cross-resistant drug combination regimen (nitrogen mustard, vincristine, procarbazine, and prednisone [MOPP]/ABVD) for 6 months for those with bulky and unfavorable disease." | 5.07 | Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients. ( Bontempi, N; Burnelli, R; Carli, M; Comelli, A; Di Tullio, MT; Pileri, S; Rosati, D; Sotti, G; Testi, AM; Vecchi, V, 1993) |
| "In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease." | 5.07 | Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study. ( Anderson, JR; Barcos, M; Burns, LJ; Cooper, MR; Gottlieb, AJ; Kirshner, JJ; Parker, B; Peterson, BA, 1993) |
| "Survivors of advanced Hodgkin disease, who were assigned randomly to treatment by mechlorethamine, vincristine, procarbazine, and prednisone (MOPP); doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD); or MOPP alternating with ABVD in a clinical trial of the Cancer and Leukemia Group B (protocol 8251), were compared in terms of their psychosocial adaptation and psychosexual function an average of 2." | 5.07 | Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD. ( Anderson, J; Canellos, GP; Cella, DF; Cherin, E; Cooper, MR; Henderson, ES; Kornblith, AB; Kosty, MP; Tross, S; Zuckerman, E, 1992) |
| " Patients were randomized in the Southwest Oncology Group (later the Pediatric Oncology Group [POG] to involved-field (IF) radiotherapy alone or IF radiotherapy followed by six courses of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP) chemotherapy; patients in the Children's Cancer Study Group (CCSG) and Cancer and Leukemia Group B (CALGB) were randomized to receive extended-field (EF) radiotherapy or IF radiotherapy followed by six courses of MOPP." | 5.06 | The intergroup Hodgkin's disease in children. A study of stages I and II. ( Fryer, C; Fuller, LM; Gehan, EA; Gilchrist, GS; Hanson, W; Hays, DM; Heller, R; Johnston, J; Kennedy, P; Sullivan, MP, 1990) |
| " The authors describe a patient with Hodgkin's disease who developed an atypical aortic dissection while receiving MOPP/ABV chemotherapy (nitrogen mustard, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine)." | 4.79 | Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report. ( Bavaria, JE; Crooks, GW; Golden, MA; Holland, GA; Vaughn, DJ, 1997) |
| " After a median follow-up of more than 6 years following MOPP (mechlorethamine/vincristine/procarbazine/prednisone) chemotherapy with or without radiotherapy, 5% of patients with Hodgkin's disease developed second primaries, 60% of which were leukemias." | 4.78 | Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects. ( Petru, E; Schmähl, D, 1991) |
| " The risk of treatment-induced acute leukemias as well as sterility can be avoided or greatly decreased with drug combinations not including procarbazine HCI and alkylating agents." | 4.77 | Chemotherapy of malignant lymphomas. ( Bonadonna, G, 1985) |
| "Colorectal cancer surveillance should be considered for HL survivors who received Infradiaphragmatic radiotherapy and a high cumulative procarbazine dose." | 3.85 | Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. ( Aleman, BM; de Boer, JP; De Bruin, ML; Janus, CP; Kremer, LC; Krol, AD; Louwman, MW; Schaapveld, M; van der Maazen, RW; van Eggermond, AM; van Leerdam, ME; van Leeuwen, FE; Visser, O; Zijlstra, JM, 2017) |
| "The proportion of intravenous drug abusers (IVDA) in HIV-HD (38%) is higher than in French HIV-infected population as a whole (20." | 3.78 | Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors. ( Andrieu, JM; Brice, P; Colonna, P; Gastaut, JA; Lévy, R; Raphaël, M; Taillan, B; Tourani, JM, 1995) |
| " We describe a 5-year-old boy with stage IV HD, successfully treated with MOPP (mechlorethamine, vincristine, procarbazine, and prednisone)/ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy followed by 35 Gy mantle radiotherapy who developed primary hyperparathyroidism because of benign PTA at the age of 20 years, and died of CS in thoracic vertebrae at the age of 22 years." | 3.76 | Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease. ( Albayrak, M; Coskun, U; Gursel, T; Kaya, Z; Keskin, EY; Kocak, U; Uluoglu, O, 2010) |
| "To determine the long-term outcome of patients presenting with synchronous lymphoma and severe liver dysfunction and to describe the outcome of patients treated with initial mechlorethamine-based therapy used as a bridge to more conventional chemotherapy." | 3.72 | Therapeutic options in patients with lymphoma and severe liver dysfunction. ( Ansell, SM; Colgan, JP; Fonseca, R; Ghobrial, IM; Habermann, TM; Inwards, DJ; Markovic, SN; Micallef, IN; Pereira, DL; Porrata, LF; White, WL; Witzig, TE; Wolf, RC, 2004) |
| "In addition to mechlorethamine, lomustine and teniposide combinations were also linked to an elevated risk of developing leukemia." | 3.69 | Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. ( Chorus, AM; Hagenbeek, A; Noyon, R; Pinedo, HM; Somers, R; van den Belt-Dusebout, AW; van Kerkhoff, EH; van Leeuwen, FE, 1994) |
| "From January 1980 to September 1986, 50 patients with Hodgkin disease, clinical stages (CS) IIIB (26 cases) and IVB (24 cases) were treated by three cycles of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy, followed by high-dose (40 Gy) (sub)total lymphoid irradiation, including the spleen." | 3.67 | Advanced Hodgkin disease (clinical stages IIIB and IV): low relapse rate after brief chemotherapy followed by high-dose total lymphoid irradiation. ( Afiane, M; Andrieu, JM; Belhadj-Merzoug, K; Colonna, P; Ghouadni, R; Krisch, C; Kubisz, P; Laugier, A; Tourani, JM; Zouaoui-Benhadji, Z, 1989) |
| "Eighteen children with Hodgkin disease (16 previously untreated; two relapsed) were treated with MOPP chemotherapy (nitrogen mustard, vincristine, prednisone, procarbazine) only." | 3.66 | Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality. ( Ekert, H; Waters, KD, 1983) |
| "A case of human fetal renal maldevelopment following the administration of nitrogen mustard, vincristine, procarbazine, and prednisone in early pregnancy for therapy of Hodgkin's disease is reported." | 3.65 | Fetal renal malformation following treatment of Hodgkin's disease during pregnancy. ( Mellman, WJ; Mennuti, MT; Shepard, TH, 1975) |
| " Seventeen patients with Hodgkin's disease and 15 with non-Hodgkin's lymphoma were subjected to nontherapeutic splenectomy as part of the staging procedure prior to their initial treatment with MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) or CVP (cyclophosphamide, vincristine, and prednisone) chemotherapy, respectively." | 3.65 | Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma. ( Canellos, GP; DeVita, VT; Ihde, DC; Young, RC, 1976) |
| "Chemotherapy for classic Hodgkin lymphoma (cHL) patients on hemodialysis (HD) is an extremely challenging situation because pharmacokinetic and pharmacodynamic studies of most chemotherapeutics are lacking for the HD patient, and the small amount of evidence available comes mostly from case reports and small case series." | 2.82 | Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations. ( Ando, J; Ando, M; Komatsu, N; Yasuda, H, 2022) |
| "After MOPP-Bleo induction for advanced Hodgkin lymphoma, ABVD provides better consolidation than local RT." | 2.74 | Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up. ( Bennett, JM; Glick, JH; Hong, F; Wiernik, PH, 2009) |
| "Treatment of early-stage Hodgkin's disease is usually tailored in line with prognostic factors that allow for reductions in the amount of chemotherapy and extent of radiotherapy required for a possible cure." | 2.73 | Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. ( Baars, JW; Berger, F; Blanc, M; Bosq, J; Brice, P; Carde, P; Carrie, C; Creemers, GJ; Diviné, M; Eghbali, H; Fermé, C; Gabarre, J; Girinsky, T; Gyan, E; Hagenbeek, A; Henry-Amar, M; Jaubert, J; Kluin-Nelemans, JC; Lederlin, P; Lugtenburg, PJ; Meerwaldt, JH; Monconduit, M; Noordijk, EM; Poortmans, P; Raemaekers, JM; Reman, O; Rieux, C; Salles, G; Thomas, J; Tirelli, U; Van den Neste, E; van't Veer, MB; Vié, B; Viseu, F; Walewski, JA, 2007) |
| "The causes of death were Hodgkin's lymphoma in 36 patients, second neoplasms in 12, cardiorespiratory diseases in 4, pulmonary diseases in 2, and unknown in 6." | 2.72 | MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors. ( Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F, 2006) |
| "In early-stage Hodgkin's lymphoma (HL), subtotal nodal irradiation (STNI) and combined chemotherapy/radiotherapy produce high disease control rates but also considerable late toxicity." | 2.72 | Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. ( Aleman, BM; Bosq, J; Carde, P; Dupouy, N; Eghbali, H; Girinsky, T; Hagenbeek, A; Henry-Amar, M; Kluin-Nelemans, JC; Krol, AD; Monconduit, M; Noordijk, EM; Pény, AM; Raemaekers, JM; Thomas, J; Tirelli, U; Verschueren, TA; Vovk, M, 2006) |
| "Adult patients (N = 856) with advanced Hodgkin's disease were randomly assigned to treatment with ABVD or MOPP/ABV." | 2.71 | Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. ( Canellos, GP; Connors, JM; Duggan, DB; Fisher, RI; Glick, JH; Johnson, JL; Peterson, BA; Petroni, GR, 2003) |
| "One hundred patients with Hodgkin's disease (97 with stage I-II disease at presentation) who relapsed after radiation therapy alone were salvaged with either MOPP or ABVD." | 2.71 | Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease. ( Fisher, DC; Li, S; Mauch, PM; Neuberg, D; Ng, AK; Silver, B; Stevenson, MA, 2004) |
| "Management of advanced-stage Hodgkin's disease with a MOPP/ABV hybrid regimen (mechlorethamine, vincristine, procarbazine, prednisone, Adriamycin, bleomycin and vinblastine) has yielded a high complete response rate (75-85%)." | 2.69 | Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy. ( Bélanger, D; Bergeron, M; Cantin, G; Couture, F; Desjardins, L; Dufresne, J; Gyger, M; Hewitt, LA; L'Espérance, B; Lacroix, L; Ouellet, PA; Pirc, L; Yelle, L, 1999) |
| "The treatment of advanced Hodgkin's disease (HD) with chemotherapy (CTx) alone or combined modality treatments has been controversial." | 2.69 | Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial. ( Berger, F; Bordessoule, D; Brice, P; Caillot, D; Diviné, M; Fermé, C; Ferrant, A; Gabarre, J; Hennequin, C; Lederlin, P; Lepage, E; Moullet, I; Sebban, C, 2000) |
| "Patients with Hodgkin's disease (HD) who fail to enter a complete remission after an initial course of combination chemotherapy are usually considered to have an induction failure (IF); this subset of patients has an extremely poor outcome with further conventional therapy." | 2.68 | High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy. ( Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ, 1995) |
| "Fourteen had Hodgkin's and four non-Hodgkin's lymphoma." | 2.68 | Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. ( Avivi, I; Ben-Shahar, M; Blumenfeld, Z; Epelbaum, R; Haim, N; Linn, S, 1996) |
| "Two cases developed a second malignancy." | 2.68 | Treatment of childhood Hodgkin's disease without radiotherapy. ( Behrendt, H; van den Berg, H; Zsiros, J, 1997) |
| "Eighty patients presented with Hodgkin's disease and a mediastinal mass greater than one third the greatest chest diameter on chest radiograph." | 2.68 | Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease. ( Bastian, AW; DeVita, VT; Duffey, PL; Glatstein, E; Hubbard, SM; Ihde, DC; Jaffe, ES; Longo, DL; Wilson, WH; Wittes, RE; Young, RC, 1997) |
| "(mean 43 yr." | 2.68 | [A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes]. ( Ziółko, E, 1997) |
| "A retrospective review of patients with Hodgkin's disease treated at Stanford University Medical Center was undertaken to determine if, within the pediatric population, children < or = 10 years of age have a unique prognosis and response to treatment." | 2.67 | Hodgkin's disease in the very young. ( Cleary, SF; Donaldson, SS; Link, MP, 1994) |
| "Of our 19 patients with Hodgkin's disease (age range, 6 to 20 years) treated with this regimen, 2 had clinical stage I disease, 10 had stage II, 6 had stage III, and 1 had stage IV." | 2.67 | Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. ( Arndt, CA; Chen, MG; Gilchrist, GS; Khan, SP; Matsumoto, JM; O'Fallon, WM; Schomberg, PJ; Smithson, WA, 1994) |
| "Twenty-four patients with Hodgkin's disease refractory or resistant to at least two chemotherapy regimens were enrolled in this study." | 2.67 | Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease. ( Balzarini, L; Bonadonna, G; Bonfante, V; Devizzi, L; Santoro, A; Valagussa, P; Viviani, S, 1994) |
| "Patients with PSIII 1A Hodgkin's disease treated with RT have a significantly higher risk of relapse and potentially a poorer survival compared with patients treated with CMT." | 2.67 | Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy. ( Canellos, GP; Coleman, CN; Kalish, LA; Marcus, KC; Mauch, PM; Rosenthal, DS; Shulman, LN, 1994) |
| "Relapses were most frequent in previously involved unirradiated areas." | 2.67 | Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience. ( Breed, WP; Burgers, JM; Carde, P; de Pauw, BE; Hagenbeek, A; Henry-Amar, M; Monconduit, M; Somers, R; Tarayre, M; Thomas, J, 1991) |
| "In patients with stage IV Hodgkin's disease mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) was randomly tested against MOPP alternated monthly with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD)." | 2.66 | Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. ( Bonadonna, G; Santoro, A; Valagussa, P, 1986) |
| "In 1982 a French cooperative study for Hodgkin's disease was designed to minimize adverse side effects of therapy in childhood." | 2.66 | [Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation]. ( Lemerle, J; Leverger, G; Oberlin, O; Schaison, G, 1987) |
| "Fifty-three children with Hodgkin's disease were clinically staged and treated with chemotherapy alone." | 2.66 | Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease. ( Ekert, H; Mauger, D; Smith, PJ; Toogood, I; Waters, KD, 1988) |
| " Buserelin (d-Ser-[TBU]6 LHRH ethylamide) was prescribed in two different dosage schedules to twenty men, and in a single dosage schedule to eight women." | 2.66 | Failure to preserve fertility in patients with Hodgkin's disease. ( Ahmed, R; Besser, GM; Crowther, D; Gregory, W; Malpas, JS; Rees, LH; Shalet, S; Smith, D; Waxman, JH; Wrigley, PF, 1987) |
| "The H5 study of supradiaphragmatic Hodgkin's disease in clinical stages I-II consisted of two controlled trials adapted to patients considered to have either favorable or unfavorable characteristics, based on prognostic factors identified in two former studies by the European Organization for Research and Treatment of Cancer." | 2.66 | Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Tr ( Burgers, JM; Carde, P; Cosset, JM; Hagenbeek, A; Hayat, M; Meerwaldt, JH; Monconduit, M; Sizoo, W; Somers, R; van der Schueren, E, 1988) |
| "Of the 188 patients with Hodgkin's disease, 157 achieved a complete response (CR) (84%), and 66% of them (101 patients) have remained disease-free more than 10 years from the end of treatment." | 2.66 | Twenty years of MOPP therapy for Hodgkin's disease. ( DeVita, VT; Duffey, PL; Hubbard, SM; Jaffe, ES; Longo, DL; Wesley, M; Young, RC, 1986) |
| "299 patients with stage III or IV Hodgkin's disease were randomised to receive cyclical chemotherapy with MOPP (mustine, Oncovin, procarbazine, prednisone) or LOPP (Leukeran substituted for mustine)." | 2.66 | Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation. ( Hancock, BW, 1986) |
| "Three patients with remission of Hodgkin's disease after involved-field (two) and extended-field (one) radiotherapy died from cardiovascular disease that could only be attributed to the prior radiotherapy." | 2.66 | Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities. ( Caravelli, J; Cirrincione, C; Cunningham, I; Koziner, B; McCormick, B; Mertelsmann, R; Myers, J; Nisce, LZ; Redman, J; Straus, DJ, 1986) |
| "From 1976 to 1981, 335 patients with untreated Hodgkin's disease, clinical stages I, II, and IIIA, have been treated by MOPP (nitrogen mustard, vincristine, procarbazine, prednisone) chemotherapy, three to six cycles according to the prognostic factors, combined with radiotherapy." | 2.66 | Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. ( Audebert, A; Bernadou, A; Diebold, J; Eghbali, H; Hoerni, B; Krulik, M; Merle-Béral, H; Parlier, Y; Rojouan, J; Zittoun, R, 1985) |
| " From 1976 to 1979 patients with Stage IV disease were treated wither with MOPP or with MOPP plus bleomycin at low dosage (B-MOPP); the incidence of complete remission was not significantly different in the two groups of patients (52 vs." | 2.65 | Combination chemotherapy for stage IV Hodgkin's disease (Report no 14). ( Goldman, JM, 1981) |
| "Eighteen patients with advanced Hodgkin's disease, refractory to combination chemotherapy with nitrogen mustard, vincristine, prednisone, and procarbazine (MOPP), were treated with vinblastine, doxorubicin (Adriamycin), bleomycin, CCNU, and dacarbazine (DTIC) (VABCD)." | 2.65 | Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine. ( Bond, WH; Chenoweth, L; Einhorn, LH; Stevens, EE; Williams, SD, 1983) |
| "Seven patients with active Hodgkin's lymphoma who had relapsed 4-39 months following six or more cycles of MOPP were treated with a combination of vinblastine-bleomycin-cis-platin (VBP)." | 2.65 | Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma. ( Clamon, GH; Corder, MP; Wiesenfeld, M, 1984) |
| "Forty-seven patients with advanced Hodgkin's disease were entered in a prospective, randomized trial comparing MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) with a regimen containing lomustine (CCNU), vinblastine, and prednisone (CCNU-VP)." | 2.65 | Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. ( Bateman, JR; Hum, GJ; Liebman, HA; Ryden, VM; Sheehan, WW, 1983) |
| "Of 209 Hodgkin's disease patients treated at least 6 months with a five-drug combination of induction chemotherapy and having a complete remission, four patients developed acute myelogenous leukemia (AML) as a second malignant neoplasm." | 2.65 | Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease. ( Bartolucci, AA; Durant, JR; Gams, RA; Liu, C, 1983) |
| "Advanced Hodgkin's disease appears to be curable by chemotherapy." | 2.65 | Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. ( Berard, CW; Canellos, GP; Carbone, PP; DeVita, VT; Frei, E; Hubbard, SM; Moxley, JH; Simon, RM; Young, RC, 1980) |
| "Thirty seven Hodgkin's lymphoma patients with recurrence after first remission induced by radiation therapy and/or chemotherapy with mustine, oncovin, procarbazine and prednisolone (MOPP) were randomised to treat with a new combination chemotherapy comprising of doxorubicin, oncovin, procarbazine and prednisolone (DOPP)." | 2.65 | A new combination chemotherapy for recurrent Hodgkin's lymphoma. ( Ahmed, Q; Rahim, MA; Sarma, SK, 1982) |
| "Twenty-one patients with advanced Hodgkin's disease resistant to MOPP (mechlorethamine, vincristine, procarbazine, prednisone) were treated with ABVD (adriamycin, bleomycin, vinblastine, dacarbazine)." | 2.65 | Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD). ( Bonadonna, G; Santoro, A, 1979) |
| "No deaths from Hodgkin's disease have occurred in patients who received combined modality therapy, whereas 24 per cent of the patients who received radiotherapy alone have died with active disease." | 2.65 | Combined modality treatment of Hodgkin's disease confined to lymph nodes. Results eight years later. ( Diggs, C; Gustafson, J; Schimpff, SC; Wiernik, PH, 1979) |
| "117 patients with stage IIIA Hodgkin's disease were randomly allocated for treatment in a multicentre trial comparing the results of total nodal irradiation (T." | 2.64 | Initial treatment of stage IIIA Hodgkin's disease. Comparison of radiotherapy with combined chemotherapy. British National Lymphoma Investigation. ( , 1976) |
| "Thirty-seven patients with advanced Hodgkin's disease have been treated for greater than or equal to 3 months with a protocol consisting of alternate monthly courses of MOPP (mechlorethamine, Oncovin [vincristine], procarbazine, and prednisone) and ABDV (adriamycin, bleomycin, DTIC, and vinblastine) with local radiotherapy (RT) to areas of originally bulky disease." | 2.64 | Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease. ( Case, DC; Clarkson, BD; Lee, BJ; Nisce, L; Young, CW, 1976) |
| "Thirty-four children with Hodgkin's disease were treated during the years 1969--75." | 2.64 | MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children. ( Armata, J; Borkowski, W; Depowska, T; Depowski, M; Kaczor, Z; Stopyrowa, J; Strzeszynski, J, 1978) |
| "Prednisone seems to be an important component of the MOPP combination in the management of stage IV Hodgkin's disease." | 2.64 | Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation. ( , 1975) |
| "204 patients with Hodgkin's disease not previously treated were given vincristine, chlormethine, procarbazine and prednisone (protocol H2-65) for six months, followed by monthly vinblastine injections." | 2.64 | [Polychemotherapy of Hodgkin's disease (author's transl)]. ( Auclerc, G; Bernard, J; Boiron, M; Chastang, CL; Chelloul, N; Delbrück, H; Jacquillat, CL; Weil, M, 1975) |
| "Hodgkin lymphoma is a rare lymphoid malignancy affecting ∼9,200 new patients in the United States annually." | 2.53 | Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond. ( Ansell, SM, 2016) |
| "We discuss the characteristics of breast cancer that occurs after Hodgkin's lymphoma and also treatment options that could be implemented." | 2.44 | Breast cancer after treatment of Hodgkin's lymphoma: general review. ( Alm El-Din, MA; El-Badawy, SA; Taghian, AG, 2008) |
| "Primary treatment of advanced Hodgkin's disease." | 2.43 | [Primary treatment of advanced Hodgkin's disease]. ( Illés, A; Molnár, Z; Udvardy, M, 2005) |
| "We describe a 59-years-old woman with limbic encephalitis, not explained by other causes, preceding diagnosis of Hodgkin's disease." | 2.42 | [Hodgkin's disease manifesting as paraneoplastic limbic encephalitis]. ( Bernard, P; Flocard, F; Kadouri, A; Talarmin, F; Vinzio, S, 2003) |
| "There are two major goals in advanced Hodgkin's disease: (1) to improve the cure rate and (2) to reduce acute and long-term toxicities." | 2.41 | Treatment of advanced stage Hodgkin's disease. ( Diehl, V; Sieber, M; Tesch, H, 2001) |
| "The patients with advanced-stage Hodgkin's disease who did not achieve a complete remission from their initial treatment with combination chemotherapy have a dismal prognosis." | 2.40 | [The management of Hodgkin's disease with chemotherapy or combined modality treatment]. ( Shimoyama, M; Tsushita, K; Utsumi, M, 1998) |
| "80% or more of patients suffering from Hodgkin's lymphoma (HD) of limited stage are cured with modern treatment." | 2.39 | [Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults]. ( Glanzmann, C; Stahel, R, 1995) |
| "Death still occurs in Hodgkin's disease (HD) patients with advanced stages, but also in early stages." | 2.39 | [Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?]. ( Carde, P, 1995) |
| "Malignant lymphoma is classified into the following five major categories: aggressive lymphoma, indolent B-lymphoma, Hodgkin's disease, T-lymphoblastic lymphoma and adult T-cell leukemia-lymphoma (ATL)." | 2.39 | [Recent progress in the chemotherapy of malignant lymphoma]. ( Tobinai, K, 1995) |
| "In most patients with newly diagnosed Hodgkin's disease, initial therapy is curative." | 2.39 | Hodgkin's disease: management of first relapse. ( Horning, SJ; Yuen, AR, 1996) |
| "The association between Hodgkin's disease and pregnancy is rare." | 2.38 | [Hodgkin's disease and pregnancy. 3 case reports and a review of the literature]. ( Abboud, J; Chahine, G; Nasnas, R; Nasrallah, T, 1993) |
| "Thymic hyperplasia was noted after treatment was initiated or completed in all but two patients; and all did well, with one exception: a 17 year-old boy who was inadvertently treated for relapsed Hodgkin disease and who died of fibrinous pneumonitis and nocardia, with pathologic CR noted at autopsy." | 2.38 | Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission. ( Erner, SM; Keller, SM; Langer, CJ, 1992) |
| "The cases of 63 children treated for Hodgkin's disease were retrospectively evaluated according to clinical and laboratory characteristics at initial appearance, clinical and pathologic staging, and treatment for their effects on survival and disease-free survival." | 2.38 | Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota. ( Aeppli, D; Day, DL; Heise, R; Lee, CK; McClain, KL; Woods, WG, 1990) |
| "Treatment of disseminated Hodgkin's disease still fails in about 50 percent of the cases." | 2.38 | [Treatment of relapses and failures in disseminated Hodgkin's disease]. ( Bastion, Y; Coiffier, B; Tigaud, JD, 1991) |
| "A case of Hodgkin's disease associated from the start with visceral leishmaniasis in the absence of antitumoral treatment shows that leishmaniasis is a severe opportunistic infection in endemic areas and can be masked by the tumoral syndrome of an underlying pathology." | 2.38 | [Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties]. ( Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N, 1991) |
| "Cutaneous manifestations of Hodgkin's disease are relatively uncommon." | 2.38 | Hodgkin's disease presenting in the skin: case report and review of the literature. ( Hayes, TG; Rabin, VR; Rosen, T; Zubler, MA, 1990) |
| "Ten patients developed SANLL between the 34th and 123rd month of CR." | 2.38 | Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease. ( Andrieu, JM; Coscas, Y; Fermanian, J; Flandrin, G; Ifrah, N; Payen, C, 1990) |
| "Pulmonary toxicity is a well recognised side effect of anticancer agents particularly bleomycin, cyclophosphamide, methotrexate, and busulphan." | 2.38 | Pulmonary toxicity following MOPP chemotherapy. ( Byrne, MJ; Cohney, SJ; Millward, MJ; Ryan, GF, 1990) |
| "Chemotherapy of malignant lymphomas has accomplished a significant progress during the two decades." | 2.38 | [Current status of chemotherapy in the treatment of malignant lymphomas]. ( Hayashi, K; Kimura, I; Mizuta, J; Murashima, M; Ohnoshi, T; Tada, A; Tagawa, S; Ueno, K, 1989) |
| "The outlook for patients with Hodgkin's disease has improved dramatically over the past 20 years." | 2.37 | Hodgkin's disease. ( Portlock, CS, 1984) |
| "Patients with advanced Hodgkin's disease not achieving a complete remission with initial MOPP therapy are significantly less responsive to adriamycin and nitrosourea-containing regimens than patients with relapsing disease following a complete remission with MOPP." | 2.37 | Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment. ( Coleman, M; Friedlander, RJ, 1988) |
| "Most patients with early-stage Hodgkin's disease can now be cured by one of several therapeutic approaches." | 2.37 | Early-stage Hodgkin's disease: current approaches to treatment. ( MacKenzie, R; Rusthoven, JJ, 1985) |
| "The prognosis of patients with Hodgkin's disease has dramatically improved over the past few decades." | 2.37 | Current management of Hodgkin's disease. ( Behrens, BC; DeVita, VT; Young, RC, 1985) |
| "Classical Hodgkin lymphomas (cHLs) include small numbers of malignant Reed-Sternberg cells within an extensive but ineffective inflammatory/immune cell infiltrate." | 1.43 | PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. ( Advani, RH; Armand, P; Chapuy, B; Connelly, CF; Daadi, SE; de Jong, D; Freeman, GJ; Homer, H; Hoppe, RT; Ligon, AH; Natkunam, Y; Neuberg, DS; Redd, RA; Rodig, SJ; Roemer, MG; Shipp, MA; Sun, HH, 2016) |
| "To quantify the incidence of thyroid cancer after Hodgkin lymphoma (HL) and determine disease characteristics, risk factors, and treatment outcomes." | 1.40 | Thyroid malignancies in survivors of Hodgkin lymphoma. ( Chen, YH; Marcus, KJ; Michaelson, EM; Ng, AK; Silver, B; Stevenson, MA; Tishler, RB, 2014) |
| "Azathioprine was withdrawn." | 1.40 | Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy. ( Khuroo, MS, 2014) |
| "Seventy-five Hodgkin lymphoma and non-Hodgkin lymphoma patients and a control group of 257 fertile men." | 1.40 | Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network. ( Auger, J; Berthaut, I; Brugnon, F; Bujan, L; Daudin, M; Hennebicq, S; Moinard, N; Rives, N; Saias, J; Szerman, E; Walschaerts, M, 2014) |
| "To assess therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS) risk in patients treated for Hodgkin lymphoma (HL) on successive generations of Stanford clinical trials." | 1.39 | Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials. ( Advani, RH; Balise, R; Greenberg, PL; Hoppe, RT; Horning, SJ; Koontz, MZ; Rosenberg, SA, 2013) |
| "Ductal invasive carcinoma and ductal carcinoma in situ represented, respectively, 51 cases (71%) and 14 cases (19%)." | 1.38 | Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option. ( Belin, L; Bollet, MA; Campana, F; Decaudin, D; Fourquet, A; Haberer, S; Kirova, YM; Le Scodan, R; Moisson, P; Pierga, JY; Reyal, F; Savignoni, A; Stevens, D, 2012) |
| "Twelve women (12%) experienced 13 miscarriages after a median of 50 months (range, 13-120) from the end of therapy." | 1.38 | Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma. ( Alfò, M; Annechini, G; Cavalieri, E; De Sanctis, V; Enrici, RM; Filippone, FR; Minniti, G; Muni, R; Osti, MF; Pulsoni, A; Valeriani, M, 2012) |
| " Prospective pharmacokinetic studies to devise a rational dosing strategy for vinblastine in patients receiving ritonavir/lopinavir are warranted." | 1.38 | Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma. ( Boro, J; Cheung, MC; Ezzat, HM; Harris, M; Hicks, LK; Leitch, HA; Lima, VD; Montaner, JS, 2012) |
| "The majority of patients with Hodgkin's disease can be cured by combination of polychemotherapy and radiotherapy (RT) that can produce late toxic pulmonary and cardiac effects which often remain at a subclinical level." | 1.36 | Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease. ( Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S, 2010) |
| "The behavior of Hodgkin's lymphoma (HL) is different in developing countries, perhaps due to differences in epidemiology and population access to health care." | 1.35 | Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. ( Alves, AC; Baiocchi, OC; Oliveira, JS; Souza, EM; Zanichelli, MA, 2009) |
| " Since survival rates for patients receiving risk-adapted programs (DAL-Hd, SPBLKH-05) were higher than in control (MOPP), relevant protocols using lower drug dosage should be recommended in groups of favorable and intermediate risk." | 1.35 | [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents]. ( Kuleva, SA, 2008) |
| "Therefore, 126 patients suffering from Hodgkin's disease were investigated after a follow-up of at least 5 years from the completion of the combined treatment." | 1.35 | Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease. ( Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S, 2009) |
| "Relative risks (RRs) of stomach cancer and the radiation-related excess relative risk (ERR) per gray were calculated by conditional logistic regression analysis." | 1.35 | Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. ( Aleman, BM; Besseling, G; de Bruin, ML; de Wit, R; Gietema, JA; Hauptmann, M; Kerst, JM; Noordijk, EM; Ribot, JG; van 't Veer, MB; van den Belt-Dusebout, AW; van Leeuwen, FE, 2009) |
| " It is suggested that total focal dosage used after chemotherapy be reviewed since total dosage for the entire lymph collector in excess of 30 Gy might contribute to hazards of cardiopathology." | 1.35 | [Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma]. ( Bozhenko, VK; Datsenko, PV; Ivashin, AV; Mel'nik, IuD; Pan'shin, GA; Podol'skiĭ, PN; Sotnikov, VM, 2009) |
| "The treatment results of our Hodgkin's disease patients improved, additionally we showed that patients with early stage favourable disease the treatment toxicity should be reduced, while patients with advanced, unfavourable prognosis (10% of all patients) aggressive primary treatment should be used even with more severe side effects and complications." | 1.34 | [Our experiences in treating patients with Hodgkin disease in the last decade]. ( Gergely, L; Illés, A; Keresztes, K; Miltényi, Z; Ress, Z; Simon, Z; Vadász, G; Váróczy, L, 2007) |
| "Hodgkin lymphoma is considered a common type of non-AIDS defining tumor among patients infected with HIV, commonly presenting as a widespread disease and with different pathologic features compared with Hodgkin lymphoma in the general population." | 1.34 | Hodgkin lymphoma among patients infected with HIV in post-HAART era. ( Buccheri, V; Calore, EE; Chamone, DA; Pessoa, VP; Pracchia, LF; Tanaka, PY, 2007) |
| "The treatment strategies of Hodgkin's lymphoma (HL) are different according to clinical stage and risk factors, yet the optimal treatment strategy remains unclear." | 1.34 | [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. ( Hu, DS; Hu, S; Song, QB; Tan, WY; Wei, L; Zeng, FY; Zhou, LQ, 2007) |
| "Of the 13 cases, 5 were Hodgkin's disease (HD), and 8 were non-Hodgkin's lymphoma (NHL)." | 1.33 | [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma]. ( Ling, JY; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ, 2006) |
| "Actuarial risk of second malignancy for adolescents and adults was not different (P = ." | 1.33 | Hodgkin's lymphoma in adolescents. ( Connors, JM; Foltz, LM; Song, KW, 2006) |
| "Of 6 patients who developed recurrence, 3 (7." | 1.33 | [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. ( Han, JZ; Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Wang, SL; Wang, WH; Yu, ZH; Zhou, LQ, 2006) |
| "Currently, 60% patients with advanced Hodgkin's lymphoma could be cured by receiving standard treatments." | 1.33 | [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. ( Fu, XH; Huang, HQ; Huang, Y; Lin, TY; Sun, XF; Wang, B; Wang, SS; Xu, RH; Zhang, L, 2006) |
| "In patients with advanced Hodgkin's disease, consolidation RT improved survival." | 1.32 | Analysis of treatment results in advanced Hodgkin's disease: the case for adjuvant radiotherapy. ( Dyduch, M; Korzeniowski, S; Skolyszewski, J; Sokolowski, A, 2003) |
| "To collect second cancers in patients treated for Hodgkin disease (HD) during adolescence and young adulthood at Salah Azaïz Institute of Tunis." | 1.32 | [Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz]. ( Belhaj Ali, Z; Benna, F; Besbes, M; Bouaouina, N; Boussen, H; Gammoudi, A; Ghilen, L; Kochbati, L; Maalej, M; Rahal, K, 2003) |
| "Children treated for Hodgkin disease are at risk for gonadal damage." | 1.32 | Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. ( Behrendt, H; Furstner, F; van den Berg, H; van den Bos, C, 2004) |
| "One Stage IV patient has died with Hodgkin's disease 28 months after treatment with combination therapy." | 1.32 | Pediatric Hodgkin's disease. ( Bertolone, S; Koerner, P; Oliapuram Jose, B; Paris, KJ; Patel, CC; Silverman, CL; Spanos, WJ; Yashar, CM, 2004) |
| "We followed-up 33 patients with non-Hodgkin's lymphoma or with Hodgkin's disease during the years 1987-1997 who were referred for semen cryopreservation." | 1.31 | Follow-up of sperm concentration and motility in patients with lymphoma. ( Botchan, A; Hauser, R; Paz, G; Tal, R; Yavetz, H; Yogev, L, 2000) |
| "We transplanted 42 patients with Hodgkin's disease between 1990-1998." | 1.31 | [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer]. ( Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O, 2000) |
| "Risk of lung cancer was borderline significantly greater in patients treated with mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy than those who did not receive this treatment (relative risk [RR] = 1." | 1.31 | Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. ( Allerton, R; Barber, JA; Cunningham, D; Horwich, A; Linch, DC; Lister, TA; Rohatiner, AZ; Schoemaker, MJ; Swerdlow, AJ; Vaughan Hudson, G; Williams, MV, 2001) |
| "Today, 80% of patients with advanced Hodgkin's disease may be cured, with low rate of long-term toxicity." | 1.31 | [The chemotherapeutic treatment of advanced Hodgkin's disease]. ( Ben-Arie, Y; Ben-Shahar, M; Cohen, Y; Epelbaum, R; Faraggi, D; Haim, N; Sharabi-Nov, A; Valtuch, I, 2001) |
| "There were no deaths from Hodgkin's disease." | 1.31 | Subdiaphragmatic Hodgkin's disease: the University of Florida experience. ( Colgan, ME; Hull, MC; Mendenhall, NP, 2002) |
| "A total of 128 patients with advanced Hodgkin's disease was included in this study." | 1.31 | [Treatment of advanced Hodgkin's disease: an analysis of 128 cases]. ( Feng, F; Wang, Q; Zhou, L, 2000) |
| "Procarbazine is a chemotherapy methylating agent that has been used in combination with other drugs, perhaps most successfully in the treatment of Hodgkin's disease." | 1.31 | Pulmonary toxicity secondary to procarbazine. ( Mahmood, T; Mudad, R, 2002) |
| "Concerning ANLL, the MOPP regimen was significantly associated with a higher risk: 3." | 1.31 | Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation. ( Andrieu, JM; Colonna, P; Delwail, V; Jais, JP, 2002) |
| "The relative risk of second cancers overall was 27." | 1.30 | Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. ( Barber, JA; Cunningham, D; Horwich, A; Milan, S; Omar, RZ; Swerdlow, AJ, 1997) |
| "Patients treated for Hodgkin's disease and non-Hodgkin lymphomas were followed for 5 years after start of therapy." | 1.30 | Five-year follow-up of saliva in patients treated for lymphomas. ( Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L, 1997) |
| "Sixteen patients with Hodgkin's disease were treated with MOPP/ABVD and filgrastim support between January 1992 and March 1994." | 1.30 | G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease. ( Gustavsson, A, 1997) |
| "In this series, risk factors for second cancer were age >/=40 years (RR = 3." | 1.30 | Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. ( André, M; Attal, M; Bastion, Y; Blaise, D; Cahn, JY; Colombat, P; Fermé, C; Fleury, J; Gisselbrecht, C; Henry-Amar, M; Kuentz, M; Milpied, N; Nedellec, G; Pico, JL, 1998) |
| "Patients treated with radiotherapy for Hodgkin's disease have a considerable risk for a second cancer in long-term follow-up." | 1.30 | Second cancer among long-term survivors from Hodgkin's disease. ( Joensuu, H; Muhonen, T; Nyandoto, P, 1998) |
| "Risk of leukemia was 0." | 1.30 | The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con ( Anselmo, AP; Baroni, CD; Bernasconi, C; Brusamolino, E; Klersy, C; Lazzarino, M; Lunghi, F; Mandelli, F; Maurizi-Enrici, R; Orlandi, E; Pagnucco, G; Santoro, M, 1998) |
| "Hodgkin's disease was diagnosed in a 12-year old boy and a 2-year old his sister whose mother had been treated with repeated cycles of nitrogen mustard for optic neuritis." | 1.30 | [Hodgkin's disease in two children of mother treated with nitrogranulogen]. ( Armata, J; Balwierz, W; Eliasińska, A; Moryl-Bujakowska, A; Tacik, J, 1998) |
| "The nephrotic syndrome is a rare complication of Hodgkin's disease." | 1.30 | [Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome]. ( Baron, F; Beguin, Y; Fassotte, MF; Fillet, G; Hermanne, JP, 1998) |
| "Hodgkin's disease is curable in the majority of patients, although a proportion of patients are resistant to or relapse after initial therapy." | 1.30 | High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. ( Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D, 1999) |
| "Optimal treatment for Hodgkin's disease during childhood is unknown." | 1.30 | Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy. ( Farah, RA; Geara, F; Hajjar, T; Khogali, M; Muwakkit, S; Nabbout, B; Shabb, NS, 1999) |
| "28 patients suffering from advanced Hodgkin's disease were treated according to protocol containing 7 cytostatic drugs including methotrexate and corticosteroids, but not cyclophosphamide, chlormethine or procarbazine." | 1.29 | [Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate]. ( Gabryś, K; Kotlarek-Haus, S; Potoczek, S, 1995) |
| "Management of Hodgkin's disease (HD) and large mediastinal adenopathy (LMA) usually includes intensive chemotherapy (CT) with or without radiation therapy (XT) regardless of stage." | 1.29 | Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches. ( Allen, PK; Besa, P; Cabanillas, F; Cox, JD; Hagemeister, FB; McLaughlin, P; Preti, A; Rodriguez, A; Swan, F, 1994) |
| "In patients with advanced Hodgkin's disease (HD), the alternation of MOPP with ABVD or hybrid MOPP/ABVD are associated with a high CR rate and a high probability of 5-year survival." | 1.29 | Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease. ( Aversa, S; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Mazzarotto, R; Pappagallo, GL; Salvagno, L; Scarzello, G; Sorarù, M; Sotti, G, 1995) |
| "We report a 54-year-old patient with Hodgkin's disease who achieved a complete remission after combined modality treatment." | 1.29 | Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease. ( Bendandi, M; Cantagalli, F; Macchi, S; Mancino, A; Simoncelli, F; Stefanati, V; Tura, S; Visani, G; Zaccaria, A; Zinzani, PL, 1995) |
| "Treatment of Hodgkin's disease resulted in complete remission and complete disappearance of the pontine abnormality." | 1.29 | Hodgkin's disease associated with central pontine myelinolysis. ( Carrol, CL; Chintagumpala, MM; Dreyer, ZE; Fishman, MA; Mahoney, DH; McClain, K; Steuber, CP, 1993) |
| "Between 1980 and 1988, 48 patients with Hodgkin's disease who had large mediastinal masses were treated at Stanford University." | 1.29 | Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy. ( Behar, RA; Hoppe, RT; Horning, SJ, 1993) |
| "The occurrence of HIV associated non-Hodgkin's lymphoma (NHL) is a well recognized event." | 1.29 | Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient. ( Brody, J; Goh, JC; Kaplan, MH; Koduru, P; Lichtman, SM; Susin, M, 1993) |
| "60 cases of Hodgkin's lymphoma were treated with combined chemotherapy and radiotherapy." | 1.29 | [Effectiveness of chemotherapy and radiotherapy in 60 cases of Hodgkin's lymphoma]. ( Wang, H; Yong, WB; Zhu, XM, 1993) |
| "Patients with Hodgkin's disease whose initial complete remissions (CR) after primary chemotherapy were longer than 1 year are thought to have better prognoses than patients whose initial remissions were shorter than 1 year." | 1.29 | Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy. ( Aversa, SM; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Pappagallo, GL; Salvagno, L; Sorarù, M, 1993) |
| "A past history of treated Hodgkin disease is a factor of risk for breast cancer and suggests the need for annual mammography screening 10 years after the end of treatment." | 1.29 | [Breast cancer after treatment of Hodgkin's disease]. ( Blanchot, J; Dugast, J; Grall, JY; Le Prise, E; Levêque, J; Meunier, B; Poulain, P, 1995) |
| "A case of Hodgkin's disease with isolated cerebral relapse is reported here." | 1.29 | Meningioma-like cerebral relapse of Hodgkin's disease. ( Catarini, M; Discepoli, G; Leoni, P; Montillo, M; Rychlicki, F; Scarpelli, M, 1994) |
| "Thirteen patients have died of their second malignancy, including two of a third malignancy, while four have been followed for less than one year." | 1.29 | Second malignant neoplasms in patients with Hodgkin's disease. ( Atkinson, CH; Colls, BM; Fitzharris, BM; Robinson, BA, 1994) |
| "The risk of second cancer was analyzed (1) relative to the general population and (2) between risk subgroups using the Cox proportional hazards model." | 1.29 | Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? ( Bodis, S; Bosq, J; Cosset, JM; Dietrich, PY; Hayat, M; Henry-Amar, M, 1994) |
| " Comparison of the dose-response relationships for humans and rats indicates that, under conditions of no depletion of O6-alkylguanine-DNA alkyltransferase (AGT), O6-meG accumulates in blood leukocyte DNA of humans at a rate which is only approximately 2-fold lower than in rats, implying that, to the extent to which O6-meG contributes to the genotoxic activity of procarbazine, human susceptibility to it is likely to be comparable to that of the rat." | 1.29 | Comparative dosimetry of O6-methylguanine in humans and rodents treated with procarbazine. ( Boussiotis, VA; Kyrtopoulos, SA; Pangalis, GA; Souliotis, VL; Valavanis, C, 1994) |
| "Two cases of malignant schwannoma are reported 13 and 15 years following combined modality treatment for Hodgkin's disease." | 1.29 | Malignant schwannoma following treatment for Hodgkin's disease. ( Bridges, LR; Cartwright, SC; Dodwell, DJ; Fisher, PM; Stone, J, 1994) |
| "The association of Hodgkin's disease and minimal-change nephrotic syndrome is well established." | 1.29 | The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease. ( Delmez, JA; Kissane, JM; Safdar, SH, 1994) |
| "Cardiotoxicity is a well recognized side effect of anthracyclines (doxorubicin and epirubicin) or antracenadiones (mitoxantrone) at cumulative or high doses." | 1.29 | Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults. ( Arévila, N; Avilés, A; Díaz Maqueo, JC; García, R; Gómez, T; Nambo, MJ, 1993) |
| "Two patients developed breast cancer 14 and 8 years after treatment of Hodgkin's disease." | 1.29 | Breast cancer developing after therapy for Hodgkin's disease. ( Cascinu, S; Catalano, G; Fedeli, A, 1993) |
| "Following irradiation alone, secondary acute nonlymphocytic leukemia (ANLL) is uncommon; following chemotherapy alone, the risk is increased, but not as much as when combined modality treatments are used." | 1.29 | Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. ( Brusamolino, E; Fiacchini, M; Gobbi, PG; Tura, S; Zinzani, PL, 1993) |
| "More than 50% of patients with non Hodgkin's lymphomas (NHL) are long-term survivors." | 1.29 | [Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993]. ( Auger, J; Bendahmane, B; Decaudin, D; Koscielny, S; Munck, JN; Naccache, P, 1996) |
| "Cholestasis was observed in all cases; in most patients a moderate increase in the transaminase activity was also seen." | 1.29 | Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients. ( Briones, J; Bruguera, M; Cervantes, F; Font, C; Grau, JM; Montserrat, E; Rozman, C, 1996) |
| "Results of recent trials in Hodgkin's disease suggest that the cure rates which increased considerably between 1960 and 1980 have reached a plateau." | 1.28 | The Second International Symposium on Hodgkin's Disease. Workshop III: Recommendations for future clinical trials. ( Diehl, V; Hasenclever, D; Lathan, B; Löffler, M; Pfreundschuh, M; Rüffer, U, 1992) |
| "Four patients with fresh Hodgkin's disease were treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride (NH2-O)." | 1.28 | [Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride]. ( Kodo, H; Kozai, Y; Ohyama, T; Tomori, G, 1992) |
| "We report about two cases of cancer of the testis occurring 2 and 7 years after Hodgkin's disease treated with combined chemotherapy and radiation therapy." | 1.28 | [Cancer of the testis after Hodgkin's disease. Apropos of 2 cases]. ( Averous, M; Chevallier, P; Grasset, D; Guiter, J; Iborra, F; Lavabre-Bertrand, T; Rebillard, X; Robert, M, 1992) |
| "2) Non-Hodgkin's lymphoma has not appeared in any of the patients in this series." | 1.28 | [Second neoplasms as a late complication of the treatment of Hodgkin's disease]. ( Alvarez, A; Colomé, JA; del Potro, E; Díaz Mediavilla, J; González, FA; Martínez, R; Morales, MD; Villegas, A, 1992) |
| "Systemic symptoms of Hodgkin's disease were present for 6 months, and rapidly developing patchy hair loss of the scalp was present for 2 weeks prior to presentation." | 1.28 | Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy. ( Berk, MA; Chan, PD; Kucuk, O; Singh, S, 1992) |
| "20 untreated Hodgkin's disease patients and 1 patient relapsing after radiotherapy (17 stage IIB-IV and 4 stage I-IIA) were given doxorubicin, bleomycin, etoposide and prednisone on a 21-day cycle." | 1.28 | ABEP as primary chemotherapy for Hodgkin's disease. ( Alberto, P; Mermillod, B; Zulian, GB, 1992) |
| "2846 patients first treated for Hodgkin's disease during 1970-87, for whom follow up was complete in 99." | 1.28 | Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. ( Bennett, MH; Douglas, AJ; Hudson, BV; Hudson, GV; MacLennan, KA; Swerdlow, AJ, 1992) |
| "Group two included Hodgkin's disease patients who were treated 12-24 years previously and have been continuously free of disease." | 1.28 | The frequency of translocations after treatment for Hodgkin's disease. ( Brown, JM; Evans, JW; Mori, M; Smith, LM, 1992) |
| "In three patients with advanced Hodgkin's disease treated with combination chemotherapy (MOPP) incorporating vincristine, and receiving at the same time a fixed daily dose of 8000 U of rHu-EPO subcutaneously for 10 to 15 days because of myelosuppressive anemia, myeloaspirates were performed one week before and 24 hours after the administration of vincristine." | 1.28 | Selective metaphasic arrest of erythroblasts by vincristine in patients receiving high doses of recombinant human erythropoietin for myelosuppressive anemia. ( Marmont, AM, 1992) |
| " All other disease stages will require a different strategy that should consist of radiotherapy combined with short-term effective regimens, such as ABVD (doxorubicin, bleomycin, vinblastine and decarbazine) or VBM (vinblastine, bleomycin and methotrexate) to reduce the incidence of MOPP-associated gonadal dysfunction and leukaemogenesis." | 1.28 | Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP. ( Banfi, A; Bonadonna, G; Bonfante, V; Devizzi, L; Santoro, A; Tesoro Tess, JD; Valagussa, P; Viviani, S; Zanini, M; Zucali, R, 1992) |
| "The frequency of chromosome aberrations in the peripheral blood of patients successfully treated for Hodgkin's disease (HD) and non-Hodgkin's lymphoma is compared with that seen in age-matched haematologically normal subjects." | 1.28 | Chromosome aberrations following cytotoxic therapy in patients in complete remission from lymphoma. ( Clark, RE; Jacobs, A; Jones, BM; White, AD, 1992) |
| " In a multivariate analysis where both disease-related and treatment-related factors were taken into account drug dosage remained a significant prognostic factor." | 1.28 | Treatment of Hodgkin's disease with MOPP chemotherapy: effect of dose and schedule modification on treatment outcome. ( Bezwoda, MA; Bezwoda, WR; Dansey, R, 1990) |
| "Three patients with Stage III or IVB Hodgkin's disease were cured with MOPP (regimen of nitrogen mustard, Oncovin, prednisone, and procarbazine) and/or B-DOPA (regimen of bleomycin, dacarbazine, Oncovin, prednisone, and Adriamycin)." | 1.28 | Secondary uncommon solid neoplasms in cured Hodgkin's disease and follow-up of the original B-DOPA chemotherapy patient group. ( Lokich, JJ, 1990) |
| "Forty-nine patients with Hodgkin's disease who relapsed after a first complete remission of more than 12 months following primary chemotherapy were treated with salvage therapy regimens." | 1.28 | Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. ( Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S, 1990) |
| "Reports on salvage treatments for Hodgkin's disease in first relapse after primary chemotherapy should include data on the proportion of patients having stage IV disease at diagnosis, B symptoms at relapse, and a time from primary treatment to relapse of less than 1 year." | 1.28 | Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988. ( Barnett, M; Connors, JM; Fairey, RN; Lohri, A; O'Reilly, SE; Phillips, GL; Reece, D; Voss, N, 1991) |
| "Sixty-three cases of Hodgkin's disease in intravenous drug users (IVDUs) have been collected by the Italian Cooperative Group on AIDS-Related Tumors (GICAT)." | 1.28 | Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT). ( Foà, R; Gavosto, F; Monfardini, S; Tirelli, U; Vaccher, E, 1991) |
| "Twenty four patients diagnosed with Hodgkin's disease were introduced to our studies." | 1.28 | Serum antithrombin III and alpha-2-antiplasmin concentrations in patients with Hodgkin's disease in the course of chemotherapy. ( Dabrowska, M; Kemona, H; Kiluk, S; Kretowska, J; Prokopowicz, J, 1991) |
| "While current medical therapies for Hodgkin's disease are usually quite effective, it has become increasingly clear that some of the therapies utilized carry an inherent risk for the induction of secondary malignancies." | 1.28 | In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients. ( Caggana, M; Coleman, CN; Kelsey, KT; Liber, HL; Mauch, PM, 1991) |
| "Sixty-two patients with advanced-stage Hodgkin's disease and a median age of 12 years (range, 3 to 22 years) were treated with four cycles of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) alternating with four cycles of doxorubicin, vinblastine, bleomycin, and dacarbazine (ABVD) followed by low-dose radiotherapy (RT)." | 1.28 | Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. ( Behm, FG; Brecher, M; Cantor, A; Chauvenet, A; Leventhal, BG; Marcus, R; Ternberg, J; Weiner, MA; Wharam, M, 1991) |
| "We report preliminary results of treatment of Hodgkin disease according to the National Protocol on Antineoplastic Drugs." | 1.28 | [Treatment of Hodgkin's disease. National Protocol of Antineoplastic Drugs: preliminary report]. ( Cao, C; García, H; Gutiérrez, J; Osorio, G; Vacarezza, R, 1991) |
| "The peak incidence of Hodgkin's disease occurs during the reproductive age, and its association with pregnancy is at a rate of between 1:1,000-1:6,000." | 1.28 | Maternal and foetal outcome following Hodgkin's disease in pregnancy. ( Degendorfer, P; Koren, G; Lishner, M; Panzarella, T; Sutcliffe, SB; Zemlickis, D, 1992) |
| "The patient remains free of Hodgkin's disease 34 months after completion of chemotherapy." | 1.28 | Transient reversal of bone marrow aplasia associated with lymphocyte depleted Hodgkin's disease after combination chemotherapy. ( Connaghan, DG; Johnston, PG; Longo, DL; Ruscetti, FW; Sullivan, FJ, 1991) |
| "Radiation pneumonitis was seen in 3% of patients receiving radiation therapy alone." | 1.28 | Thoracic irradiation in Hodgkin's disease: disease control and long-term complications. ( Mauch, P; Tarbell, NJ; Thompson, L, 1990) |
| "The progeny of patients treated for Hodgkin's disease appear normal and no excess fetal wastage has been noted." | 1.28 | Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. ( Donaldson, SS; Ortin, TT; Shostak, CA, 1990) |
| "A patient with advanced Hodgkin's disease being treated with MOPP chemotherapy presented with delayed life-threatening pulmonary toxicity secondary to procarbazine." | 1.28 | Delayed life-threatening pneumonitis secondary to procarbazine. ( Alvarez, S; Ancalmo, N; Brooks, BJ; Grinton, SF; Hendler, NB, 1990) |
| " There were three fatal toxic events, two due to viral infection and one to a second malignant tumor (NHL)." | 1.28 | Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity. ( Berry, M; Blanchette, V; Chan, H; Doherty, M; Doyle, J; Freedman, M; Greenberg, M; Jenkin, D; Panzarella, T; Saunders, F, 1990) |
| "Since pediatric Hodgkin's disease is a curable malignancy, it is essential to limit treatment sequelae." | 1.28 | Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. ( Donaldson, SS; Link, MP; Mefferd, JM, 1989) |
| "Eight patients with refractory Hodgkin's disease received intensive combination chemotherapy conditioning with cyclophosphamide, carmustine (BCNU), and etoposide (VP 16-213), and allogeneic marrow transplants." | 1.28 | Allogeneic marrow transplantation for refractory Hodgkin's disease. ( Barnett, MJ; Connors, JM; Fay, JW; Herzig, GP; Herzig, RH; Klingemann, HG; Phillips, GL; Reece, DE; Shepherd, JD; Wolff, SN, 1989) |
| "Seventeen patients with advanced stage Hodgkin's disease who relapsed or failed to respond to multiple regimens of combination chemotherapy (mostly Mechlorethamine, Vincristine, Procarbarzine, Prednisone and Adriamycin, Bleomycin, Vinblastine, Dacarbazine) were treated with accelerated hyperfractionated total lymphoid irradiation (TLI) and high-dose chemotherapy followed by autologous bone marrow transplantation (AuBMT)." | 1.28 | Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease. ( Clarkson, B; Fuks, Z; Gulati, S; Shank, B; Yahalom, J, 1989) |
| "Neoadjuvant chemotherapy in Hodgkin's disease has improved survival time and tolerance to irradiation, allowing a lowering of the total doses used and the volumes irradiated." | 1.28 | [Radiotherapy with neoadjuvant chemotherapy]. ( Alapetite, C; Baillet, F; Dessard-Diana, B; Housset, M; Jacquillat, C; Michel-Langlet, P, 1989) |
| "A 58-year-old man with Hodgkin's disease exhibited erythrodermia due to allergic reaction to vincristine sulfate (VCR) and vindesine sulfate (VDS)." | 1.28 | [A case of Hodgkin's disease exhibiting erythrodermia probably due to allergic reaction to vinca alkaloids]. ( Kosaka, M; Matsumoto, N; Okagawa, K; Saito, S; Yoshimoto, K, 1989) |
| "Hence a diagnosis of Hodgkin's disease (HD) stage IVB was made." | 1.28 | [Hodgkin's disease diagnosed from the numerous Reed-Sternberg cells in the bone marrow]. ( Abe, T; Hasegawa, Y; Mori, N; Nakazawa, M; Noguchi, Y; Yoda, Y, 1989) |
| " The predictive value of mechlorethamine dosage with regard to OS was retained in an analysis restricted to the patients receiving greater than or equal to six cycles of chemotherapy." | 1.28 | Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease. ( de Meijer, AJ; Dekker, AW; Haanen, C; van Rijswijk, RE; Verbeek, J, 1989) |
| "At Kanazawa University 28 patients with Hodgkin's disease were treated between 1975 and 1988." | 1.28 | [Hodgkin's disease]. ( Nakamura, S; Ohtake, S, 1989) |
| "Fifty-three patients with advanced Hodgkin's disease, most of them previously treated, received 8 to 16 courses of modified MOPP regimens (nitrogen mustard replaced by trichlormethine in arm A, with addition of vinblastine to the 4-drug regimen in arm B, and alternation of three drugs--trichlormethine, vincristine, and prednisone--with probably non-cross resistant two drugs--vinblastine and procarbazine in arm C)." | 1.28 | Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation. ( Bohunický, L; Cerný, V; Gyárfás, J; Koza, I; Mardiak, J; Svancárová, L, 1989) |
| "Between 1979 and 1987, 28 children with Hodgkin's disease were treated with MOPP (nitrogen mustard, Oncovin, prednisone, procarbazine) combination chemotherapy without radiotherapy." | 1.28 | MOPP therapy in children with Hodgkin's disease. ( Madanat, FF, 1989) |
| "A patient with hypogonadotropic hypogonadism owing to endogenous gonadotropin releasing hormone deficiency, who developed Hodgkin's disease is described." | 1.28 | Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases? ( Nikolaou, N; Orfanos, S; Pavlidis, N; Tolis, C; Tolis, G, 1989) |
| "Hodgkin's disease is one of the most curable cancers thanks to progress in radiotherapy and multi-drug chemotherapy regimens such as mechloretamine-vincristine-procarbazine-prednisone, best known as MOPP." | 1.28 | Ten-year nodular sclerosis Hodgkin's disease and second malignancies. ( Mirimanoff, RO; Zulian, GB, 1989) |
| "Four patients with Hodgkin's disease and bone marrow fibrosis are presented in whom the clinical presentation was dominated by cytopenias; this was associated with a delayed diagnosis for an average of 20 months." | 1.28 | Hodgkin's disease presenting as myelofibrosis. ( Crawford, J; Kaufman, RE; Laszlo, J; Meadows, LM; Moore, JO; Rosse, WR, 1989) |
| "Skin involvement with Hodgkin's disease is rare." | 1.28 | Cutaneous Hodgkin's disease in a patient with human immunodeficiency virus infection. ( Jacobs, SR; Shaw, MT, 1989) |
| "The Hodgkin's disease was insensitive to conventional MOPP chemotherapy in two of two, and was sensitive to combined MOPP-Bleomycin in one patient." | 1.27 | Hodgkin's disease in renal transplant recipients. ( Doyle, TJ; Maeda, K; Saeed, SM; Tilchen, EJ; Venkatachalam, KK, 1983) |
| "Fourteen patients with Hodgkin's disease resistant to ABVD were treated with MOPP chemotherapy (nitrogen mustard, vincristine, procarbazine, prednisone)." | 1.27 | MOPP treatment of resistant Hodgkin's disease following ABVD failure. ( Anselmo, AP; Cimino, G; Mandelli, F; Marzullo, A; Maurizi Enrici, R; Mauro, F; Papa, G, 1983) |
| "Bone and soft tissue sarcomas have rarely been observed after treatment of Hodgkin's disease, and only a few cases are described in the literature." | 1.27 | Bone and soft tissue sarcomas in the follow-up of Hodgkin's disease. ( Banfi, A; Zanini, M; Zucali, R, 1983) |
| "Although most patients with Hodgkin's disease refractory to MOPP treatment will respond to either ABVD or B-CAVe chemotherapy, subsequent long-term disease-free survival is unusual." | 1.27 | Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. ( Harker, WG; Kushlan, P; Rosenberg, SA, 1984) |
| "Twenty-seven children with Hodgkin's disease were treated with MVOPP (mustine, Velban [vinblastine], Oncovin [vincristine], procarbazine, prednisone) combination chemotherapy." | 1.27 | Hodgkin's disease in children. A ten-year experience in South Africa. ( Hartley, P; Jacobs, P; Karabus, C; King, HS; Werner, D, 1984) |
| "The example of Hodgkin's lymphoma staging and treatment selection is used." | 1.27 | A decision-analysis methodology for consideration of morbidity factors in clinical decision-making. ( Corder, MP; Ellwein, LB, 1984) |
| "The patients would have symptomatic Hodgkin's lymphoma." | 1.27 | Comparison of treatments for symptomatic Hodgkin's lymphoma employing decision analysis. ( Corder, MP; Ellwein, LB, 1984) |
| "Thirty-four subsequent second malignant neoplasms were observed in 33 patients among those treated for Hodgkin's disease." | 1.27 | Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. ( DeVita, VT; Glatstein, E; Kelley, PA; Kinsella, TJ; Makuch, RW; Tester, WJ; Waller, B, 1984) |
| "A patient suffering from Hodgkin's disease exhibiting acute allergic reaction to vincristine sulfate with mild to moderate dermatologic and cardiovascular signs is described." | 1.27 | Acute allergic reaction due to vincristine sulfate. A case report. ( Gassel, WD; Gropp, C; Havemann, K, 1984) |
| "This case of optic neuropathy is supposed to be a rare example of involvement of the 2nd cranial nerve due to vinca alkaloids." | 1.27 | Transient optic neuropathy secondary to MOPP chemotherapy in Hodgkin's disease: report of a case. ( Guidelli Guidi, S; Maccolini, E; Oddo Bravetti, G; Serra, L; Vecchi, V, 1984) |
| "Appropriate management of Hodgkin's disease is based on both the stage of disease and the specific anatomic sites of involvement within each stage." | 1.27 | Diagnosis and management of Hodgkin's disease in the adult. ( Fuller, LM; Hagemeister, FB, 1983) |
| "Hodgkin disease was confirmed histologically in three, and confirmed by electron microscopy in two." | 1.27 | Simultaneous occurrence of mycosis fungoides and Hodgkin disease: clinical and histologic correlations in three cases with ultrastructural studies in two. ( Amorosi, EL; Hawkins, KA; Ramsey, D; Schinella, R; Schwartz, M; Silber, R; Weintraub, AH, 1983) |
| "In 164 patients with Hodgkin's disease staged between 1973 and 1979 the response to the 3 initial cycles of multiagent chemotherapy was evaluated as a prognosticator of survival." | 1.27 | Early response to chemotherapy as a prognostic factor in Hodgkin's disease. ( Bierling, P; Brun, B; Dreyfus, B; Farcet, JP; Imbert, M; Kuentz, M; Le Bezu, M; Lebourgeois, JP; Reyes, F; Rochant, H; Vernant, JP, 1983) |
| "Patients who had a relapse of Hodgkin's disease did not have an increased incidence of second malignancy." | 1.27 | Second malignancy complicating Hodgkin's disease. ( Mercier, JP; Tawil, E, 1983) |
| "Of 157 patients with Hodgkin's disease treated between 1970 and 1981 an assessment of the clinical course was possible in 134 cases." | 1.27 | [Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)]. ( Denz, H; Huber, H; Lechleitner, M; Peer, L; Peschel, C, 1983) |
| "The rate of recurrence formation was found to be in a significant correlation with general symptoms, age, size of the largest cluster of involved lymph nodes, combination of drugs and type of consolidating therapy." | 1.27 | [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy]. ( Kharatishvili, ZV; Kolygin, BA, 1983) |
| "A patient with primary Hodgkin's disease of the lung is described." | 1.27 | Primary Hodgkin's disease of the lung. Case report and review of the literature. ( Czembirek, H; Homan, R; Lechner, K; Moritz, H; Neumann, E; Resch, F, 1983) |
| "There was no significant difference in recurrence rates between patients without mediastinal mass and patients with a small mass, and in these patients adjuvant chemotherapy MOPP after radiotherapy showed an evident benefit in reducing the relapse rate." | 1.27 | Prognostic significance of large mediastinal involvement in Hodgkin's disease. ( Baccarani, M; Cantore, M; Dominici, G; Emiliani, E; Faedi, M; Fiacchini, M; Frezza, G; Lauria, F; Mazza, P; Sciascia, R, 1983) |
| "A dose-response analysis of the results of MOPP chemotherapy in 132 patients with Hodgkin's disease was carried out." | 1.27 | A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy. ( Carde, P; MacKintosh, FR; Rosenberg, SA, 1983) |
| "Six patients with Hodgkin's disease who failed MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy, with recurrences confined to lymph node areas, are reported." | 1.27 | Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy. ( Baldwin, PE; Diehl, LF; Dorn, RV; Hurwitz, M; Kimball, DB; Perry, DJ; Terebelo, H, 1983) |
| "Seventy patients with advanced Hodgkin's disease, 54 with new disease, and 16 in first relapse after initial radiotherapy, have been treated with a seven-drug, 8-month program: MOPP (nitrogen mustard, vincristine, procarbazine, prednisone)/ABV (Adriamycin [Adria Laboratories of Canada, Mississauga, Ontario], bleomycin, vinblastine) hybrid." | 1.27 | MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease. ( Connors, JM; Klimo, P, 1985) |
| "Eight patients with disseminated Hodgkin's disease resistant to MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) chemotherapy were treated with high-dose chemoradiotherapy and marrow transplantation from an HLA-identical sibling." | 1.27 | Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease. ( Appelbaum, FR; Buckner, CD; Clift, RA; Deeg, HJ; Neiman, PE; Sanders, JE; Stewart, P; Storb, R; Sullivan, KM; Thomas, ED, 1985) |
| "A strategy for treatment of malignant lymphoma requires fundamentally a field of multidisciplinary treatment including mainly radiotherapy and chemotherapy in a collaboration with surgical procedure and immunotherapeutic maneuver." | 1.27 | [Malignant lymphoma]. ( Kita, K; Shirakawa, S; Tanaka, I, 1985) |
| " It is noteworthy that in all subsets, ABVD (Adriamycin + bleomycin + vinblastine + dacarbazine), either combined with irradiation or alternated with MOPP (mechlorethamine + vincristine + procarbazine + prednisone), yielded superior results compared with MOPP with or without irradiation." | 1.27 | Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy. ( Bonadonna, G; Santoro, A; Valagussa, P, 1985) |
| "Sixty-eight patients with Hodgkin's disease stage III and IV were evaluated after three out of six MOPP cycles." | 1.27 | Prognostic value of response after three MOPP cycles in Hodgkin's disease--stage III and IV. ( Barbot, A; Le Fur, R; Menard, JF; Monconduit, M; Piguet, H; Tilly, H, 1987) |
| "Five hundred and seven patients with Hodgkin's lymphoma (HL), forming the basis of our 18 years experience, are retrospectively analyzed." | 1.27 | Hodgkin's disease (HD): a historical perspective. ( Baccarani, M; Bandini, G; Emiliani, E; Fiacchini, M; Gobbi, M; Lauria, F; Mazza, P; Tura, S; Verlicchi, F; Zinzani, PL, 1986) |
| "Most of the children with Hodgkin's disease diagnosed before or during puberty can be cured with chemotherapy alone, and thus will not suffer from the damaging late effects of radiotherapy." | 1.27 | Treatment of Hodgkin's disease in children with or without radiotherapy. ( Behrendt, H; Van Bunningen, BN; Van Leeuwen, EF, 1987) |
| "Thirty eight patients with Hodgkin's disease, stage I to IIIA, previously untreated, received three courses of this regimen before radical radiotherapy." | 1.27 | [The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials]. ( Audebert, A; Blanc, CM; David, B; Debray, J; Eghbali, H; Hoerni, B; Rojouan, J; Zittoun, R, 1987) |
| "The observed cure rates in childhood Hodgkin's disease (85 to 95%) and the knowledge of late complications of treatments, radiotherapy as well as chemotherapy, lead to studies aiming at decreasing the treatment burden without compromising these good results." | 1.27 | [Hodgkin's disease in children. Current therapeutic strategies]. ( Habrand, JL; Lemerle, J; Leverger, G; Oberlin, O; Olive, D; Schaison, G; Zucker, JM, 1988) |
| "In 82 children affected with Hodgkin's disease, in whom a complete remission was obtained, the first relapses occurred in 13 patients, their outcome was a follows: one child died of relapse and in 12 others second complete remissions were achieved." | 1.27 | Is first salvage chemotherapy the last-line chemotherapy in children with Hodgkin's disease? A tentative answer based on long observation of two patients. ( Armata, J; Balwierz, W; Moryl-Bujakowska, A; Pekacki, A, 1987) |
| "Results of treatment of 25 Hodgkin's disease patients at Kyushu University Hospital from 1981 to 1985 were reviewed." | 1.27 | [Improved survival rates in Hodgkin's disease]. ( Hayabuchi, N; Hirata, H; Ishii, E; Jingu, K; Kikuchi, M; Komiyama, S; Masuda, K; Miyoshi, M; Nishimura, J; Shibuya, T, 1988) |
| "Fifty patients with recurrent Hodgkin's disease have been treated with high-dose therapy followed by autologous bone marrow transplantation." | 1.27 | High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report. ( Carella, AM; Cimino, G; Congiu, AM; Coser, P; Gaozza, E; Mangoni, L; Mazza, P; Meloni, G; Ricci, P; Visani, G, 1988) |
| "A patient is described who developed Hodgkin's disease 16 years after treatment of Wilms' tumor with radiation and actinomycin D." | 1.27 | Hodgkin's disease following Wilms' tumor: a case report. ( Bell, BA; Esseltine, DW; Freeman, CR, 1987) |
| "This case shows that relapse of Hodgkin's disease may occur after a 10 year interval and furthermore it may preceded by nephrotic syndrome." | 1.27 | Glomerulonephritis preceding late relapse of Hodgkin's disease. ( Lynn, WA; Marcus, RE, 1988) |
| "Two patients developed breast cancer after treatment of Hodgkin's disease." | 1.27 | Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. ( Anderson, T; Cox, JD; Gillin, M; Greenberg, M; Janjan, NA; Schewe, K; Wilson, JF, 1988) |
| "Two hundred ninety patients with Hodgkin's disease pathologic stage (PS) I or II were treated in the prospective randomized trial of the Danish National Hodgkin Study (see Appendix) with radiotherapy +/- adjuvant combination chemotherapy." | 1.27 | Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment. ( Clausen, NT; Cold, S; Nissen, NI; Nordentoft, AM; Specht, L, 1988) |
| "We have described a patient with Hodgkin's disease who had fever and pulmonary infiltrates after treatment with mantle x-ray therapy and two courses of MOPP." | 1.27 | Gallium citrate Ga 67 accumulation in pulmonary lesions after chemotherapy (MOPP). ( Davenport, OL; Huskison, WT; Wells, JD, 1986) |
| "Nineteen patients with Hodgkin's disease who relapsed primarily in nodal sites after intensive combination chemotherapy were retreated with wide-field radiation therapy alone or with additional chemotherapy between January 1971 and December 1984." | 1.27 | Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy. ( Mauch, P; Rosenthal, D; Skarin, A; Tarbell, N; Weinstein, H, 1987) |
| "In 41 patients with Hodgkin's disease nitroblue tetrazolium (NBT) dye reduction with resting and stimulated granulocytes, before, in the course and after chemotherapy was examined." | 1.27 | Nitroblue tetrazolium test in patients with Hodgkin's disease in the course of chemotherapy. ( Kemona, H; Kiluk, S; Prokopowicz, J; Wysocka, J, 1987) |
| "Of 244 patients with Hodgkin's disease, 126 (52%) had an abnormal mediastinum." | 1.27 | Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure. ( Chan, PY; Hintz, BL; Kagan, AR; McMahon, J; Nussbaum, H; Rao, AR; Ryoo, MC; Wollin, M, 1987) |
| "A case of recurrent Hodgkin's disease of the "sarcomatoid" or "syncytial variant" type was seen that occurred as an extension from the mediastinum to a previously uninvolved extranodal site (breast) and pericardium after treatment of classical nodular sclerosing Hodgkin's disease based in the lymph nodes." | 1.27 | Recurrent "syncytial variant" of Hodgkin's disease: an immunohistologic diagnosis. ( Blaustein, JC; Lewkow, L, 1987) |
| "Seven patients with newly-diagnosed Hodgkin's disease, having standard mustine-vinblastine-prednisolone-procarbazine therapy, had a large and regular pattern of rise in SCE frequency in their peripheral lymphocytes, which apparently started to fall before the end of the course (32 wk)." | 1.27 | Variation of SCE frequency in lymphocyte cultures from patients with Hodgkin's disease before, during, and after treatment. ( Brown, T; Bullock, I; Dawson, AA; King, DJ; Watt, JL, 1986) |
| "A patient seen at presentation for Hodgkin's disease (HD) at stage IV B was successfully treated with MOPP." | 1.27 | Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease. ( Eridani, S; Singh, AK, 1986) |
| "Hodgkin's disease is characterized by its peculiar histopathology and by the early and consistent existence of impaired cell-mediated immunity, although its oncogenetic mechanisms still remains unsolved." | 1.27 | [Clinical features and treatment of Hodgkin's disease]. ( Kita, K; Kobayashi, T; Ohno, T; Shirakawa, S, 1986) |
| "In addition, acute renal failure developed in both patients, and myolysis in one." | 1.27 | Purpura fulminans in pneumococcal sepsis. ( Berneman, ZN; Bieger, R; Bridts, C; Buyssens, N; Hautekeete, ML; Peetermans, ME; Stevens, WJ, 1986) |
| "Localized pneumonitis and fibrosis are well-known sequelae of this treatment." | 1.27 | Unusual thoracic radiographic findings in children treated for Hodgkin's disease. ( Jochelson, MS; Tarbell, NJ; Weinstein, HJ, 1986) |
| "We report here a case of Hodgkin's disease that progressed untreated for almost four years by virtue of a delayed diagnosis before constitutional symptoms developed." | 1.27 | A rare opportunity to observe aspects of the natural history of untreated Hodgkin's disease. ( Haines, IE; Schwarz, MA, 1986) |
| "94 patients with Hodgkin's disease PS I or II, treated during the period 1969-78 and followed until death, or from 33 to 136 months after initiation of therapy, were analysed." | 1.27 | Prognostic significance of tumour burden in Hodgkin's disease PS I and II. ( Nissen, NI; Specht, L, 1986) |
| "The results of treatment of I-II stage Hodgkin's disease in children aged 2-14 have been studied." | 1.27 | [The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children]. ( Chikrizov, SI; Kanaev, SV; Kolygin, BA; Malinin, AP, 1986) |
| "Central nervous system involvement with Hodgkin's disease is extremely rare and is almost always a late complication in patients who have widely disseminated disease in the usual nodal sites." | 1.27 | Hodgkin's disease presenting with isolated craniospinal involvement. ( Bender, BL; Mayernik, DG, 1986) |
| "Thymic hyperplasia is a poorly understood, apparently benign process that may be confused with recurrent lymphoma." | 1.27 | Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature. ( Edington, H; Longo, DL; Pass, H; Roth, JA; Salwitz, J, 1986) |
| "A case of thymic Hodgkin's disease presenting with an anterior mediastinal mass is reported." | 1.27 | Cystic degeneration of thymic Hodgkin's disease following radiation therapy. ( Haas, A; Kim, HC; Lewis, R; Nosher, J; Sweeney, W, 1985) |
| "Thirty-four patients with Hodgkin's disease and non-Hodgkin's lymphoma underwent therapeutic splenectomies to improve hematologic tolerance for chemotherapy." | 1.27 | The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas. ( Cox, RS; Hoppe, RT; Jacobs, C; Rosenberg, SA; Schreiber, DP, 1985) |
| " Demonstration of systemic signs, bioptically confirmed bone-marrow infiltration and suboptimal cytostatic dosage correlated significantly with a lower full-remission rate." | 1.27 | [Chemotherapy of advanced lymphogranulomatosis. Results of MOPP/COPP treatment at the West German Tumor Center, Essen]. ( Becher, R; Höffken, K; Ippisch, A; Pfeiffer, R; Schmidt, CG; Seeber, S, 1985) |
| "Intracranial hodgkin's disease, an extremely uncommon finding, is reported in a 21-year-old man." | 1.27 | Hodgkin's disease, intracranial involvement. Report of a case and review of the literature. ( Enriquez, R; Papac, R; Vera, R, 1985) |
| "Br." | 1.27 | [Pregnancy and fetal development after therapy of Hodgkin's disease]. ( Slanina, J; Spratler, J; Wannenmacher, M, 1985) |
| "47 patients with advanced Hodgkin's disease (stage IIIB or IV) and mediastinal involvement, treated during the period 1969-78 and followed till death or from 36 to 126 months after initiation of therapy, were analysed." | 1.27 | Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease. ( Nissen, NI; Specht, L; Walbom-Jørgensen, S, 1985) |
| "Twenty-one percent of all Hodgkin's disease in India was seen in the pediatric age groups at the Tata Memorial Hospital (Bombay, India)." | 1.27 | Pediatric Hodgkin's disease in India. ( Advani, S; Desai, P; Dinshaw, K; Nair, C; Notani, P; Pande, S; Ramakrishnan, G; Rao, DN; Rao, R; Talvalkar, G, 1985) |
| "Three cases of primary gastric Hodgkin's disease confirmed by pathology are reported." | 1.27 | [Primary gastric Hodgkin's disease]. ( Bo, YK, 1985) |
| "Twenty-two patients with Hodgkin's disease were treated at Kanazawa University between 1975 and 1982." | 1.27 | [The role of radiotherapy in the treatment of Hodgkin's disease]. ( Chohtoh, S; Hirose, J; Kamimura, R; Kobayashi, A; Nakamura, S; Nishijima, H; Ohtake, S; Saito, Y; Takashima, T; Yoshida, T, 1985) |
| "Of 602 patients treated for non-Hodgkin's lymphomas, 9 developed overt acute nonlymphocytic leukemia or preleukemia with refractory cytopenia and cytogenetic abnormalities of the bone marrow." | 1.27 | Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. ( Ersbøll, J; Keiding, N; Larsen, MS; Larsen, SO; Nissen, NI; Pedersen-Bjergaard, J; Philip, P; Schultz, H; Sørensen, HM, 1985) |
| "One patient with Hodgkin's disease involving the liver is alive at 36 months with further therapy." | 1.26 | Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease. ( Gamble, JF; Loh, KK; Rodgers, RW; Shullenberger, CC, 1980) |
| " Reduced drug dosage was associated with treatment failure in 19 out of 37 patients receiving suboptimal chemotherapy compared to only four of 27 patients in the relapse-free group (P less than 0." | 1.26 | Factors affecting relapse following chemotherapy for Hodgkin's disease. ( Hudson, GV; Jelliffe, AM; Yarnold, JR, 1982) |
| "The eight patients who reported pretreatment nausea had more extensive disease than the other patients and had received twice as much chemotherapy." | 1.26 | Pretreatment nausea in cancer chemotherapy: a conditioned response? ( Carli, T; Curtis, GC; Kleinman, PD; Nesse, RM, 1980) |
| " The planned dosage intensity had to be significantly reduced in over half of the patients because of marrow toxicity." | 1.26 | Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease. ( Dawson, AA; Fell, LF; Green, JA; Murray, S, 1980) |
| "50 patients with Hodgkin's disease were treated with MOPP chemotherapy." | 1.26 | [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)]. ( Neumann, E, 1981) |
| "Thirty-six patients with advanced Hodgkin's disease who were treated primarily with MOPP were evaluated to determine the reasons for MOPP failure." | 1.26 | Reasons for failure of MOPP to cure Hodgkin's disease: The importance of dose and schedule. ( Armitage, JO; Corder, MP, 1982) |
| "A case of Hodgkin's disease is reported in which acute promyelocytic leukaemia developed within 5 months of initiation of chemotherapy." | 1.26 | Hodgkin's disease and acute promyelocytic leukaemia. A case report. ( King, JB; Rosenstrauch, WJ; Steytler, JG; van der Merwe, AM; van Eeden, PJ, 1980) |
| "Long-term survivors of advanced diffuse histiocytic lymphoma treated with comparable chemotherapy, who served as a control population, had significantly higher percentages of E rosettes and no reduction in mitogen-induced lymphocyte proliferation." | 1.26 | Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease. ( Bostick, F; DeVita, VT; Fisher, RI; Howser, DM; Hubbard, SM; Vanhaelen, C; Young, RC, 1980) |
| "Persistent amenorrhea has occurred in 11 of 24 patients (46 percent) treated with MOPP alone or MOPP plus radiation excluding the pelvis." | 1.26 | Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. ( DeVita, VT; Hubbard, SM; Schilsky, RL; Sherins, RJ; Wesley, MN; Young, RC, 1981) |
| "Stage II Hodgkin's disease probably should be divided into two substages requiring different treatment." | 1.26 | [The current state of curability of Hodgkin's disease]. ( Streuli, RA; Ultmann, JE, 1981) |
| "We present a case of Hodgkin's disease and extensive skin infiltration with a favorable outcome." | 1.26 | Skin infiltration in Hodgkin's disease. ( Abt, AB; Gordon, RA; Lookingbill, DP, 1980) |
| "58 patients with early stages of Hodgkin's disease (I, II, III l) were treated by 3 courses of MOPP chemotherapy followed by extended field irradiation." | 1.26 | [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)]. ( Alaoui, Y; Baillet, F; Brun, B; Dreyfus, B; Kuentz, M; Maylin, C; Pierquin, B; Reyes, F; Rochant, H; Vernant, JP, 1980) |
| "Thirty South African children with Hodgkin's disease were studied over a 7-year period (1970 - 1977)." | 1.26 | Hodgkin's disease in South African children. ( Clinton, C; de Moor, NG; Jacobson, RJ; Klappenbach, RS; Wong, O, 1981) |
| "In 18 patients with advanced Hodgkin's disease, refractory to previous 'C-MOPP' treatment, a new therapeutic protocol of adriamycin, DTIC, CCNU and bleomycin was introduced." | 1.26 | [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)]. ( Bruntsch, U; Gallmeier, WM; Osieka, R; Schmidt, CG; Seeber, S, 1976) |
| "Twenty-four patients with advanced Hodgkin's disease, resistant to the MOPP regimen, were treated with a combination of Adriamycin, bleomycin, dacarbazine and vinblastine (ABDV)." | 1.26 | Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV). ( Case, DC; Lee, BJ; Young, CW, 1977) |
| "Our present knowledge of Hodgkin's disease is briefly reviewed and the prognostic importance of histologic subtype and stage is demonstrated." | 1.26 | [Hodgkin's disease: classification, staging, therapy]. ( Wewerka, JR, 1978) |
| "Of 14 splenectomized patients with Hodgkin's disease who were treated with total nodal irradiation and combination chemotherapy (MOPP), fulminant sepsis developed in three (21." | 1.26 | Fulminant sepsis after the successful treatment of Hodgkin's disease. ( Aisenberg, AC; Weitzman, S, 1977) |
| "The ideal management of stage IIB Hodgkin's disease is less certain; it is our plan to study the efficacy of combined modality treatment." | 1.26 | Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment. ( Goldstein, M; Goodman, R; Hellman, S; Mauch, P; Piro, A; Rosenthal, D; Tullis, J, 1977) |
| "Thirty-two patients with Hodgkin's disease who relapsed after a first complete remission induced by nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) were retreated with MOPP chemotherapy." | 1.26 | Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. ( DeVita, VT; Fisher, RI; Hubbard, SP; Simon, R; Young, RC, 1979) |
| "Malignant myelosclerosis or acute myelofibrosis is a rare acute myeloproliferative disorder characterized by pancytopenia, myeloblastosis and marrow fibrosis." | 1.26 | Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy. ( Ali, NO; Janes, WO, 1979) |
| "Despite the dramatic response of Hodgkin's disease to intensive chemotherapy, the skin lesion was rapidly transformed into squamous cell carcinoma in 10 weeks." | 1.26 | Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease? ( Poleksic, S; Yeung, KY, 1978) |
| "After 12 cycles of MOPP therapy for Hodgkin's Disease, an adolescent black male developed hemorrhagic cystitis, which clinically and histologically was similar to that induced by cyclophosphamide." | 1.26 | Hemorrhagic cystitis with MOPP therapy. ( Royal, JE; Seeler, RA, 1978) |
| "Gynecomastia was not associated with an increase in either serum estradiol or prolactin concentrations." | 1.26 | Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. ( Olweny, CL; Sherins, RJ; Ziegler, JL, 1978) |
| "Between 1967 and 1977, 48 patients with Hodgkin's disease under 16-years-old were treated with MOPP chemotherapy alone at the Uganda Cancer Institute because radiotherapy facilities are not available." | 1.26 | Childhood Hodgkin's disease in Uganda: a ten year experience. ( Katongole-Mbidde, E; Kiire, C; Lwanga, SK; Magrath, I; Olweny, CL; Ziegler, JL, 1978) |
| "Sixty-three patients with Hodgkin's disease, in stages I or II, asymptomatic (A) or symptomatic (B), were diagnosed and followed at the Chaim Sheba Medical Center from 1969 to 1976." | 1.26 | Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment. ( Aghai, E; Ben-Bassat, I; Berkowicz, M; Brenner, H; Hulu, N; Many, A; Ramot, B; Rath, P, 1978) |
| "Procarbazine may have been the responsible agent." | 1.26 | Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone. ( Armstrong, JD; Farney, RJ; Hammer, S; Morris, AH, 1977) |
| "Study 81 cases of Hodgkin's disease at stages I, II or III led to the following conclusions from a therapeutic standpoint (in relation to the apparent results obtained): The addition of chemotherapy on the form of three courses of MOPP before irradiation improved the results of the latter on the one hand and, principally, by reducing the number of failures and, secondly, by reducing the complications." | 1.26 | [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)]. ( Baillet, F; Brun, B; Dreyfus, B; Maylin, C; Mazeron, JJ; Pierquin, B, 1977) |
| "We studied 680 patients with Hodgkin's disease, treated at Stanford University Medical Center from July 1, 1968, through December 31, 1975, to determine the risk of development of hematologic neoplasia." | 1.26 | Hematologic neoplasia in patients treated for Hodgkin's disease. ( Coleman, CN; Flint, A; Glatstein, EJ; Kaplan, HS; Rosenberg, SA; Williams, CJ, 1977) |
| "Thirty-eight patients with advanced Hodgkin's disease were treated with a combination of cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP)." | 1.26 | Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP. ( Bloomfield, CD; Fortuny, I; Kennedy, BJ; Vosika, G; Weiss, RB, 1976) |
| "A new treatment program for advanced Hodgkin's disease employing five-drug combination chemotherapy and low dose radiation to the sites of bulk disease (nodal or parenchymal) was designed in 1969." | 1.26 | Long term remissions with combined modality therapy for advanced Hodgkin's disease. ( Bertino, JR; Farber, LR; Fischer, DB; Fischer, JJ; Prosnitz, LR, 1976) |
| "Forty-five children with advanced Hodgkin's disease (stages III and IV) received combination chemotherapy in three schedules: MOPP (mustargen, Oncovin, procarbazine, prednisolone); COPP (cyclophosphamide was substituted for mustargen); and CVPP (cyclophosphamide, vinblastine, procarbazine, prednisone)." | 1.26 | Combination chemotherapy of Hodgkin's disease in children. ( Kolygin, BA, 1976) |
| "A case of nodular sclerosis Hodgkin's disease, stage IVB, with lung involvement and hypertrophic pulmonary osteoarthropathy (HPOA), was treated with quadruple cytotoxic chemotherapy." | 1.26 | Hypertrophic pulmonary osteoarthropathy in Hodgkin's disease: reversal with chemotherapy. ( Atkinson, MK; McElwain, TJ; Peckham, MJ; Thomas, PP, 1976) |
| "Twenty-five cases of hodgkin's Disease (15 males and 10 females) aged 5 to 17 years were studied from April 1970 to July 1976 (75 month period)." | 1.26 | Staging laparotomy and splenectomy: treatment and complications of Hodgkin's disease in children. ( Aral, I; Karayalcin, G; Lanzkowsky, P; Shende, A, 1976) |
| "A 27 year old man with Hodgkin's disease experienced three separate episodes of chest pain, each occurring on the sixth day of a cycle of mustargen, oncovin, procarbazine, prednisone (MOPP) combination chermotherapy." | 1.26 | Unusual cardiac reaction to chemotherapy following mediastinal irradiation in a patient with Hodgkin's disease. ( Greenwald, ES; Grossman, J; Weinstein, P, 1976) |
| "It is found that the spinal cord compression caused by malignant lymphomas is generally a late manifestation of the illness, although primary or early involvements are occasionally seen." | 1.26 | Spinal cord compression in malignant lymphoma. Treatment and results. ( Friedman, M; Kim, TH; Panahon, AM, 1976) |
| "Treatment of advanced Hodgkin's disease by associating vincristine, adriblastine, prednisone and procarbazine is compared with other widely employed protocols." | 1.25 | [Current problems in therapy of evolutive malignant granuloma. Our experience with a new scheme of polychemotherapy]. ( Buttolo, Q; Colle, R; Maiolini, E; Marinone, G; Mauro, PL, 1975) |
| "Progress in the chemotherapy of Hodgkin's disease and experimental therapeutic, pharmacologic, and clinical studies of the antitumor antibiotic, adriamycin, are presented in this abstract." | 1.25 | Progress in the chemotherapy of hematologic diseases. ( Frei, E, 1975) |
| "The results of modern radiotherapy for Hodgkin's disease are correlated to the stage of the disease." | 1.25 | Combination chemotherapy in Hodgkin's disease: relation to radiotherapy. ( Rosenberg, SA, 1975) |
| " Methodology and dosage schemes are discussed." | 1.25 | Towards curative treatment of advanced Hodgkin's disease. ( Falkson, G; Falkson, HC, 1975) |
| "Fifty-two patients with generalized Hodgkin's disease were treated with a combination of mustine hydrochloride, vinblastine, procarbazine, and prednisolone." | 1.25 | Combination chemotherapy in generalized Hodgkin's disease. ( Beard, ME; Crowther, D; Fairley, GH; Malpas, JS; Nicholson, WM; Scott, RB; Stansfeld, AG; Vartan, CP, 1970) |
| "Urethane is the best treatment available for multiple myeloma." | 1.23 | New therapy for leukemia, polycythemia, and lymphoma. ( BARTLETT, GR; MARLOW, AA, 1953) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 803 (65.60) | 18.7374 |
| 1990's | 265 (21.65) | 18.2507 |
| 2000's | 114 (9.31) | 29.6817 |
| 2010's | 38 (3.10) | 24.3611 |
| 2020's | 4 (0.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yasuda, H | 1 |
| Komatsu, N | 1 |
| Ando, J | 1 |
| Ando, M | 1 |
| Purvis, KN | 1 |
| Swanson, HD | 1 |
| Niloy, KK | 1 |
| Zhou, Y | 1 |
| Panetta, JC | 1 |
| Crews, KR | 1 |
| Flerlage, JE | 1 |
| Zawati, I | 1 |
| Adouni, O | 1 |
| Finetti, P | 1 |
| Manai, M | 2 |
| Gamoudi, A | 1 |
| Birnbaum, D | 1 |
| Bertucci, F | 1 |
| Mezlini, A | 2 |
| Mou, E | 1 |
| Advani, RH | 6 |
| von Eyben, R | 1 |
| Rosenberg, SA | 29 |
| Hoppe, RT | 25 |
| van Eggermond, AM | 1 |
| Schaapveld, M | 1 |
| Janus, CP | 1 |
| de Boer, JP | 1 |
| Krol, AD | 2 |
| Zijlstra, JM | 1 |
| van der Maazen, RW | 4 |
| Kremer, LC | 1 |
| van Leerdam, ME | 1 |
| Louwman, MW | 1 |
| Visser, O | 1 |
| De Bruin, ML | 3 |
| Aleman, BM | 7 |
| van Leeuwen, FE | 4 |
| Filatova, LV | 3 |
| Plotnikova, AA | 1 |
| Gershanovich, ML | 5 |
| Semiglazova, TIu | 1 |
| Canellos, GP | 24 |
| Friedberg, JW | 4 |
| Lister, TA | 10 |
| Devita, VT | 34 |
| Michaelson, EM | 1 |
| Chen, YH | 1 |
| Silver, B | 4 |
| Tishler, RB | 1 |
| Marcus, KJ | 1 |
| Stevenson, MA | 2 |
| Ng, AK | 2 |
| Khuroo, MS | 1 |
| Bujan, L | 1 |
| Walschaerts, M | 1 |
| Brugnon, F | 1 |
| Daudin, M | 1 |
| Berthaut, I | 1 |
| Auger, J | 2 |
| Saias, J | 1 |
| Szerman, E | 1 |
| Moinard, N | 1 |
| Rives, N | 1 |
| Hennebicq, S | 1 |
| Englund, A | 1 |
| Hopstadius, C | 1 |
| Enblad, G | 3 |
| Gustafsson, G | 1 |
| Ljungman, G | 1 |
| Nagai, H | 1 |
| Zietman, AL | 1 |
| Hong, F | 6 |
| Fisher, RI | 9 |
| Bartlett, NL | 6 |
| Robinson, KS | 1 |
| Gascoyne, RD | 5 |
| Wagner, H | 4 |
| Stiff, PJ | 4 |
| Cheson, BD | 5 |
| Stewart, DA | 2 |
| Gordon, LI | 5 |
| Kahl, BS | 5 |
| Blum, KA | 3 |
| Habermann, TM | 4 |
| Tuscano, JM | 3 |
| Horning, SJ | 16 |
| Cao, Z | 1 |
| Wang, Z | 1 |
| Sun, J | 1 |
| Peng, C | 1 |
| Feng, S | 1 |
| Zhou, X | 1 |
| Yang, Q | 1 |
| Diefenbach, CS | 1 |
| Li, H | 2 |
| Crump, M | 3 |
| Ansell, SM | 2 |
| Almagro-Casado, E | 1 |
| Sánchez, A | 1 |
| Cantos, B | 1 |
| Salas, C | 2 |
| Pérez-Callejo, D | 1 |
| Provencio, M | 1 |
| Roemer, MG | 1 |
| Ligon, AH | 1 |
| Natkunam, Y | 1 |
| Redd, RA | 1 |
| Homer, H | 1 |
| Connelly, CF | 1 |
| Sun, HH | 1 |
| Daadi, SE | 1 |
| Freeman, GJ | 1 |
| Armand, P | 1 |
| Chapuy, B | 1 |
| de Jong, D | 2 |
| Neuberg, DS | 1 |
| Rodig, SJ | 1 |
| Shipp, MA | 1 |
| Conway, JL | 1 |
| Connors, JM | 12 |
| Tyldesley, S | 1 |
| Savage, KJ | 1 |
| Campbell, BA | 1 |
| Zheng, YY | 1 |
| Hamm, J | 2 |
| Pickles, T | 1 |
| Celkan, T | 1 |
| Yildiz, I | 1 |
| Evens, AM | 2 |
| Hutchings, M | 1 |
| Diehl, V | 8 |
| ANDERSEN, BJ | 1 |
| BRØCHNER-MORTENSEN, K | 1 |
| ZANES, RP | 1 |
| DOAN, CA | 2 |
| HOSTER, HA | 2 |
| DE LANDSHEERE, B | 3 |
| COTTE, P | 1 |
| WINTROBE, MM | 4 |
| HUGULEY, CM | 3 |
| SHERRY, M | 1 |
| SCHNEIDER, M | 1 |
| POTH, EJ | 1 |
| LEVIN, WC | 1 |
| OTTO, P | 1 |
| Souza, EM | 1 |
| Baiocchi, OC | 1 |
| Zanichelli, MA | 1 |
| Alves, AC | 1 |
| Oliveira, JS | 1 |
| Alm El-Din, MA | 1 |
| El-Badawy, SA | 1 |
| Taghian, AG | 1 |
| Abuzetun, JY | 1 |
| Loberiza, F | 1 |
| Vose, J | 3 |
| Bierman, P | 1 |
| Bociek, RG | 1 |
| Enke, C | 1 |
| Bast, M | 1 |
| Weisenburger, D | 2 |
| Armitage, JO | 2 |
| Niu, Y | 1 |
| Shi, YK | 2 |
| He, XH | 2 |
| Feng, FY | 1 |
| Zhou, LQ | 4 |
| Gu, DZ | 1 |
| Pass, AK | 1 |
| McLin, VA | 1 |
| Rushton, JR | 1 |
| Kearney, DL | 1 |
| Hastings, CA | 1 |
| Margolin, JF | 1 |
| Régis, A | 1 |
| Ben Salem, D | 1 |
| Lambert, A | 1 |
| Couaillier, JF | 1 |
| Casasnovas, O | 2 |
| Piard, F | 1 |
| Krausé, D | 1 |
| Kuleva, SA | 1 |
| van Beek, RD | 3 |
| van den Heuvel-Eibrink, MM | 3 |
| Hakvoort-Cammel, FG | 4 |
| van den Bos, C | 4 |
| van der Pal, HJ | 1 |
| Krenning, EP | 1 |
| de Rijke, YB | 1 |
| Pieters, R | 3 |
| de Muinck Keizer-Schrama, SM | 3 |
| Villani, F | 4 |
| Busia, A | 2 |
| Villani, M | 1 |
| Laffranchi, A | 2 |
| Viviani, S | 19 |
| Bonfante, V | 20 |
| Aversa, SM | 3 |
| Trentin, C | 1 |
| Sorarů, M | 4 |
| Di Bona, E | 1 |
| Marino, D | 1 |
| Canova, F | 1 |
| Salvagno, L | 4 |
| Adami, F | 1 |
| Wiernik, PH | 9 |
| Glick, JH | 6 |
| Bennett, JM | 2 |
| García-Sanz, R | 1 |
| González-López, TJ | 1 |
| Vázquez, L | 1 |
| Hermida, G | 1 |
| Graciani, IF | 1 |
| San Miguel, JF | 1 |
| van den Belt-Dusebout, AW | 2 |
| Besseling, G | 1 |
| Hauptmann, M | 2 |
| van 't Veer, MB | 2 |
| de Wit, R | 1 |
| Ribot, JG | 1 |
| Noordijk, EM | 7 |
| Kerst, JM | 1 |
| Gietema, JA | 1 |
| Podol'skiĭ, PN | 1 |
| Datsenko, PV | 1 |
| Pan'shin, GA | 2 |
| Sotnikov, VM | 2 |
| Mel'nik, IuD | 1 |
| Ivashin, AV | 1 |
| Bozhenko, VK | 1 |
| Niedzwiecki, D | 1 |
| Johnson, JL | 2 |
| Kuruvilla, J | 1 |
| Al-Tonbary, Y | 1 |
| Sarhan, MM | 1 |
| El-Ashry, RA | 1 |
| Salama, E | 1 |
| Sedki, M | 1 |
| Fouda, A | 1 |
| ApTHOMAS, MI | 1 |
| CULLUMBINE, H | 1 |
| HOFMEYR, HO | 1 |
| Reddy, N | 1 |
| Thompson-Arildsen, MA | 1 |
| Keskin, EY | 1 |
| Gursel, T | 1 |
| Uluoglu, O | 1 |
| Albayrak, M | 1 |
| Kaya, Z | 1 |
| Coskun, U | 1 |
| Kocak, U | 1 |
| GOODMAN, LS | 2 |
| Haberer, S | 1 |
| Belin, L | 1 |
| Le Scodan, R | 1 |
| Kirova, YM | 1 |
| Savignoni, A | 1 |
| Stevens, D | 1 |
| Moisson, P | 1 |
| Decaudin, D | 2 |
| Pierga, JY | 1 |
| Reyal, F | 1 |
| Campana, F | 1 |
| Fourquet, A | 1 |
| Bollet, MA | 1 |
| Chisesi, T | 6 |
| Bellei, M | 2 |
| Luminari, S | 3 |
| Montanini, A | 1 |
| Marcheselli, L | 1 |
| Levis, A | 6 |
| Gobbi, P | 1 |
| Vitolo, U | 3 |
| Stelitano, C | 2 |
| Pavone, V | 3 |
| Merli, F | 2 |
| Liberati, M | 2 |
| Baldini, L | 2 |
| Bordonaro, R | 2 |
| Pesce, EA | 1 |
| Federico, M | 8 |
| De Sanctis, V | 1 |
| Filippone, FR | 1 |
| Alfò, M | 1 |
| Muni, R | 1 |
| Cavalieri, E | 1 |
| Pulsoni, A | 1 |
| Annechini, G | 1 |
| Valeriani, M | 1 |
| Osti, MF | 1 |
| Minniti, G | 1 |
| Enrici, RM | 2 |
| Niembro, A | 1 |
| Lozano, V | 1 |
| Gallardo, E | 1 |
| Molina, B | 1 |
| Sánchez, S | 1 |
| Ramos, S | 1 |
| Carnevale, A | 1 |
| Pérez-Vera, P | 1 |
| Rivera Luna, R | 1 |
| Frias, S | 1 |
| Ezzat, HM | 1 |
| Cheung, MC | 1 |
| Hicks, LK | 1 |
| Boro, J | 1 |
| Montaner, JS | 1 |
| Lima, VD | 1 |
| Harris, M | 2 |
| Leitch, HA | 1 |
| Dunleavy, K | 1 |
| Grant, C | 1 |
| Eberle, FC | 1 |
| Pittaluga, S | 1 |
| Jaffe, ES | 6 |
| Wilson, WH | 2 |
| Kochbati, L | 2 |
| Fdhila, F | 1 |
| Belaid, I | 1 |
| Rifi, H | 1 |
| Barsaoui, S | 1 |
| Ben Romdhane, N | 1 |
| Bel Hadj Ali, Z | 2 |
| Oubich, F | 1 |
| Maalej, M | 2 |
| Baer, D | 1 |
| Mason, J | 1 |
| Warnke, R | 1 |
| Allen, J | 1 |
| Daadi, S | 1 |
| Xing, PY | 1 |
| Dong, M | 1 |
| Yang, JL | 1 |
| Liu, P | 1 |
| Gospodarowicz, M | 2 |
| Advani, R | 4 |
| Schlienger, M | 1 |
| Ferroir, JP | 1 |
| Huguet, F | 1 |
| Deluen, F | 1 |
| Pène, F | 1 |
| Marseguerra, R | 1 |
| Touboul, E | 2 |
| Metzger, ML | 1 |
| Billett, A | 1 |
| Link, MP | 6 |
| Koontz, MZ | 1 |
| Balise, R | 1 |
| Greenberg, PL | 1 |
| Miller, TP | 3 |
| Kanakry, JA | 1 |
| Gellert, LL | 1 |
| Lemas, MV | 1 |
| Hsieh, WS | 1 |
| Tan, KL | 1 |
| Stiff, P | 1 |
| Ambinder, RF | 1 |
| Spina, M | 3 |
| Gabarre, J | 5 |
| Rossi, G | 1 |
| Fasan, M | 2 |
| Schiantarelli, C | 1 |
| Nigra, E | 1 |
| Mena, M | 1 |
| Antinori, A | 1 |
| Ammassari, A | 1 |
| Talamini, R | 1 |
| Vaccher, E | 5 |
| di Gennaro, G | 1 |
| Tirelli, U | 9 |
| Radman, I | 1 |
| Basić, N | 1 |
| Labar, B | 1 |
| Kovacević, J | 1 |
| Aurer, I | 1 |
| Bogdanić, V | 1 |
| Zupancić-Salek, S | 1 |
| Nemet, D | 1 |
| Jakić-Razumović, J | 1 |
| Mrsić, M | 1 |
| Santek, F | 1 |
| Grgić-Markulin, L | 1 |
| Boban, D | 1 |
| Zanotti, R | 1 |
| Trolese, A | 1 |
| Ambrosetti, A | 1 |
| Nadali, G | 1 |
| Visco, C | 1 |
| Ricetti, MM | 1 |
| Benedetti, F | 1 |
| Pizzolo, G | 2 |
| Veronesi, G | 1 |
| Spaggiari, L | 1 |
| Solli, PG | 1 |
| Leo, F | 1 |
| Villa, G | 1 |
| Pastorino, U | 1 |
| Chronowski, GM | 2 |
| Wilder, RB | 2 |
| Tucker, SL | 1 |
| Ha, CS | 3 |
| Sarris, AH | 1 |
| Hagemeister, FB | 17 |
| Barista, I | 2 |
| Hess, MA | 1 |
| Cabanillas, F | 6 |
| Cox, JD | 5 |
| Duggan, DB | 2 |
| Petroni, GR | 2 |
| Peterson, BA | 6 |
| Bernard, P | 1 |
| Vinzio, S | 1 |
| Talarmin, F | 1 |
| Kadouri, A | 1 |
| Flocard, F | 1 |
| Dyduch, M | 1 |
| Skolyszewski, J | 1 |
| Korzeniowski, S | 1 |
| Sokolowski, A | 1 |
| Raemaekers, JM | 5 |
| Bortolus, R | 3 |
| Lybeert, ML | 3 |
| Keuning, JJ | 1 |
| Carde, P | 14 |
| Girinsky, T | 5 |
| Tomsic, R | 2 |
| Vovk, M | 3 |
| van Hoof, A | 2 |
| Demeestere, G | 2 |
| Lugtenburg, PJ | 2 |
| Thomas, J | 9 |
| Schroyens, W | 1 |
| De Boeck, K | 1 |
| Baars, JW | 2 |
| Kluin-Nelemans, JC | 3 |
| Carrie, C | 2 |
| Aoudjhane, M | 1 |
| Bron, D | 1 |
| Eghbali, H | 7 |
| Smit, WG | 2 |
| Meerwaldt, JH | 7 |
| Hagenbeek, A | 9 |
| Pinna, A | 4 |
| Henry-Amar, M | 12 |
| Brice, P | 10 |
| Brugiatelli, M | 1 |
| Nagler, A | 2 |
| Gisselbrecht, C | 7 |
| Moretti, L | 1 |
| Colombat, P | 3 |
| Fabbiano, F | 1 |
| Di Renzo, N | 3 |
| Goldstone, A | 1 |
| Carella, AM | 5 |
| Longo, DL | 14 |
| NARDI, FL | 1 |
| WISNIEWSKI, B | 1 |
| ROSE, LW | 1 |
| TUCKER, HS | 2 |
| RICHMAN, S | 1 |
| WILLIAMS, JP | 1 |
| MARLOW, AA | 1 |
| BARTLETT, GR | 1 |
| CROIZAT, P | 2 |
| PAPILLON, J | 2 |
| PINET, F | 2 |
| HARRIS, MW | 1 |
| JUSTIN-BESANCON, L | 1 |
| LAMOTTE-BARRILLON, S | 1 |
| DEBRAY, J | 2 |
| KLIMA, R | 1 |
| HORNISCHER, R | 1 |
| HOLY, J | 1 |
| SUCHAN, M | 1 |
| DEUSCHLE, KW | 1 |
| WIGGINS, WS | 1 |
| SIEVERS, K | 1 |
| HARWERTH, HG | 1 |
| PIEMONTE, M | 1 |
| VALDIVIESO CONDE, L | 1 |
| MORANDEIRA VAAMONDE, L | 1 |
| BERNARD, J | 15 |
| GENIS GALVEZ, JM | 2 |
| CASALLA CHACON, JM | 1 |
| PETRONE, P | 1 |
| MEYER, OO | 1 |
| GASALLA CHACON, JM | 1 |
| PERIERA, JR | 1 |
| CHEVALLIER, P | 2 |
| BILSKI-PASQUIER, G | 1 |
| CHRISTOL, D | 1 |
| BOIRON, M | 12 |
| SEDAN, J | 2 |
| INTROZZI, P | 2 |
| MARINONE, G | 2 |
| CORDIVIOLA, LA | 1 |
| BOSQ, P | 2 |
| ROSSELLI, S | 1 |
| BEATTIE, JW | 1 |
| HOWELLS, LH | 1 |
| DESAIVE, P | 1 |
| CLOSON, J | 1 |
| LAVIGNE, J | 1 |
| GOHR, H | 1 |
| GORGES, T | 1 |
| BOLDER, H | 1 |
| VIDEBAEK, A | 3 |
| KAAE, S | 2 |
| HOCHMAN, A | 2 |
| ICKOWICZ, M | 1 |
| VIDEBAEK, AA | 1 |
| SOROKIN, NM | 1 |
| MOURIQUAND, C | 1 |
| CAKMAKCI, A | 1 |
| GIL, YG | 1 |
| RAMIOUL, H | 1 |
| JAMAR, B | 1 |
| LARIONOV, LF | 2 |
| RINGENBACH, MG | 1 |
| BOURONCLE, BA | 1 |
| WISEMAN, BK | 1 |
| FRAJOLA, WJ | 1 |
| SELLEI, C | 2 |
| ECKHARDT, S | 1 |
| HARTAI, F | 2 |
| DUMBOVICH, B | 1 |
| KUDRIASHOVA, OI | 2 |
| MATHE, G | 4 |
| WEIL, M | 10 |
| MIROWSKA-STELMACHOWSKA, A | 1 |
| TOPOLSKA, P | 1 |
| HORLIN, W | 1 |
| SCHMITT, W | 1 |
| ROTTINO, A | 2 |
| CHIARIONI, T | 1 |
| FRACASSO, I | 1 |
| NARDI, E | 1 |
| SHAMINA, EV | 1 |
| BROWN, FA | 1 |
| KAPLAN, HS | 11 |
| LIBANSKY, J | 2 |
| CHUDOMEL, V | 2 |
| SOCHMAN, J | 2 |
| BRABEC, V | 2 |
| PERNOT, C | 1 |
| SCHOUMACHER, P | 1 |
| PERNOT, M | 1 |
| MASSE, P | 1 |
| IVANOVA, EM | 1 |
| DIESSNER, GR | 1 |
| HECK, FJ | 1 |
| VASILE, B | 2 |
| MOSCHIDIS, C | 1 |
| KIOSOGLOU, K | 1 |
| MAOUNI, F | 1 |
| ZULIK, R | 1 |
| LOVISETTO, P | 2 |
| CASTELLANO, M | 1 |
| ZIV, MA | 1 |
| CHILOV, K | 1 |
| IVANOV, S | 1 |
| KIRCHEV, P | 1 |
| GERBRANDY, J | 1 |
| HELLENDOORN, HB | 1 |
| RUDCHENKO, NB | 1 |
| CAPUTI, S | 1 |
| Gupta, T | 1 |
| Sanghavi, V | 1 |
| Laskar, S | 1 |
| ROUSSO, C | 1 |
| CONRAD, ME | 1 |
| CROSBY, WH | 1 |
| COOK, JC | 1 |
| KRABBENHOFT, KL | 1 |
| LEUCUTIA, T | 1 |
| SPEAR, PW | 1 |
| PATNO, ME | 1 |
| GYENES, G | 1 |
| SAMPEY, JR | 4 |
| SCOTT, JL | 1 |
| MOLANDER, DW | 1 |
| REWCASTLE, NB | 1 |
| TAGLIORETTI, D | 1 |
| TESTERO, S | 1 |
| TISO, R | 1 |
| ERIDANI, S | 2 |
| HENNESSY, JP | 1 |
| KARNOFSKY, DA | 3 |
| MILLER, DG | 1 |
| PHILLIPS, RF | 1 |
| BRINDLEY, CO | 1 |
| SALVIN, LG | 1 |
| POTEE, KG | 1 |
| LIPOWSKA, B | 1 |
| SHNIDER, BI | 1 |
| REGELSON, W | 1 |
| COLSKY, J | 1 |
| MAUER, AM | 1 |
| KRILL, CE | 1 |
| HEINEMAN, HS | 1 |
| JENSEN, WN | 1 |
| COOPER, WM | 1 |
| BRAUDE, AI | 1 |
| DOGLIOTTI, GC | 1 |
| CREPALDI, G | 1 |
| PARPAJOLA, A | 1 |
| KURZ, GH | 1 |
| VIGI, F | 1 |
| MURPHY, WT | 2 |
| BILGE, N | 2 |
| LANE, M | 1 |
| BERLIN, NI | 1 |
| MENGEL, CE | 1 |
| ROKICKA-MILEWSKA, R | 2 |
| KOEROES, Z | 1 |
| MATE WOJCINSKA, U | 1 |
| TANIDA, T | 1 |
| STEEL, SJ | 1 |
| WATILLON, M | 1 |
| PRIJOT, E | 1 |
| FARRA, M | 1 |
| TEILUM, G | 2 |
| PAPAC, RJ | 2 |
| WOOD, DA | 2 |
| SHINGLETON, WW | 1 |
| PARKER, RT | 1 |
| IRIARTE, P | 1 |
| JAGASIA, H | 1 |
| THURMAN, WG | 1 |
| HUNEYCUTT, HC | 1 |
| ANDERSON, WR | 1 |
| HENDRY, WS | 1 |
| FRIEDMAN, BI | 1 |
| SAENGER, EL | 1 |
| KREINDLER, MS | 1 |
| HUTCHISON, JL | 1 |
| CHEEVER, AW | 1 |
| VALSAMIS, MP | 1 |
| RABSON, AS | 1 |
| TODD, ID | 3 |
| BERNHARDT, G | 1 |
| LUDEWIG, H | 1 |
| KEIDAN, SE | 1 |
| MAINWARING, D | 1 |
| HALNAN, KE | 1 |
| SMITH, JC | 1 |
| BOLANDE, RP | 1 |
| MORROW, LB | 1 |
| ANDERSON, RE | 1 |
| MATTOSO, LF | 1 |
| STONE, DL | 1 |
| FERRARA, A | 1 |
| BRAUN, H | 2 |
| EICKE, WJ | 1 |
| VESIN, S | 1 |
| KEIBL, E | 1 |
| HANRATTY, WJ | 1 |
| POSLAVSKII, EV | 1 |
| LEKSIKOV, IM | 1 |
| RABENKO, J | 2 |
| CORREA URQUIZA, LM | 1 |
| SANDOR, L | 1 |
| CERNY, V | 2 |
| UJHAZY, V | 1 |
| WINKLER, A | 1 |
| RAEVSKII, IG | 1 |
| Stevanato, F | 1 |
| Pancotto, P | 1 |
| Reimers, P | 1 |
| Salvano, L | 1 |
| Cella, G | 1 |
| Boussen, H | 1 |
| Benna, F | 1 |
| Belhaj Ali, Z | 1 |
| Gammoudi, A | 1 |
| Bouaouina, N | 1 |
| Besbes, M | 1 |
| Ghilen, L | 1 |
| Rahal, K | 1 |
| Ogawa, M | 3 |
| Hodgson, DC | 2 |
| Tsang, RW | 1 |
| Pintilie, M | 1 |
| Sun, A | 1 |
| Wells, W | 1 |
| Gospodarowicz, MK | 1 |
| van den Berg, H | 5 |
| Furstner, F | 1 |
| Behrendt, H | 6 |
| Li, S | 1 |
| Neuberg, D | 1 |
| Fisher, DC | 1 |
| Mauch, PM | 7 |
| LENZI, F | 1 |
| WEICKER, H | 1 |
| MOESER, H | 1 |
| LINDEMANN, M | 1 |
| GUMMEL, H | 1 |
| MASOUREDIS, SP | 1 |
| LOW-BEER, BV | 1 |
| BIERMAN, HR | 3 |
| CHERNEY, LS | 1 |
| SHIMKIN, MB | 3 |
| GARDIKAS, C | 1 |
| WILKINSON, JF | 1 |
| GIL y GIL, C | 2 |
| LEQUESNE, M | 1 |
| di PIETRO, S | 1 |
| GIACOMELLI, V | 1 |
| NINNI, M | 1 |
| LEVI, M | 1 |
| MENE, G | 1 |
| FERRI, A | 1 |
| de LORENZO, J | 1 |
| JANNINI, P | 1 |
| KELLY, KH | 1 |
| LOWENHAUPT, E | 1 |
| FURST, A | 1 |
| BARENGHI, G | 1 |
| ABOU SINNA, I | 1 |
| BOLAND, J | 1 |
| INNES, J | 1 |
| GELLHORN, A | 2 |
| COLLINS, VP | 1 |
| KIELER, J | 1 |
| INGRASSIA, G | 1 |
| STORTI, E | 2 |
| BILLERBECK, K | 1 |
| CALARESU, I | 1 |
| ROSWIT, B | 1 |
| PISETSKY, JE | 1 |
| LEIBETSEDER, F | 1 |
| RABL, I | 1 |
| LENTINI, S | 1 |
| POLIMENI, R | 2 |
| MEDETTI, M | 1 |
| Ghobrial, IM | 1 |
| Wolf, RC | 1 |
| Pereira, DL | 1 |
| Fonseca, R | 1 |
| White, WL | 1 |
| Colgan, JP | 1 |
| Inwards, DJ | 1 |
| Markovic, SN | 1 |
| Micallef, IN | 1 |
| Porrata, LF | 1 |
| Witzig, TE | 1 |
| Oliapuram Jose, B | 1 |
| Koerner, P | 1 |
| Bertolone, S | 1 |
| Patel, CC | 1 |
| Spanos, WJ | 1 |
| Paris, KJ | 1 |
| Silverman, CL | 1 |
| Yashar, CM | 1 |
| Buitendijk, S | 1 |
| van den Heuvel-Eibrink, M | 1 |
| Hählen, K | 1 |
| Vassilakopoulos, TP | 1 |
| Angelopoulou, MK | 1 |
| Siakantaris, MP | 1 |
| Kontopidou, FN | 1 |
| Dimopoulou, MN | 1 |
| Kokoris, SI | 1 |
| Kyrtsonis, MC | 1 |
| Tsaftaridis, P | 1 |
| Karkantaris, C | 1 |
| Anargyrou, K | 1 |
| Boutsis, DE | 1 |
| Variamis, E | 1 |
| Michalopoulos, T | 1 |
| Boussiotis, VA | 2 |
| Panayiotidis, P | 1 |
| Papavassiliou, C | 1 |
| Pangalis, GA | 2 |
| Hohaus, S | 1 |
| Di Febo, A | 1 |
| Storti, S | 1 |
| Teofili, L | 2 |
| Voso, MT | 1 |
| Leone, G | 1 |
| Mazzarotto, R | 2 |
| Boso, C | 1 |
| Gaion, F | 1 |
| Chiarion-Sileni, V | 1 |
| De Franchis, G | 1 |
| Favaretto, AG | 1 |
| Crivellari, G | 1 |
| Banna, GL | 1 |
| Sotti, G | 3 |
| Monfardini, S | 5 |
| SARTORI, P | 1 |
| AJELLI, C | 1 |
| PITZURRA, M | 1 |
| ROZABAL, F | 1 |
| ORTIZ VAZQUEZ, J | 1 |
| RUIZ FALCO, F | 1 |
| PAVAN, S | 1 |
| DE RITIS, F | 1 |
| SCALFI, L | 1 |
| MATTHEWS, WB | 1 |
| NAVARRO, F | 1 |
| PINKER, H | 1 |
| SPURR, CL | 3 |
| SMITH, TR | 1 |
| BLOCK, M | 1 |
| JACOBSON, LO | 1 |
| ALBER, M | 1 |
| BETHELL, FH | 1 |
| ANDREWS, GA | 1 |
| NELIGH, RB | 1 |
| MEYERS, MC | 1 |
| HETTIG, RA | 1 |
| TEWES, H | 1 |
| Balwierz, W | 7 |
| Moryl-Bujakowska, A | 6 |
| Depowska, T | 7 |
| Klekawka, T | 1 |
| Stanuch, H | 1 |
| Matysiak, M | 3 |
| Sopyło, B | 2 |
| Kołakowska-Mrozowska, B | 2 |
| Krenke, K | 1 |
| Chybicka, A | 1 |
| Raś, M | 1 |
| Sońta-Jakimczyk, D | 3 |
| Moszant, A | 1 |
| Wachowiak, J | 1 |
| Kaczmarek-Kanold, M | 2 |
| Kowalczyk, J | 2 |
| Odój, T | 1 |
| Balcerska, A | 1 |
| Drozyńska, E | 1 |
| Wysocki, M | 1 |
| Kołtan, A | 1 |
| Krawczuk-Rybak, M | 1 |
| Stolarska, M | 1 |
| Wessels, G | 2 |
| Bernard Hesseling, P | 1 |
| Illés, A | 2 |
| Udvardy, M | 1 |
| Molnár, Z | 1 |
| Kneller, A | 1 |
| Cohen, N | 1 |
| Berkowicz, M | 2 |
| Reichart, M | 1 |
| Rosner, E | 1 |
| Sokolovski, M | 1 |
| Rechavi, G | 1 |
| Amariglio, N | 1 |
| Trakhtenbrot, L | 1 |
| Bonadonna, G | 31 |
| Gianni, AM | 3 |
| Valagussa, P | 21 |
| DeLair, SM | 1 |
| White, RW | 1 |
| Kurzrock, EA | 1 |
| Strijk, S | 1 |
| Meijnders, P | 1 |
| Olofsen-van Acht, MJ | 1 |
| Lievens, Y | 2 |
| Poortmans, PM | 1 |
| Campbell, B | 1 |
| Wirth, A | 2 |
| Milner, A | 1 |
| Di Iulio, J | 1 |
| MacManus, M | 1 |
| Ryan, G | 1 |
| Marisavljević, D | 1 |
| Ristić, B | 1 |
| Hajder, J | 1 |
| Gobbi, PG | 6 |
| Broglia, C | 3 |
| Cavanna, L | 4 |
| Santini, G | 3 |
| Deliliers, GL | 2 |
| Angelucci, E | 1 |
| Comella, P | 1 |
| Abate, G | 1 |
| Fiore, M | 1 |
| Di Finizio, G | 1 |
| Frezza, P | 1 |
| Scoppa, G | 1 |
| Anania, C | 1 |
| Coucourde, F | 1 |
| Zarrilli, D | 1 |
| Morbidini-Gaffney, S | 1 |
| Alpert, TE | 1 |
| Hatoum, GF | 1 |
| Sagerman, RH | 1 |
| La Sala, A | 1 |
| Valentino, F | 1 |
| Sacchi, S | 1 |
| Corbella, F | 2 |
| Iannitto, E | 3 |
| Molica, S | 2 |
| Corazza, GR | 1 |
| Fermé, C | 9 |
| Mounier, N | 1 |
| Divine, M | 4 |
| Sonet, A | 1 |
| Bouafia, F | 1 |
| Bastard-Stamatoullas, A | 1 |
| Bordessoule, D | 2 |
| Voillat, L | 1 |
| Reman, O | 2 |
| Blanc, M | 3 |
| Zhen, ZJ | 1 |
| Sun, XF | 2 |
| Xia, Y | 1 |
| Wang, ZH | 1 |
| Ling, JY | 1 |
| Foltz, LM | 1 |
| Song, KW | 1 |
| Dupouy, N | 2 |
| Monconduit, M | 8 |
| Bosq, J | 3 |
| Verschueren, TA | 1 |
| Pény, AM | 1 |
| Kung, FH | 1 |
| Schwartz, CL | 1 |
| Ferree, CR | 1 |
| London, WB | 1 |
| Ternberg, JL | 2 |
| Behm, FG | 3 |
| Wharam, MD | 2 |
| Falletta, JM | 1 |
| de Alarcon, P | 1 |
| Chauvenet, AR | 2 |
| Wang, WH | 1 |
| Li, YX | 1 |
| Song, YW | 1 |
| Jin, J | 1 |
| Liu, YP | 1 |
| Wang, SL | 1 |
| Liu, XF | 1 |
| Yu, ZH | 1 |
| Han, JZ | 1 |
| Fu, XH | 1 |
| Wang, SS | 1 |
| Huang, Y | 1 |
| Wang, B | 1 |
| Huang, HQ | 1 |
| Zhang, L | 1 |
| Xu, RH | 1 |
| Lin, TY | 1 |
| Pivnik, AV | 1 |
| Rastrigin, NA | 1 |
| Moiseeva, TN | 1 |
| Lutsenko, IN | 1 |
| Dudarova, RG | 1 |
| Shavlokhov, VS | 1 |
| Efimov, IV | 1 |
| Kozhurin, SV | 1 |
| Shitareva, IV | 1 |
| Gemdzhian, EG | 1 |
| Tsyba, NN | 1 |
| Kolosova, LIu | 1 |
| Melikian, AL | 1 |
| Skidan, NI | 1 |
| Dotsenko, PV | 1 |
| Nechistiuk, AV | 1 |
| Majhail, NS | 1 |
| Weisdorf, DJ | 1 |
| Defor, TE | 1 |
| Miller, JS | 1 |
| McGlave, PB | 1 |
| Slungaard, A | 1 |
| Arora, M | 1 |
| Ramsay, NK | 1 |
| Orchard, PJ | 1 |
| MacMillan, ML | 1 |
| Burns, LJ | 3 |
| Tomiŝiĉ, R | 1 |
| Baaijens, MH | 1 |
| Lugtenburg, P | 1 |
| Chow, LM | 1 |
| Nathan, PC | 1 |
| Jenkin, D | 7 |
| Weitzman, S | 2 |
| Grant, RM | 1 |
| Manson, D | 1 |
| Bross, A | 1 |
| Doyle, JJ | 1 |
| Danjoux, C | 1 |
| Greenberg, ML | 1 |
| Mandal, S | 1 |
| Mandal, AK | 1 |
| Simon, Z | 1 |
| Keresztes, K | 1 |
| Miltényi, Z | 1 |
| Ress, Z | 1 |
| Váróczy, L | 1 |
| Vadász, G | 1 |
| Gergely, L | 1 |
| Giuseppe, L | 1 |
| Attilio, G | 1 |
| Edoardo, DN | 1 |
| Loredana, G | 1 |
| Cristina, L | 1 |
| Vincenzo, L | 1 |
| Tanaka, PY | 1 |
| Pessoa, VP | 1 |
| Pracchia, LF | 1 |
| Buccheri, V | 1 |
| Chamone, DA | 1 |
| Calore, EE | 1 |
| Maeda, L | 1 |
| Lavori, P | 1 |
| Quon, A | 1 |
| Hoppe, R | 1 |
| Breslin, S | 1 |
| Fuchs, M | 1 |
| Laven, JS | 1 |
| de Jong, FH | 2 |
| Themmen, AP | 1 |
| Huisbrink, J | 1 |
| Kuenen, MA | 1 |
| Ouwens, GM | 1 |
| van't Veer, MB | 2 |
| Diez, P | 1 |
| Hoskin, PJ | 1 |
| Aird, EG | 1 |
| Smit, M | 1 |
| Weber, RF | 1 |
| Rieux, C | 1 |
| Berger, F | 3 |
| Walewski, JA | 1 |
| Lederlin, P | 4 |
| Van den Neste, E | 1 |
| Gyan, E | 1 |
| Salles, G | 2 |
| Creemers, GJ | 1 |
| Vié, B | 1 |
| Viseu, F | 1 |
| Poortmans, P | 1 |
| Jaubert, J | 1 |
| Tan, WY | 1 |
| Hu, DS | 1 |
| Zeng, FY | 1 |
| Song, QB | 1 |
| Hu, S | 1 |
| Wei, L | 1 |
| BEN-ASHER, S | 1 |
| MEYER, AH | 1 |
| OVERMILLER, WC | 1 |
| CORNELL, VH | 1 |
| BLAUW, AS | 1 |
| DAMESHEK, W | 2 |
| WEISFUSE, L | 1 |
| STEIN, T | 1 |
| ERF, LA | 1 |
| BAUER, RD | 1 |
| OTTE, P | 1 |
| NABARRO, JD | 1 |
| KAY, WR | 1 |
| GROEN, J | 1 |
| GODFRIED, EG | 1 |
| Olweny, CL | 4 |
| Ziegler, JL | 4 |
| Joensuu, H | 2 |
| Brauer, MJ | 1 |
| McEvoy, BF | 1 |
| Mitus, WJ | 1 |
| Shohat, B | 1 |
| Gitter, S | 1 |
| Lavie, D | 1 |
| Goguel, A | 1 |
| Jacquillat, C | 12 |
| Tanzer, J | 2 |
| Santoro, A | 25 |
| Lombardi, C | 1 |
| Ragni, G | 2 |
| Lira, P | 1 |
| Grebe, G | 1 |
| Bakemeier, RF | 2 |
| Anderson, JR | 4 |
| Costello, W | 2 |
| Rosner, G | 1 |
| Horton, J | 1 |
| Hines, JD | 1 |
| Berard, CW | 3 |
| Straus, DJ | 11 |
| Myers, J | 7 |
| Passe, S | 1 |
| Young, CW | 4 |
| Nisce, LZ | 6 |
| Lee, BJ | 8 |
| Koziner, B | 7 |
| Arlin, Z | 2 |
| Kempin, S | 2 |
| Gee, T | 2 |
| Clarkson, BD | 6 |
| Rodgers, RW | 2 |
| Gamble, JF | 7 |
| Loh, KK | 1 |
| Shullenberger, CC | 8 |
| Malpas, JS | 9 |
| Sutcliffe, SB | 7 |
| Economopoulos, T | 1 |
| Wrigley, PF | 11 |
| Stansfeld, AG | 6 |
| Goldman, JM | 2 |
| Armata, J | 12 |
| Borkowski, W | 5 |
| Kaczor, Z | 3 |
| Grozea, PN | 2 |
| De Persio, EJ | 1 |
| Coltman, CA | 6 |
| Fabian, CJ | 2 |
| Morrison, FS | 1 |
| Gehan, EA | 7 |
| Jones, SE | 4 |
| Fossati Bellani, F | 1 |
| Franchi, F | 1 |
| Banfi, A | 4 |
| Mayer, RJ | 1 |
| Prosnitz, LR | 9 |
| Farber, LR | 6 |
| Kapp, DS | 3 |
| Bertino, JR | 4 |
| Nordlund, M | 1 |
| Lawrence, R | 2 |
| DePersio, EJ | 1 |
| Dixon, DO | 2 |
| Gassmann, W | 3 |
| Schmitz, N | 3 |
| Löffler, H | 3 |
| Klastersky, J | 1 |
| Cech, P | 1 |
| Testa, U | 1 |
| Dubart, A | 1 |
| Schneider, P | 1 |
| Bachmann, F | 1 |
| Guerrasio, A | 1 |
| Beuzard, Y | 1 |
| Schmidt, PM | 1 |
| Clément, F | 1 |
| Rosa, J | 1 |
| Bartual, J | 1 |
| Roquette, J | 1 |
| Gil, M | 1 |
| Magro, E | 1 |
| Bascuas, JL | 1 |
| Yarnold, JR | 1 |
| Jelliffe, AM | 2 |
| Hudson, GV | 3 |
| Doyle, TJ | 1 |
| Venkatachalam, KK | 1 |
| Maeda, K | 2 |
| Saeed, SM | 1 |
| Tilchen, EJ | 1 |
| Papa, G | 4 |
| Mandelli, F | 4 |
| Anselmo, AP | 6 |
| De Luca, AM | 1 |
| Maurizienrici, R | 1 |
| Mauro, F | 2 |
| Testi, AM | 2 |
| Amadori, S | 2 |
| Biagini, C | 2 |
| Haut, A | 1 |
| Weick, JK | 1 |
| Wilson, HE | 2 |
| Grozea, P | 1 |
| McKelvey, E | 1 |
| Byrne, GE | 1 |
| Hartsock, R | 1 |
| Einhorn, LH | 2 |
| Williams, SD | 1 |
| Stevens, EE | 1 |
| Bond, WH | 1 |
| Chenoweth, L | 1 |
| Moser, K | 1 |
| Pohl, A | 1 |
| Hubbard, SM | 14 |
| Moxley, JH | 2 |
| Come, SE | 3 |
| Skarin, AT | 1 |
| Ricciardi, O | 2 |
| Dal Fior, S | 2 |
| Cappellari, F | 2 |
| Pozza, F | 2 |
| Battista, R | 1 |
| Cortelazzo, S | 1 |
| Capnist, G | 1 |
| D'Emilio, A | 1 |
| Rodeghiero, F | 1 |
| Cimino, G | 7 |
| Marzullo, A | 1 |
| Maurizi Enrici, R | 3 |
| Zanini, M | 6 |
| Zucali, R | 9 |
| Olver, IN | 2 |
| Wolf, MM | 2 |
| Bishop, JF | 1 |
| Ding, JC | 2 |
| Cooper, IA | 3 |
| Matthews, J | 2 |
| McCormick, B | 3 |
| Mertelsmann, R | 2 |
| Tannir, N | 1 |
| Hagemeister, F | 1 |
| Velasquez, W | 2 |
| Corder, MP | 5 |
| Clamon, GH | 2 |
| Wiesenfeld, M | 1 |
| Portlock, CS | 7 |
| Harker, WG | 1 |
| Kushlan, P | 1 |
| Teillet, F | 11 |
| D'Agay, MF | 4 |
| Sagar, HJ | 1 |
| Read, DJ | 1 |
| Krikler, SH | 1 |
| Bain, GO | 1 |
| Gordon, PA | 1 |
| Liebman, HA | 1 |
| Hum, GJ | 1 |
| Sheehan, WW | 1 |
| Ryden, VM | 1 |
| Bateman, JR | 2 |
| Khayat, D | 1 |
| Desprez-Curely, JP | 2 |
| Brocheriou, C | 1 |
| Auclerc, G | 6 |
| Chamseddine, N | 1 |
| Goodman, MJ | 1 |
| Gilman, A | 1 |
| McLennan, MT | 1 |
| Anderson, H | 3 |
| Deakin, DP | 5 |
| Wagstaff, J | 3 |
| Jones, JM | 1 |
| Wilkinson, PM | 3 |
| James, RD | 2 |
| Steward, WP | 2 |
| Blackledge, G | 3 |
| Scarffe, JH | 2 |
| Cooper, MR | 6 |
| Pajak, TF | 4 |
| Gottlieb, AJ | 4 |
| Glicksman, AS | 1 |
| Nissen, N | 2 |
| Richards, F | 1 |
| Bloomfield, C | 1 |
| Holland, JF | 7 |
| Crowther, D | 12 |
| Deakin, D | 1 |
| Todd, I | 2 |
| Wilkinson, P | 1 |
| Jones, M | 1 |
| Dein, RA | 1 |
| Mennuti, MT | 2 |
| Kovach, P | 1 |
| Gabbe, SG | 1 |
| Marty, M | 3 |
| Whitehead, E | 4 |
| Shalet, SM | 8 |
| Beardwell, CG | 2 |
| Specht, L | 4 |
| Hansen, MM | 1 |
| Geisler, C | 1 |
| Westberg, MW | 1 |
| Burns, CP | 1 |
| Klassen, LW | 1 |
| Goeken, NE | 1 |
| Ray, TL | 1 |
| Macfarlane, DE | 1 |
| Jacobs, P | 1 |
| King, HS | 1 |
| Karabus, C | 1 |
| Hartley, P | 1 |
| Werner, D | 1 |
| Kovryzhkina, TA | 1 |
| Ellwein, LB | 2 |
| Semenov, II | 2 |
| Artiushkin, AV | 1 |
| Vorob'ev, AI | 2 |
| Brilliant, MD | 2 |
| Voltarelli, JC | 1 |
| Falcão, RP | 1 |
| Bottura, C | 1 |
| Weitberg, AB | 1 |
| Harmon, DC | 1 |
| Bayle-Weisgerber, C | 4 |
| Lemercier, N | 1 |
| Asselain, B | 4 |
| Gout, M | 1 |
| Schweisguth, O | 2 |
| da Cunha, MF | 1 |
| Meistrich, ML | 2 |
| Fuller, LM | 18 |
| Cundiff, JH | 1 |
| Velasquez, WS | 6 |
| McLaughlin, P | 6 |
| Riggs, SA | 1 |
| Cabanillas, FF | 1 |
| Salvador, PG | 1 |
| Tester, WJ | 1 |
| Kinsella, TJ | 1 |
| Waller, B | 1 |
| Makuch, RW | 1 |
| Kelley, PA | 1 |
| Glatstein, E | 7 |
| Coyne, J | 1 |
| Dervan, P | 1 |
| Sampi, K | 2 |
| Honda, T | 1 |
| Hattori, M | 1 |
| Schmitt, K | 1 |
| Tulzer, W | 1 |
| Yosida, T | 1 |
| Nakanisi, J | 1 |
| Kobayasi, S | 1 |
| Ohtake, S | 4 |
| Ito, K | 1 |
| Nakamura, S | 3 |
| Hattori, K | 1 |
| Saito, Y | 2 |
| Tanimoto, K | 1 |
| Heinz, R | 1 |
| Hanak, H | 1 |
| Berényi, E | 1 |
| Szegedi, G | 1 |
| Dorreen, MS | 2 |
| Laidlow, JM | 1 |
| Plowman, PN | 1 |
| Neudachin, L | 1 |
| Tucker, AK | 1 |
| Faux, MM | 1 |
| Jones, AE | 4 |
| Gassel, WD | 1 |
| Gropp, C | 1 |
| Havemann, K | 1 |
| Cyklis, R | 1 |
| Grześkowiak-Melanowska, J | 1 |
| Vecchi, V | 2 |
| Maccolini, E | 1 |
| Oddo Bravetti, G | 1 |
| Guidelli Guidi, S | 1 |
| Serra, L | 1 |
| Kayser, W | 1 |
| Hansz, J | 1 |
| Burchardt, K | 1 |
| Komarnicki, M | 2 |
| Trepińska, E | 1 |
| Psuja, P | 1 |
| Bartolucci, AA | 2 |
| Liu, C | 1 |
| Durant, JR | 3 |
| Gams, RA | 1 |
| Weinstein, H | 4 |
| Botnick, L | 2 |
| Belli, J | 1 |
| Cassady, JR | 3 |
| Amiel, JL | 2 |
| Spielmann, M | 1 |
| Kerbrat, P | 1 |
| Droz, JP | 1 |
| Tursz, T | 1 |
| Ben Ayed, F | 1 |
| Auclerc, MF | 1 |
| Maral, J | 1 |
| Hawkins, KA | 1 |
| Schinella, R | 1 |
| Schwartz, M | 1 |
| Ramsey, D | 1 |
| Weintraub, AH | 1 |
| Silber, R | 1 |
| Amorosi, EL | 1 |
| Andrieu, JM | 19 |
| Ochoa-Molina, ME | 2 |
| Kuentz, M | 3 |
| Reyes, F | 3 |
| Brun, B | 4 |
| Lebourgeois, JP | 1 |
| Bierling, P | 1 |
| Farcet, JP | 1 |
| Vernant, JP | 3 |
| Imbert, M | 1 |
| Le Bezu, M | 1 |
| Rochant, H | 3 |
| Dreyfus, B | 4 |
| Tawil, E | 1 |
| Mercier, JP | 1 |
| Denz, H | 1 |
| Lechleitner, M | 1 |
| Peschel, C | 1 |
| Peer, L | 1 |
| Huber, H | 1 |
| Kolygin, BA | 5 |
| Kharatishvili, ZV | 1 |
| Aisenberg, AC | 5 |
| Homan, R | 1 |
| Lechner, K | 2 |
| Neumann, E | 2 |
| Moritz, H | 1 |
| Czembirek, H | 1 |
| Resch, F | 1 |
| Wagener, DJ | 2 |
| Burgers, JM | 4 |
| Dekker, AW | 2 |
| Kazem, I | 1 |
| van Peperzeel, HA | 1 |
| Qasim, MM | 1 |
| Sizoo, W | 3 |
| Somers, R | 8 |
| Kroese, WF | 2 |
| Murray, F | 1 |
| Daly, PA | 1 |
| Freyne, PJ | 1 |
| Mazza, P | 5 |
| Lauria, F | 6 |
| Sciascia, R | 3 |
| Emiliani, E | 3 |
| Fiacchini, M | 6 |
| Baccarani, M | 6 |
| Frezza, G | 1 |
| Dominici, G | 1 |
| Cantore, M | 1 |
| Faedi, M | 1 |
| Patricio, MB | 1 |
| Ricardo, JA | 1 |
| Vilhena, M | 1 |
| Branco, F | 1 |
| De Ponte, MA | 1 |
| Cabral, R | 1 |
| Neves, M | 1 |
| De Sousa, JV | 1 |
| Ekert, H | 4 |
| Waters, KD | 2 |
| Kovalenko, NS | 1 |
| Fokina, NT | 2 |
| Matusewicz, W | 1 |
| Drzewoski, J | 1 |
| Robak, T | 3 |
| Krykowski, E | 4 |
| Dini, E | 1 |
| Faux, M | 1 |
| MacKintosh, FR | 1 |
| Sullivan, JA | 4 |
| Johnston, D | 1 |
| North, L | 4 |
| Butler, JJ | 8 |
| Cramer, P | 4 |
| Tea, N | 1 |
| Tricot, G | 2 |
| Flandrin, G | 2 |
| Schaison, G | 5 |
| Mantovani, G | 1 |
| Del Giacco, GS | 1 |
| Marongiu, F | 1 |
| Tognella, S | 1 |
| Carassi, UE | 1 |
| Weidenmaier, W | 1 |
| Röttinger, EM | 1 |
| Gallmeier, WM | 3 |
| Bruntsch, U | 3 |
| Waxman, JH | 2 |
| Terry, YA | 1 |
| Rees, LH | 2 |
| Besser, GM | 2 |
| Tura, S | 7 |
| Cadman, E | 1 |
| Bloom, AF | 1 |
| Prosnitz, L | 1 |
| Farber, L | 1 |
| Vera, R | 2 |
| Bertino, J | 1 |
| Fischer, D | 1 |
| Diehl, LF | 1 |
| Perry, DJ | 1 |
| Terebelo, H | 1 |
| Baldwin, PE | 1 |
| Hurwitz, M | 1 |
| Kimball, DB | 1 |
| Dorn, RV | 1 |
| Simon, RM | 1 |
| Young, RC | 22 |
| Frei, E | 12 |
| Carbone, PP | 5 |
| Nesse, RM | 1 |
| Carli, T | 1 |
| Curtis, GC | 1 |
| Kleinman, PD | 1 |
| Green, JA | 1 |
| Dawson, AA | 3 |
| Fell, LF | 1 |
| Murray, S | 1 |
| Kim, YH | 1 |
| Fayos, JV | 1 |
| Fil'kova, EM | 1 |
| Conrad, FG | 1 |
| Faguet, GB | 1 |
| Davis, HC | 1 |
| McLeod, R | 1 |
| Estes, RG | 1 |
| Baĭsogolov, GD | 1 |
| Casassus, P | 2 |
| Coscas, Y | 2 |
| Darmont, J | 1 |
| Goubeau, C | 1 |
| Katz, M | 3 |
| Rahim, MA | 1 |
| Sarma, SK | 1 |
| Ahmed, Q | 1 |
| Rosenstrauch, WJ | 1 |
| van der Merwe, AM | 1 |
| King, JB | 1 |
| van Eeden, PJ | 1 |
| Steytler, JG | 1 |
| Weiner, MJ | 1 |
| Sicular, A | 1 |
| Blaugrund, SM | 1 |
| Sattler, SM | 1 |
| Steel, NR | 1 |
| Carr, D | 1 |
| Finney, RD | 1 |
| Horikoshi, N | 1 |
| Allan, E | 1 |
| Bostick, F | 1 |
| Vanhaelen, C | 1 |
| Howser, DM | 1 |
| Nissen, NI | 13 |
| Nordentoft, AM | 3 |
| Brincker, H | 1 |
| Andersen, E | 2 |
| Jensen, MK | 1 |
| Nielsen, JB | 1 |
| Pedersen-Bjergaard, J | 3 |
| Jensen, TS | 1 |
| Jensen, KB | 1 |
| Pedersen, M | 1 |
| Walbom-Jørgensen, S | 2 |
| Bayle, C | 1 |
| Clot, P | 2 |
| Dana, M | 4 |
| Brière, J | 2 |
| Barnes, JM | 1 |
| Neiman, RS | 1 |
| Orlow, EL | 1 |
| Glidewell, OJ | 4 |
| Bloomfield, CD | 2 |
| Sullivan, MP | 4 |
| Chen, T | 1 |
| Fisher, R | 1 |
| Fryer, C | 2 |
| Gehan, E | 1 |
| Gilchrist, GS | 4 |
| Hays, D | 1 |
| Hanson, W | 2 |
| Heller, R | 2 |
| Higgins, G | 1 |
| Kung, F | 1 |
| Sheehan, W | 1 |
| Tefft, M | 1 |
| Ternberg, J | 2 |
| Wharam, M | 2 |
| Chan, H | 2 |
| Freedman, M | 3 |
| Greenberg, M | 4 |
| Gribbin, M | 1 |
| McClure, P | 2 |
| Saunders, F | 3 |
| Sonley, M | 2 |
| Coleman, CN | 7 |
| Cox, RS | 3 |
| Cunningham, J | 1 |
| Mauch, P | 11 |
| Rosenthal, DS | 9 |
| Johnston, DA | 2 |
| Jones, PH | 1 |
| Hellman, S | 7 |
| Delbrück, H | 2 |
| Lelièvre, P | 1 |
| Lawson, JP | 1 |
| Friedlaender, GE | 1 |
| Pezzimenti, JF | 1 |
| Chapman, RM | 1 |
| Strickland, P | 1 |
| Schilsky, RL | 2 |
| Sherins, RJ | 5 |
| Wesley, MN | 2 |
| Streuli, RA | 2 |
| Ultmann, JE | 3 |
| Velazquez, WS | 1 |
| North, LB | 3 |
| Martin, RG | 1 |
| Nadiminti, Y | 1 |
| Wang, JC | 1 |
| Chou, SY | 1 |
| Pineles, E | 1 |
| Tobin, MS | 1 |
| Timothy, AR | 2 |
| Stutzman, L | 5 |
| Brunner, K | 2 |
| Cuttner, J | 2 |
| Falkson, G | 3 |
| Grunwald, H | 1 |
| Bank, A | 2 |
| Leone, L | 2 |
| Seligman, BR | 1 |
| Silver, RT | 2 |
| Weiss, RB | 3 |
| Haurani, F | 2 |
| Blom, J | 3 |
| Gordon, RA | 1 |
| Lookingbill, DP | 1 |
| Abt, AB | 1 |
| Albala, MM | 1 |
| Steinfeld, AD | 1 |
| Khilnani, MT | 1 |
| Alaoui, Y | 1 |
| Baillet, F | 4 |
| Maylin, C | 2 |
| Pierquin, B | 3 |
| Jacobson, RJ | 1 |
| Klappenbach, RS | 1 |
| Clinton, C | 1 |
| de Moor, NG | 1 |
| Wong, O | 1 |
| Golomb, HM | 1 |
| Sweet, DL | 1 |
| Kotlarek-Haus, S | 1 |
| Gabryś, K | 1 |
| Potoczek, S | 1 |
| Glanzmann, C | 1 |
| Stahel, R | 2 |
| Kingreen, D | 1 |
| Dalal, BI | 1 |
| Heyman, M | 1 |
| Phillips, GL | 3 |
| Horsman, D | 1 |
| Kidd, P | 1 |
| Loughran, TP | 1 |
| Cleary, SF | 1 |
| Donaldson, SS | 6 |
| Abboud, J | 1 |
| Nasrallah, T | 1 |
| Chahine, G | 1 |
| Nasnas, R | 1 |
| Mah, K | 1 |
| Keane, TJ | 1 |
| Van Dyk, J | 1 |
| Braban, LE | 1 |
| Poon, PY | 1 |
| Hao, Y | 1 |
| Tarayre, M | 2 |
| de Pauw, BE | 2 |
| Breed, WP | 2 |
| Verdonck, L | 1 |
| Siena, S | 2 |
| Bregni, M | 2 |
| Lombardi, F | 2 |
| Gandola, L | 1 |
| Di Nicola, M | 1 |
| Magni, M | 1 |
| Peccatori, F | 1 |
| Moreau, P | 2 |
| Milpied, N | 2 |
| Mechinaud-Lacroix, F | 1 |
| Mahe, B | 1 |
| Rapp, MJ | 1 |
| Le Tortorec, S | 1 |
| Bourdin, S | 1 |
| Dupas, B | 1 |
| Harousseau, JL | 1 |
| Brusamolino, E | 5 |
| Lazzarino, M | 4 |
| Orlandi, E | 4 |
| Canevari, A | 2 |
| Morra, E | 3 |
| Castelli, G | 3 |
| Alessandrino, EP | 2 |
| Pagnucco, G | 4 |
| Astori, C | 3 |
| Livraghi, A | 2 |
| Mandard, AM | 1 |
| Mellink, WA | 1 |
| Santagostino, A | 1 |
| Bernasconi, C | 2 |
| Preti, A | 1 |
| Swan, F | 3 |
| Rodriguez, A | 1 |
| Besa, P | 1 |
| Allen, PK | 2 |
| Bernasconi, P | 1 |
| Koeppel, MC | 1 |
| Horschowski, N | 1 |
| Terrier, G | 1 |
| Andrac, L | 1 |
| Stoppa, AM | 1 |
| Signoret, R | 1 |
| Sayag, J | 1 |
| Hunger, SP | 1 |
| Khan, SP | 1 |
| Arndt, CA | 1 |
| Smithson, WA | 1 |
| Chen, MG | 1 |
| Schomberg, PJ | 1 |
| Matsumoto, JM | 1 |
| O'Fallon, WM | 1 |
| Hermann, R | 1 |
| Greminger, P | 1 |
| Dommann-Scherrer, C | 1 |
| Krestin, GP | 1 |
| Soncini, F | 3 |
| Devizzi, L | 6 |
| Castellani, MR | 1 |
| Negretti, E | 3 |
| Crennan, E | 1 |
| D'Costa, I | 1 |
| Liew, KH | 2 |
| Thompson, J | 1 |
| Laidlaw, C | 2 |
| Cooper, I | 2 |
| Quong, G | 1 |
| Fried, G | 1 |
| Ben Arieh, Y | 1 |
| Haim, N | 4 |
| Dale, J | 1 |
| Stein, M | 1 |
| Balzarini, L | 1 |
| Kozielski, J | 1 |
| Rauer, R | 1 |
| Ziora, D | 1 |
| Spychałowicz, W | 1 |
| Myint, H | 1 |
| McGregor, J | 1 |
| Edwards, R | 1 |
| Lucie, NP | 1 |
| Hancock, SL | 2 |
| Pollicardo, N | 1 |
| Pungolino, E | 2 |
| Frassoni, F | 2 |
| Giordano, D | 3 |
| Bruni, R | 2 |
| Spriano, M | 2 |
| Rossi, E | 2 |
| Aversa, S | 1 |
| Chiarion Sileni, V | 2 |
| Scarzello, G | 1 |
| Bianco, A | 2 |
| Pappagallo, GL | 2 |
| Fiorentino, MV | 2 |
| Lévy, R | 1 |
| Colonna, P | 7 |
| Tourani, JM | 2 |
| Gastaut, JA | 1 |
| Raphaël, M | 1 |
| Taillan, B | 1 |
| Bendandi, M | 1 |
| Zaccaria, A | 1 |
| Zinzani, PL | 3 |
| Visani, G | 2 |
| Stefanati, V | 1 |
| Cantagalli, F | 1 |
| Mancino, A | 1 |
| Macchi, S | 1 |
| Simoncelli, F | 1 |
| Errante, D | 1 |
| Dolcetti, R | 1 |
| Gloghini, A | 1 |
| Serraino, D | 1 |
| Franceschi, S | 1 |
| Boiocchi, M | 1 |
| Carbone, A | 2 |
| Reece, DE | 2 |
| Barnett, MJ | 2 |
| Shepherd, JD | 2 |
| Hogge, DE | 1 |
| Klasa, RJ | 1 |
| Nantel, SH | 1 |
| Sutherland, HJ | 1 |
| Klingemann, HG | 2 |
| Fairey, RN | 2 |
| Voss, NJ | 1 |
| Jekunen, A | 1 |
| Maiche, A | 1 |
| Laurila, P | 1 |
| Franssila, K | 1 |
| Elomaa, I | 1 |
| Boice, JD | 1 |
| Travis, LB | 1 |
| Tobinai, K | 2 |
| Gui, W | 1 |
| Zhen, YP | 1 |
| Chang, XQ | 1 |
| Barcos, M | 2 |
| Radford, JA | 6 |
| Rohatiner, AZ | 2 |
| Ryder, WD | 2 |
| Gupta, RK | 1 |
| Oza, A | 2 |
| Arnott, S | 2 |
| Sullivan, JW | 1 |
| Cooper, JS | 1 |
| Martino, R | 1 |
| Nomdedeu, J | 1 |
| Brunet, S | 1 |
| Spector, N | 1 |
| Costa, MA | 1 |
| Pulcheri, W | 1 |
| Salgado, RC | 1 |
| Nucci, M | 1 |
| Andrade, CA | 1 |
| de Morais, JC | 1 |
| de Castro, O | 1 |
| Scaletsky, AF | 1 |
| Brabo, E | 1 |
| Chintagumpala, MM | 1 |
| Mahoney, DH | 1 |
| McClain, K | 1 |
| Dreyer, ZE | 1 |
| Fishman, MA | 1 |
| Carrol, CL | 1 |
| Steuber, CP | 1 |
| Behar, RA | 1 |
| Pieresca, C | 1 |
| Narni, F | 1 |
| Grignani, G | 1 |
| Avanzini, P | 1 |
| Partesotti, G | 1 |
| Uematsu, M | 1 |
| Tarbell, NJ | 4 |
| Shulman, LN | 2 |
| Canellos, G | 1 |
| Bader, SB | 1 |
| Lepage, E | 5 |
| Fermand, JP | 2 |
| Castaigne, S | 3 |
| Frija, J | 2 |
| Miot, C | 2 |
| Lichtman, SM | 1 |
| Brody, J | 1 |
| Kaplan, MH | 1 |
| Susin, M | 1 |
| Koduru, P | 1 |
| Goh, JC | 1 |
| Simmonds, P | 1 |
| Silberstein, M | 1 |
| McKendrick, J | 1 |
| Gerhartz, HH | 1 |
| Beykirch, M | 1 |
| Hiller, E | 1 |
| Wilmanns, W | 2 |
| Pileri, S | 1 |
| Burnelli, R | 1 |
| Bontempi, N | 1 |
| Comelli, A | 1 |
| Carli, M | 1 |
| Rosati, D | 1 |
| Di Tullio, MT | 1 |
| Yong, WB | 1 |
| Wang, H | 1 |
| Zhu, XM | 1 |
| Hayat, M | 4 |
| Burgers, MJ | 1 |
| Tanguy, A | 2 |
| Le Fur, R | 2 |
| Levêque, J | 1 |
| Meunier, B | 1 |
| Poulain, P | 1 |
| Blanchot, J | 1 |
| Dugast, J | 1 |
| Le Prise, E | 1 |
| Grall, JY | 2 |
| Clark, ST | 2 |
| Swindell, R | 3 |
| Rysenga, E | 1 |
| Linden, MD | 1 |
| Carey, JL | 1 |
| Ross, CW | 1 |
| Schnitzer, B | 1 |
| Sawdyk, M | 1 |
| Pautier, P | 1 |
| Marolleau, JP | 1 |
| Montillo, M | 1 |
| Scarpelli, M | 1 |
| Discepoli, G | 1 |
| Catarini, M | 1 |
| Rychlicki, F | 1 |
| Leoni, P | 1 |
| Kessinger, A | 1 |
| Lee, CK | 3 |
| Levitt, SH | 1 |
| Onoshi, T | 1 |
| Robinson, BA | 1 |
| Colls, BM | 1 |
| Fitzharris, BM | 1 |
| Atkinson, CH | 1 |
| Marcus, KC | 1 |
| Kalish, LA | 1 |
| Dietrich, PY | 1 |
| Cosset, JM | 3 |
| Bodis, S | 1 |
| Holmes, SJ | 1 |
| Whitehouse, RW | 1 |
| Crowther, DC | 1 |
| Adams, JE | 1 |
| Souliotis, VL | 1 |
| Valavanis, C | 1 |
| Kyrtopoulos, SA | 1 |
| Purugganan, R | 1 |
| Fuller, L | 1 |
| Romaguera, J | 1 |
| Rodriguez, M | 1 |
| Fisher, PM | 1 |
| Dodwell, DJ | 2 |
| Bridges, LR | 1 |
| Cartwright, SC | 1 |
| Stone, J | 1 |
| Brandriff, BF | 1 |
| Gordon, LA | 1 |
| Carrano, AV | 1 |
| Liang, JC | 2 |
| Chorus, AM | 1 |
| Noyon, R | 1 |
| van Kerkhoff, EH | 1 |
| Pinedo, HM | 1 |
| Bokemeyer, C | 1 |
| Schmoll, HJ | 1 |
| van Rhee, J | 1 |
| Kuczyk, M | 1 |
| Schuppert, F | 1 |
| Poliwoda, H | 1 |
| Delmez, JA | 1 |
| Safdar, SH | 1 |
| Kissane, JM | 1 |
| Avilés, A | 5 |
| Arévila, N | 1 |
| Díaz Maqueo, JC | 1 |
| Gómez, T | 1 |
| García, R | 1 |
| Nambo, MJ | 1 |
| Gosselin, M | 1 |
| Podgorsak, EB | 1 |
| Evans, MD | 1 |
| Pla, M | 1 |
| Shenouda, G | 1 |
| Grundstein-Amado, R | 1 |
| Dhabhar, BN | 1 |
| Malhotra, H | 1 |
| Joseph, R | 1 |
| Garde, S | 1 |
| Bhasin, S | 1 |
| Sheth, A | 1 |
| Advani, SH | 2 |
| Cascinu, S | 1 |
| Fedeli, A | 1 |
| Catalano, G | 1 |
| Grigoraki, V | 1 |
| Lilienthal, F | 1 |
| Binet, JL | 1 |
| Merle-Béral, H | 2 |
| Kirshner, JJ | 1 |
| Parker, B | 1 |
| Kaźmierczak, M | 1 |
| Kroll, R | 1 |
| Fitzgerald, A | 1 |
| Björkholm, M | 2 |
| Axdorph, U | 1 |
| Grimfors, G | 1 |
| Merk, K | 1 |
| Johansson, B | 1 |
| Landgren, O | 1 |
| Svedmyr, E | 1 |
| Mellstedt, H | 1 |
| Holm, G | 1 |
| Abdallah, JM | 1 |
| Lombardi, DP | 1 |
| Kirsch, IR | 1 |
| Naccache, P | 1 |
| Koscielny, S | 1 |
| Bendahmane, B | 1 |
| Munck, JN | 1 |
| Cervantes, F | 1 |
| Briones, J | 1 |
| Bruguera, M | 1 |
| Font, C | 1 |
| Grau, JM | 1 |
| Rozman, C | 1 |
| Montserrat, E | 1 |
| Yuen, AR | 1 |
| Prencipe, E | 1 |
| Lerma, E | 1 |
| Occhini, D | 2 |
| Gatti, AM | 1 |
| Nati, S | 2 |
| Pierluigi, D | 2 |
| Congiu, M | 1 |
| Vimercati, R | 1 |
| Ravetti, JL | 1 |
| Ifrah, N | 2 |
| Hunault, M | 1 |
| Jais, JP | 2 |
| Desablens, B | 1 |
| Le Maignan, C | 1 |
| Glimelius, B | 2 |
| Kalkner, M | 1 |
| Gustavsson, A | 2 |
| Jakobsson, M | 1 |
| Branehog, I | 1 |
| Lenner, P | 1 |
| Heikens, J | 1 |
| Adriaanse, R | 1 |
| Berghout, A | 1 |
| Blumenfeld, Z | 2 |
| Avivi, I | 1 |
| Linn, S | 1 |
| Epelbaum, R | 2 |
| Ben-Shahar, M | 3 |
| Kumari, PK | 1 |
| Chellam, VG | 1 |
| Madhavan, J | 1 |
| Ratheesan, K | 1 |
| Pillai, GR | 1 |
| Kumar, SR | 1 |
| Nair, MK | 1 |
| Swerdlow, AJ | 3 |
| Barber, JA | 2 |
| Horwich, A | 3 |
| Cunningham, D | 2 |
| Milan, S | 1 |
| Omar, RZ | 1 |
| Falchero, L | 1 |
| Coiffier, B | 3 |
| Guibert, B | 1 |
| Souquet, PJ | 1 |
| Isaac Pinet, S | 1 |
| Trillet-Lenoir, V | 1 |
| Harif, M | 1 |
| Trachli, A | 1 |
| Quessar, A | 1 |
| Sehraoui, S | 1 |
| Benchekroun, S | 1 |
| Benchemsi, N | 1 |
| Redei, I | 1 |
| Mangan, KF | 1 |
| Ming, PL | 1 |
| Mullaney, MT | 1 |
| Rao, PN | 1 |
| Goldberg, SL | 1 |
| Klumpp, TR | 1 |
| Balzarotti, M | 2 |
| Meurman, JH | 2 |
| Laine, P | 2 |
| Keinànen, S | 1 |
| Pyrhönen, S | 2 |
| Teerenhovi, L | 2 |
| Lindqvist, C | 2 |
| Varterasian, ML | 1 |
| Aref, A | 1 |
| Karanes, C | 1 |
| Stuve, W | 1 |
| Marjańska-Radziszewska, J | 1 |
| Zawiła, K | 1 |
| Cieśla, E | 1 |
| Zsiros, J | 1 |
| Bossi, G | 1 |
| Cerveri, I | 1 |
| Volpini, E | 1 |
| Corsico, A | 1 |
| Baio, A | 1 |
| Klersy, C | 2 |
| Arico, M | 1 |
| Raemaekers, J | 1 |
| Burgers, M | 1 |
| Mandard, A | 1 |
| Breed, W | 1 |
| Noordijk, E | 1 |
| Klimo, P | 5 |
| Adams, G | 1 |
| Burns, BF | 1 |
| Meyer, RM | 1 |
| O'Reilly, SE | 3 |
| Pater, J | 1 |
| Quirt, I | 1 |
| Sadura, A | 1 |
| Shustik, C | 1 |
| Skillings, J | 1 |
| Sutcliffe, S | 1 |
| Verma, S | 1 |
| Yoshida, S | 1 |
| Zee, B | 1 |
| Schellong, G | 1 |
| Riepenhausen, M | 1 |
| Creutzig, U | 1 |
| Ritter, J | 1 |
| Harbott, J | 1 |
| Mann, G | 1 |
| Gadner, H | 1 |
| Kamieńska, E | 1 |
| Crosbie, OM | 1 |
| Crown, JP | 1 |
| Nolan, NP | 1 |
| Murray, R | 1 |
| Hegarty, JE | 1 |
| Imrie, KR | 1 |
| Sheridan, B | 1 |
| Colwill, R | 1 |
| Stewart, AK | 1 |
| McCrae, J | 1 |
| Danish, R | 1 |
| Sutton, D | 1 |
| Romeyer, F | 1 |
| Keating, A | 1 |
| Weiner, MA | 2 |
| Leventhal, B | 1 |
| Brecher, ML | 1 |
| Marcus, RB | 1 |
| Cantor, A | 2 |
| Gieser, PW | 1 |
| Kulkarni, SS | 1 |
| Sastry, PS | 1 |
| Saikia, TK | 1 |
| Parikh, PM | 1 |
| Gopal, R | 1 |
| Corry, J | 1 |
| Duffey, PL | 8 |
| Ihde, DC | 2 |
| Bastian, AW | 2 |
| Wittes, RE | 1 |
| Golden, MA | 1 |
| Vaughn, DJ | 1 |
| Crooks, GW | 1 |
| Holland, GA | 1 |
| Bavaria, JE | 1 |
| Ziółko, E | 1 |
| Young, ML | 1 |
| Harrington, D | 1 |
| Beck, T | 1 |
| Neiman, R | 1 |
| Oken, MM | 2 |
| Ritter, M | 1 |
| Shen-Orr, Z | 1 |
| Shariki, K | 1 |
| Tsodikov, A | 1 |
| Loeffler, M | 1 |
| Yakovlev, A | 1 |
| Hutchinson, RJ | 1 |
| Fryer, CJ | 1 |
| Davis, PC | 1 |
| Nachman, J | 1 |
| Krailo, MD | 1 |
| O'Brien, RT | 1 |
| Collins, RD | 1 |
| Whalen, T | 1 |
| Reardon, D | 1 |
| Trigg, ME | 1 |
| Constine, LS | 1 |
| Camerini, E | 1 |
| Fornier, M | 1 |
| Verderio, P | 1 |
| Hesseling, PB | 1 |
| Van Jaarsveld, D | 1 |
| Van Riet, FA | 1 |
| Bairey, O | 1 |
| Gabbay, U | 1 |
| Blickstein, D | 1 |
| Stark, P | 1 |
| Prokocimer, M | 1 |
| Epstein, O | 1 |
| Shaklai, M | 1 |
| Lahav, J | 1 |
| Dunlop, DJ | 1 |
| Eatock, MM | 1 |
| Paul, J | 2 |
| Anderson, S | 1 |
| Reed, NS | 1 |
| Soukop, M | 2 |
| Lucie, N | 1 |
| Fitzsimmons, EJ | 1 |
| Tansey, P | 1 |
| Warzocha, K | 1 |
| Bienvenu, J | 1 |
| Ribeiro, P | 1 |
| Moullet, I | 2 |
| Dumontet, C | 1 |
| Neidhardt-Berard, EM | 1 |
| André, M | 1 |
| Blaise, D | 1 |
| Fleury, J | 1 |
| Cahn, JY | 1 |
| Pico, JL | 1 |
| Bastion, Y | 2 |
| Nedellec, G | 1 |
| Attal, M | 1 |
| Arranz, R | 1 |
| Gil-Fernández, JJ | 1 |
| Muñoz, E | 1 |
| Acevedo, A | 1 |
| Sobrino, MP | 1 |
| Fernández-Rañada, JM | 1 |
| Nyandoto, P | 1 |
| Muhonen, T | 1 |
| Santoro, M | 1 |
| Lunghi, F | 1 |
| Maurizi-Enrici, R | 1 |
| Baroni, CD | 1 |
| Tacik, J | 1 |
| Eliasińska, A | 1 |
| Tsushita, K | 1 |
| Utsumi, M | 1 |
| Shimoyama, M | 1 |
| Baron, F | 1 |
| Hermanne, JP | 1 |
| Fassotte, MF | 1 |
| Beguin, Y | 1 |
| Fillet, G | 1 |
| Klapper, SR | 1 |
| Jordan, DR | 1 |
| McLeish, W | 1 |
| Pelletier, C | 1 |
| Yilmaz, U | 1 |
| Salloum, E | 1 |
| Tanoue, LT | 1 |
| Wackers, FJ | 1 |
| Zelterman, D | 1 |
| Hu, GL | 1 |
| Cooper, DL | 1 |
| Cantin, G | 1 |
| L'Espérance, B | 1 |
| Yelle, L | 2 |
| Desjardins, L | 1 |
| Couture, F | 1 |
| Bergeron, M | 1 |
| Lacroix, L | 1 |
| Dufresne, J | 1 |
| Bélanger, D | 1 |
| Ouellet, PA | 1 |
| Hewitt, LA | 1 |
| Pirc, L | 1 |
| Gyger, M | 1 |
| Chim, CS | 1 |
| Kwong, YL | 1 |
| Lie, AK | 1 |
| Ho, FC | 1 |
| Liang, R | 1 |
| Delain, M | 1 |
| Cartron, G | 1 |
| Bout, M | 1 |
| Benboubker, L | 1 |
| Linassier, C | 1 |
| Lamagnere, JP | 1 |
| Bogusławska-Jaworska, J | 1 |
| Pisarek, J | 1 |
| Janik-Moszant, A | 1 |
| Kołecki, P | 1 |
| Skomra, S | 1 |
| Newecka-Samól, T | 1 |
| Harrison, CN | 1 |
| Gregory, W | 3 |
| Devereux, S | 1 |
| Goldstone, AH | 1 |
| Hancock, B | 1 |
| Winfield, D | 1 |
| MacMillan, AK | 1 |
| Hoskin, P | 1 |
| Newland, AC | 1 |
| Milligan, D | 1 |
| Linch, DC | 2 |
| Lucas, JB | 1 |
| Horwitz, SM | 1 |
| Sayegh, A | 1 |
| Fouillard, L | 1 |
| Laporte, J | 1 |
| Douay, L | 1 |
| Lesage, S | 1 |
| Najman, A | 1 |
| Gourmelon, P | 1 |
| Gorin, NC | 1 |
| Lishner, M | 2 |
| Manor, Y | 1 |
| Kitay-Cohen, Y | 1 |
| Avishay, AE | 1 |
| Aglietta, M | 1 |
| Montemurro, F | 1 |
| Fagioli, F | 1 |
| Volta, C | 1 |
| Botto, B | 1 |
| Cantonetti, M | 1 |
| Racanelli, V | 1 |
| Ferrara, R | 1 |
| Castoldi, GL | 1 |
| Dammacco, F | 1 |
| Muwakkit, S | 1 |
| Geara, F | 1 |
| Nabbout, B | 1 |
| Farah, RA | 1 |
| Shabb, NS | 1 |
| Hajjar, T | 1 |
| Khogali, M | 1 |
| Meddeb, B | 1 |
| Ben Lakhal, R | 1 |
| Ben Abid, H | 1 |
| Hafsia, R | 1 |
| Hafsia, A | 1 |
| Sebban, C | 1 |
| Hennequin, C | 1 |
| Ferrant, A | 4 |
| Caillot, D | 1 |
| Bertè, R | 1 |
| Petrilli, MP | 1 |
| Angrilli, F | 1 |
| Ghirardelli, ML | 1 |
| Ascari, E | 2 |
| Tomasević, Z | 1 |
| Jelić, S | 1 |
| Tal, R | 1 |
| Botchan, A | 1 |
| Hauser, R | 1 |
| Yogev, L | 1 |
| Paz, G | 1 |
| Yavetz, H | 1 |
| Sauter, C | 1 |
| Petera, J | 1 |
| Macharová, H | 1 |
| Pohanková, R | 1 |
| Malír, A | 1 |
| Coupek, P | 1 |
| Konecný, M | 1 |
| Patera, J | 1 |
| Pecina, J | 1 |
| Drbal, J | 1 |
| Koukalová, H | 1 |
| Vásová, I | 1 |
| Powles, T | 1 |
| Bower, M | 1 |
| Choe, JG | 1 |
| Kong, JS | 1 |
| Oh, YK | 1 |
| Edmund, E | 1 |
| Geissler, K | 1 |
| Gisslinger, H | 1 |
| Knöbl, P | 1 |
| Sperr, W | 1 |
| Valent, P | 1 |
| Dieckmann, K | 1 |
| Chott, A | 1 |
| Pötter, R | 1 |
| Jäger, U | 1 |
| Pérez, JA | 1 |
| Ramírez, R | 1 |
| Carpio, D | 1 |
| Carrasco, C | 1 |
| Pérez, A | 1 |
| Avigdor, A | 1 |
| Hardan, I | 1 |
| Shpilberg, O | 1 |
| Raanani, P | 1 |
| Grotto, I | 1 |
| Ben-Bassat, I | 2 |
| Elconin, JH | 1 |
| Roberts, KB | 2 |
| Rizzieri, DA | 1 |
| Vermont, C | 1 |
| Clough, RW | 1 |
| Kim, C | 1 |
| Dodge, RK | 1 |
| Soriano Guillén , L | 1 |
| Muñoz Calvo , MT | 1 |
| Pozo Román , J | 1 |
| Contra Gómez , T | 1 |
| Buño Soto , M | 1 |
| Argente Oliver , J | 1 |
| Homenda, W | 1 |
| Hellmann, A | 1 |
| Maslovsky, I | 1 |
| Volchek, L | 1 |
| Blumental, R | 1 |
| Ducach, A | 1 |
| Lugassy, G | 1 |
| Nicolatou-Galitis, O | 1 |
| Papadaki, T | 1 |
| Moschovi, M | 1 |
| Moshovi, M | 1 |
| Kamma, JJ | 1 |
| van Vliet-Constantinidou, C | 1 |
| Tsoumakas, C | 1 |
| Kattamis, A | 1 |
| Tzortzatou-Stathopoulou, F | 1 |
| Tesch, H | 1 |
| Sieber, M | 1 |
| Schoemaker, MJ | 1 |
| Allerton, R | 1 |
| Vaughan Hudson, G | 2 |
| Williams, MV | 1 |
| Cellai, E | 1 |
| Magrini, SM | 3 |
| Masala, G | 1 |
| Alterini, R | 1 |
| Costantini, AS | 1 |
| Rigacci, L | 1 |
| Olmastroni, L | 1 |
| Papi, MG | 1 |
| Spediacci, MA | 1 |
| Innocenti, F | 1 |
| Bellesi, G | 1 |
| Ferrini, PR | 1 |
| Biti, G | 1 |
| Valtuch, I | 1 |
| Faraggi, D | 1 |
| Sharabi-Nov, A | 1 |
| Ben-Arie, Y | 1 |
| Cohen, Y | 1 |
| Colin, P | 1 |
| de Kerviler, E | 1 |
| Bouaffia, F | 1 |
| Kerneis, Y | 1 |
| Molin, D | 1 |
| Sundström, C | 1 |
| Venge, P | 1 |
| Hull, MC | 1 |
| Mendenhall, NP | 1 |
| Colgan, ME | 1 |
| Zhou, L | 1 |
| Wang, Q | 1 |
| Feng, F | 1 |
| Neri, N | 1 |
| Cavalli, F | 1 |
| Franklin, J | 1 |
| Schlembach, PJ | 1 |
| Jones, D | 1 |
| Younes, A | 1 |
| Mahmood, T | 1 |
| Mudad, R | 1 |
| Linfomi, MB | 1 |
| Delwail, V | 1 |
| Vettore, L | 1 |
| Maiolini, E | 1 |
| Buttolo, Q | 1 |
| Mauro, PL | 1 |
| Colle, R | 1 |
| Johnson, LP | 1 |
| Rivkin, SE | 1 |
| Weber, EL | 1 |
| De Lena, M | 3 |
| Uslenghi, C | 1 |
| Naysmith, A | 1 |
| Hancock, BW | 3 |
| Cullen, DR | 1 |
| Richmond, J | 1 |
| Wilde, CE | 1 |
| Osieka, R | 1 |
| Seeber, S | 2 |
| Schmidt, CG | 2 |
| Lokich, JJ | 3 |
| Jaffe, N | 3 |
| Tullis, J | 2 |
| Case, DC | 2 |
| Nisce, L | 1 |
| Anderson, T | 2 |
| Walser, A | 1 |
| Alberto, P | 2 |
| Garrett, MJ | 2 |
| Das, S | 1 |
| Smith, JD | 1 |
| Freedman, LS | 1 |
| Dold, U | 1 |
| Porzig, KJ | 1 |
| Robertson, A | 1 |
| Krikorian, JG | 1 |
| Johnson, SA | 1 |
| Hawkins, DF | 1 |
| Fiaccini, M | 1 |
| Glatstein, EJ | 2 |
| Wewerka, JR | 1 |
| Magrath, I | 3 |
| Henle, W | 1 |
| Owor, R | 1 |
| Olweny, C | 1 |
| Le Blanc, DH | 1 |
| Trump, DL | 1 |
| Cowall, DE | 1 |
| Sieber, SM | 1 |
| Stopyrowa, J | 2 |
| Depowski, M | 2 |
| Strzeszynski, J | 3 |
| Lewis, BJ | 1 |
| Rozencweig, M | 1 |
| Muggia, FM | 1 |
| Glidewell, O | 3 |
| Sawitsky, A | 1 |
| Coleman, M | 3 |
| Harley, JB | 1 |
| Seligman, B | 1 |
| Cornell, C | 1 |
| Henry, P | 1 |
| Senn, HJ | 2 |
| Martz, G | 1 |
| Maurice, P | 1 |
| Shapiro, L | 1 |
| James, GW | 1 |
| Briere, JF | 1 |
| Gustafson, J | 1 |
| Schimpff, SC | 1 |
| Diggs, C | 1 |
| Greenberger, JS | 1 |
| Weichselbaum, RR | 1 |
| Botnick, LE | 1 |
| Goodman, R | 3 |
| Filler, R | 1 |
| Levi, JA | 1 |
| Madoc-Jones, H | 1 |
| Fernandez, CH | 1 |
| Piro, A | 1 |
| Rosenthal, D | 2 |
| Goldstein, M | 1 |
| Desforges, JF | 1 |
| Rutherford, CJ | 1 |
| Hubbard, SP | 1 |
| Simon, R | 1 |
| Smith, PG | 1 |
| Wald, N | 1 |
| Ali, NO | 1 |
| Janes, WO | 1 |
| Hoogstraten, B | 2 |
| Perlberg, HJ | 1 |
| Kramer, S | 3 |
| Piro, AJ | 1 |
| Sinniah, D | 1 |
| Lin, HP | 1 |
| Peters, V | 1 |
| Kluin-Neleman, JC | 1 |
| Neleman, FA | 1 |
| Meuwissen, OJ | 1 |
| Maes, RA | 1 |
| Vinokurova, NA | 1 |
| Chekharina, EA | 1 |
| Volterrani, F | 1 |
| Sigurtà, D | 1 |
| Severini, A | 1 |
| Roeser, HP | 1 |
| Roberts, SJ | 1 |
| Kynaston, B | 1 |
| Whitaker, SV | 1 |
| Hocker, GA | 1 |
| Poleksic, S | 1 |
| Yeung, KY | 1 |
| Peto, J | 1 |
| Whitehouse, JM | 1 |
| Royal, JE | 1 |
| Seeler, RA | 1 |
| Horner, RJ | 1 |
| Chaffey, JT | 1 |
| Moloney, WC | 3 |
| Babini, L | 1 |
| Franchini, A | 1 |
| Katongole-Mbidde, E | 1 |
| Kiire, C | 1 |
| Lwanga, SK | 1 |
| Chabner, BA | 2 |
| Goodman, RL | 2 |
| Neretto, G | 1 |
| Giovanelli, E | 1 |
| Agricola, R | 1 |
| Furno, F | 1 |
| Zieliński, T | 1 |
| Krajewska, B | 1 |
| Solska, E | 1 |
| Karnicka-Młodkowska, H | 1 |
| Rath, P | 1 |
| Aghai, E | 2 |
| Many, A | 2 |
| Hulu, N | 1 |
| Ramot, B | 2 |
| Brenner, H | 1 |
| Klein, HO | 1 |
| O'Brien, PH | 1 |
| Wallace, K | 1 |
| Rambo, VB | 1 |
| Barbieri, E | 2 |
| Gobbi, M | 2 |
| Oluboyede, OA | 1 |
| Esan, GJ | 1 |
| Farney, RJ | 1 |
| Morris, AH | 1 |
| Armstrong, JD | 1 |
| Hammer, S | 1 |
| Mazurowa, A | 1 |
| Pluzańska, A | 2 |
| Dmochowska, M | 1 |
| Polkowska-Kulesza, E | 1 |
| Skorek, TO | 1 |
| Fajndt, S | 1 |
| Boguszewska, E | 1 |
| Jacquillat, Cl | 2 |
| Dickey, JM | 1 |
| Duchamp, C | 1 |
| Clément, R | 1 |
| Juin, P | 1 |
| Mazeron, JJ | 2 |
| Clay, A | 1 |
| Swain, A | 1 |
| Trounce, JR | 1 |
| Williams, CJ | 1 |
| Flint, A | 1 |
| Pinon, G | 1 |
| Gemon-Auclerc, MF | 2 |
| Chastang, C | 2 |
| Bauters, F | 1 |
| Jouet, JP | 2 |
| Caulier, MT | 1 |
| Wurtz, A | 1 |
| Ribet, M | 1 |
| Goudemand, M | 1 |
| Fortuny, I | 1 |
| Vosika, G | 1 |
| Kennedy, BJ | 1 |
| Fischer, JJ | 3 |
| Fischer, DB | 1 |
| Weller, SA | 1 |
| Gunale, S | 1 |
| Hardiman, P | 1 |
| Stott, P | 1 |
| Huang, A | 1 |
| Zelkowitz, L | 1 |
| Kukrika, M | 1 |
| Tucker, W | 1 |
| Wilms, K | 1 |
| Koos, T | 1 |
| Atkinson, MK | 1 |
| McElwain, TJ | 2 |
| Peckham, MJ | 2 |
| Thomas, PP | 1 |
| Viollier, AF | 1 |
| Jedrzejczak, WW | 1 |
| Siekierzyński, M | 1 |
| Czarnecki, C | 1 |
| Dziuk, E | 1 |
| Odegaard, A | 1 |
| Lamvik, J | 1 |
| Jacobs, C | 2 |
| Lanzkowsky, P | 1 |
| Shende, A | 1 |
| Karayalcin, G | 1 |
| Aral, I | 1 |
| Grant, MD | 1 |
| O'Connell, MJ | 1 |
| Brace, KC | 1 |
| Byhardt, RW | 1 |
| Greene, WH | 1 |
| Sahakian, GJ | 2 |
| Chastang, CL | 1 |
| Chelloul, N | 2 |
| Shepard, TH | 1 |
| Mellman, WJ | 1 |
| Borromeo, VD | 1 |
| Wilner, FR | 1 |
| Axelrod, AR | 1 |
| Schneider, JR | 1 |
| Moores, RR | 1 |
| Chan, YK | 1 |
| Dorfman, RF | 1 |
| Johnson, L | 1 |
| Falkson, HC | 1 |
| Búzás, E | 1 |
| Rák, K | 1 |
| Garçon, C | 1 |
| Chantalou, JP | 1 |
| Delobel, J | 1 |
| Izrael, V | 1 |
| Weisgerber, C | 2 |
| De Heaulme, M | 1 |
| Longueville, J | 1 |
| Syenave, P | 1 |
| Beauduin, M | 1 |
| Maisin, H | 1 |
| Focan, C | 3 |
| Bricteux, N | 2 |
| Lemaire, M | 2 |
| Hugues, J | 3 |
| Michaux, JL | 4 |
| Hulhoven, R | 1 |
| Rodhain, J | 1 |
| Cornu, G | 1 |
| Naets, E | 1 |
| Dutriéux-Fauchet, MC | 1 |
| Stenuit, L | 1 |
| Sokal, G | 2 |
| Lichtenfeld, JL | 1 |
| Asbjornsen, G | 1 |
| Molne, K | 1 |
| Klepp, O | 1 |
| Aakvaag, A | 1 |
| Weinstein, P | 1 |
| Greenwald, ES | 1 |
| Grossman, J | 1 |
| Friedman, M | 1 |
| Kim, TH | 1 |
| Panahon, AM | 1 |
| Haanen, C | 2 |
| Hart, AA | 1 |
| Wollner, N | 1 |
| Pfreundschuh, M | 2 |
| Lathan, B | 1 |
| Löffler, M | 1 |
| Rüffer, U | 1 |
| Hasenclever, D | 1 |
| Fischer, RI | 1 |
| Kozai, Y | 1 |
| Ohyama, T | 1 |
| Kodo, H | 1 |
| Tomori, G | 1 |
| Robert, M | 1 |
| Averous, M | 1 |
| Lavabre-Bertrand, T | 1 |
| Iborra, F | 1 |
| Rebillard, X | 1 |
| Guiter, J | 1 |
| Grasset, D | 1 |
| Tenovuo, J | 1 |
| Murtomaa, H | 1 |
| Morales, MD | 1 |
| González, FA | 1 |
| Villegas, A | 1 |
| del Potro, E | 1 |
| Díaz Mediavilla, J | 1 |
| Martínez, R | 1 |
| Alvarez, A | 1 |
| Colomé, JA | 1 |
| Díaz-Maqueo, JC | 2 |
| Ayala, JR | 1 |
| Cortés, HD | 1 |
| García, EL | 2 |
| Virgolini, L | 1 |
| De Maglio, A | 1 |
| Yahalom, J | 3 |
| Gaynor, J | 2 |
| Caravelli, J | 4 |
| Bajorunas, D | 1 |
| House, KW | 1 |
| Simon, SR | 1 |
| Pugh, RP | 1 |
| Tombolini, V | 1 |
| Capua, A | 1 |
| Pompili, E | 1 |
| Chan, PD | 1 |
| Berk, MA | 1 |
| Kucuk, O | 1 |
| Singh, S | 1 |
| Ganesan, TS | 2 |
| Perry, N | 1 |
| D'Ardenne, J | 1 |
| Shand, WS | 1 |
| de Campos, ES | 1 |
| Zulian, GB | 2 |
| Mermillod, B | 1 |
| Langer, CJ | 1 |
| Keller, SM | 1 |
| Erner, SM | 1 |
| Oberlin, O | 6 |
| Leverger, G | 4 |
| Pacquement, H | 1 |
| Raquin, MA | 1 |
| Chompret, A | 1 |
| Habrand, JL | 3 |
| Terrier-Lacombe, MJ | 1 |
| Bey, P | 4 |
| Bertrand, Y | 1 |
| Rubie, H | 1 |
| Propert, KJ | 1 |
| Henderson, ES | 2 |
| Green, MR | 1 |
| Gottlieb, A | 1 |
| Brouet, JC | 1 |
| Machiels, JP | 1 |
| Martiat, P | 1 |
| Doyen, C | 1 |
| Bosly, A | 1 |
| Kornblith, AB | 1 |
| Anderson, J | 1 |
| Cella, DF | 1 |
| Tross, S | 1 |
| Zuckerman, E | 1 |
| Cherin, E | 1 |
| Kosty, MP | 1 |
| Biti, GP | 3 |
| Cartoni, C | 3 |
| Douglas, AJ | 1 |
| Hudson, BV | 1 |
| Bennett, MH | 2 |
| MacLennan, KA | 2 |
| Comer, M | 1 |
| Harvey, AR | 1 |
| Smith, LM | 1 |
| Evans, JW | 1 |
| Mori, M | 1 |
| Brown, JM | 1 |
| Marmont, AM | 1 |
| Tesoro Tess, JD | 1 |
| Djulbegovic, B | 1 |
| Hendler, FJ | 1 |
| Hadley, T | 1 |
| Woodcock, TM | 1 |
| Oza, AM | 1 |
| Dorreen, M | 1 |
| Johnson, PW | 1 |
| Waxman, J | 1 |
| Lim, J | 1 |
| Wright, J | 1 |
| Dadiotis, L | 1 |
| Barbounis, V | 1 |
| Marín, J | 1 |
| Lasa, R | 1 |
| Egurbide, I | 1 |
| Etxebeste, MA | 1 |
| Bengoetxea, E | 1 |
| Angulo, P | 1 |
| Antigüedad, M | 1 |
| Furundarena, JR | 1 |
| Peinado, F | 1 |
| Navarro, E | 1 |
| Allavena, C | 1 |
| Conroy, T | 2 |
| Aletti, P | 1 |
| White, AD | 1 |
| Jones, BM | 1 |
| Clark, RE | 1 |
| Jacobs, A | 1 |
| Sen, P | 1 |
| Bailey, NM | 1 |
| Bezwoda, WR | 1 |
| Dansey, R | 1 |
| Bezwoda, MA | 1 |
| Gaynor, JJ | 1 |
| Merke, DP | 1 |
| Chapman, D | 2 |
| McClain, KL | 1 |
| Heise, R | 1 |
| Day, DL | 1 |
| Woods, WG | 1 |
| Aeppli, D | 1 |
| Shanley, DJ | 1 |
| Lerud, KS | 1 |
| Luetkehans, TJ | 1 |
| Feuer, EJ | 1 |
| Kessler, LG | 1 |
| Baker, SG | 1 |
| Triolo, HE | 1 |
| Green, DT | 1 |
| al-Idrissi, HY | 1 |
| Ibrahim, EM | 1 |
| Talavera, A | 1 |
| Guzmán, R | 1 |
| Lohri, A | 1 |
| Barnett, M | 1 |
| Reece, D | 1 |
| Voss, N | 1 |
| Hoskins, P | 1 |
| Gianni, L | 1 |
| Foà, R | 1 |
| Gavosto, F | 1 |
| Goodrick, MJ | 1 |
| Daniel, F | 1 |
| Prentice, AG | 1 |
| Copplestone, JA | 1 |
| Tyrrell, CJ | 1 |
| Phares, JC | 1 |
| Dabrowska, M | 1 |
| Kemona, H | 4 |
| Prokopowicz, J | 4 |
| Kretowska, J | 1 |
| Kiluk, S | 4 |
| Caggana, M | 2 |
| Liber, HL | 1 |
| Kelsey, KT | 2 |
| Leventhal, BG | 1 |
| Marcus, R | 1 |
| Brecher, M | 1 |
| Chauvenet, A | 1 |
| Carlier, P | 1 |
| Congiu, A | 1 |
| Bacigalupo, A | 1 |
| Damasio, E | 1 |
| Tigaud, JD | 1 |
| Magnan, A | 1 |
| Jacquème, P | 1 |
| Sudan, N | 1 |
| Redding, E | 1 |
| Blanc, AP | 1 |
| Poirier, R | 1 |
| Zepeda, G | 1 |
| Cruz, J | 1 |
| Najbar, A | 1 |
| Radwańska, U | 1 |
| Kaczmarek, M | 1 |
| Ochocka, M | 2 |
| Stańczak, E | 1 |
| Gutiérrez, J | 1 |
| Osorio, G | 1 |
| García, H | 1 |
| Vacarezza, R | 1 |
| Cao, C | 1 |
| Zemlickis, D | 1 |
| Degendorfer, P | 1 |
| Panzarella, T | 2 |
| Koren, G | 1 |
| Bellesi, GP | 2 |
| Bosi, A | 2 |
| Giannarelli, D | 1 |
| Hovgaard, DJ | 1 |
| Ranson, MR | 1 |
| Johnson, RJ | 1 |
| Błasińska-Morawiec, M | 1 |
| Płuzańska, A | 2 |
| Mrówka, I | 1 |
| Harding, MJ | 1 |
| McNulty, LJ | 1 |
| Lee, F | 1 |
| Brown, A | 1 |
| Rosenberg, W | 1 |
| Johnston, PG | 1 |
| Ruscetti, FW | 1 |
| Connaghan, DG | 1 |
| Sullivan, FJ | 1 |
| O'Brien, P | 1 |
| Crow, J | 1 |
| Brada, M | 1 |
| Ashley, S | 1 |
| Bergsagel, D | 1 |
| Basco, V | 1 |
| Brown, T | 3 |
| Bush, R | 1 |
| Gillies, J | 1 |
| Israels, L | 1 |
| Miller, A | 1 |
| Rideout, D | 1 |
| Whitelaw, D | 1 |
| Russo, A | 1 |
| Hill, JB | 1 |
| Tournaye, H | 1 |
| Camus, M | 1 |
| Bollen, N | 1 |
| Wisanto, A | 1 |
| Van Steirteghem, AC | 1 |
| Devroey, P | 1 |
| Redman, JR | 1 |
| Rodriguez, MA | 1 |
| Dixon, D | 1 |
| Silvermintz, K | 1 |
| Vaughan Hudson, B | 1 |
| Haybittle, JL | 1 |
| Urba, WJ | 1 |
| Raubitschek, A | 1 |
| Petru, E | 1 |
| Schmähl, D | 1 |
| Jensen, BV | 1 |
| Carlsen, NL | 1 |
| Thompson, L | 1 |
| Li, XJ | 1 |
| Zhao, BL | 1 |
| Hou, JW | 1 |
| Xin, WJ | 1 |
| Xie, RF | 1 |
| Chen, YR | 1 |
| Hayes, TG | 1 |
| Rabin, VR | 1 |
| Rosen, T | 1 |
| Zubler, MA | 1 |
| Payen, C | 1 |
| Fermanian, J | 1 |
| Millward, MJ | 1 |
| Cohney, SJ | 1 |
| Byrne, MJ | 1 |
| Ryan, GF | 1 |
| Ortin, TT | 1 |
| Shostak, CA | 1 |
| Lavey, RS | 1 |
| Roach, M | 1 |
| Brophy, N | 1 |
| Cox, R | 1 |
| Varghese, A | 1 |
| Cohen, MH | 1 |
| Brooks, BJ | 1 |
| Hendler, NB | 1 |
| Alvarez, S | 1 |
| Ancalmo, N | 1 |
| Grinton, SF | 1 |
| Givens, SS | 1 |
| Doyle, J | 2 |
| Berry, M | 1 |
| Blanchette, V | 1 |
| Doherty, M | 1 |
| Talbot, JA | 1 |
| Tsatsoulis, A | 3 |
| Grabinski, M | 1 |
| Robertson, WR | 3 |
| Testa, NG | 1 |
| Johnston, J | 1 |
| Kennedy, P | 1 |
| Hays, DM | 1 |
| Emerson, JD | 1 |
| Moses, LE | 1 |
| Bestetti, O | 1 |
| Appelbaum, FR | 1 |
| Sullivan, KM | 1 |
| Thomas, ED | 1 |
| Buckner, CD | 1 |
| Clift, RA | 1 |
| Deeg, HJ | 1 |
| Neiman, PE | 1 |
| Sanders, JE | 1 |
| Stewart, P | 1 |
| Storb, R | 1 |
| Shirakawa, S | 2 |
| Tanaka, I | 1 |
| Kita, K | 2 |
| Lowenthal, RM | 1 |
| Jestrimski, KW | 1 |
| Inagaki, J | 1 |
| Dumont, J | 1 |
| Villarreal, CJ | 1 |
| Delfino, A | 1 |
| LaMonte, CS | 1 |
| Yeh, SD | 1 |
| Kholin, AV | 4 |
| Tsiatis, A | 1 |
| Rusthoven, JJ | 2 |
| Berner, J | 1 |
| Kowalczyński, M | 1 |
| Dowgier-Witczak, I | 1 |
| Chmielowska, E | 1 |
| Woźniak, L | 1 |
| Pagnoni, AM | 1 |
| Musumeci, R | 1 |
| Crippa, F | 1 |
| Tilly, H | 1 |
| Menard, JF | 1 |
| Barbot, A | 1 |
| Piguet, H | 1 |
| Verlicchi, F | 1 |
| Bandini, G | 1 |
| Watchie, J | 1 |
| Raffin, TA | 1 |
| Raubitschek, AA | 1 |
| Fahey, T | 1 |
| Van Kessel, A | 1 |
| Van Bunningen, BN | 2 |
| Van Leeuwen, EF | 1 |
| Vicente, J | 1 |
| Lemerle, J | 4 |
| Zori Comba, A | 1 |
| Zittoun, R | 3 |
| Audebert, A | 2 |
| Rojouan, J | 3 |
| David, B | 1 |
| Blanc, CM | 1 |
| Hoerni, B | 3 |
| Buzaid, AC | 1 |
| Lippman, SM | 1 |
| Wysocka, J | 3 |
| Schiffer, CA | 1 |
| Scott, J | 1 |
| Cadman, EC | 1 |
| Zucker, JM | 1 |
| Olive, D | 2 |
| Sagher, D | 1 |
| Karrison, T | 1 |
| Schwartz, JL | 1 |
| Larson, R | 1 |
| Meier, P | 1 |
| Strauss, B | 1 |
| Pekacki, A | 1 |
| Hayabuchi, N | 1 |
| Jingu, K | 1 |
| Miyoshi, M | 1 |
| Hirata, H | 1 |
| Masuda, K | 1 |
| Shibuya, T | 1 |
| Nishimura, J | 1 |
| Komiyama, S | 1 |
| Ishii, E | 1 |
| Kikuchi, M | 1 |
| Trédaniel, J | 1 |
| Gerota, I | 1 |
| Dionet, C | 1 |
| Vilcoq, J | 1 |
| Madelain, M | 1 |
| Dutou, L | 1 |
| Lefur, R | 1 |
| Thierry, P | 1 |
| Le Floch, O | 1 |
| García Alfonso, P | 1 |
| Flores Sañudo, E | 1 |
| Carrión Galindo, R | 1 |
| Jara Sánchez, C | 1 |
| Cosín Ochaita, J | 1 |
| Congiu, AM | 1 |
| Gaozza, E | 1 |
| Ricci, P | 1 |
| Meloni, G | 1 |
| Mangoni, L | 1 |
| Coser, P | 1 |
| Giguere, JK | 1 |
| Douglas, DM | 1 |
| Lupton, GP | 1 |
| Baker, JR | 1 |
| Tubiana, M | 2 |
| Van der Schueren, E | 2 |
| Mefferd, JM | 1 |
| Albisinni, U | 1 |
| Ammendolia, I | 1 |
| Tondi, L | 1 |
| Milanowski, A | 1 |
| Kulus, M | 1 |
| Peiffert, D | 1 |
| Witz, F | 1 |
| Fay, JW | 1 |
| Herzig, GP | 1 |
| Herzig, RH | 1 |
| Wolff, SN | 1 |
| Gulati, S | 1 |
| Shank, B | 1 |
| Clarkson, B | 1 |
| Fuks, Z | 1 |
| Merke, D | 1 |
| Bonnet, M | 1 |
| Dufillot, D | 1 |
| de Lumley, L | 1 |
| Schaadt, M | 1 |
| McDougall, IR | 1 |
| Parker, BR | 1 |
| Shochat, SJ | 1 |
| Silingardi, V | 1 |
| Frassoldati, A | 1 |
| Barbieri, F | 1 |
| Palomba, G | 1 |
| Mauri, C | 1 |
| Housset, M | 1 |
| Dessard-Diana, B | 1 |
| Michel-Langlet, P | 1 |
| Alapetite, C | 1 |
| Matsumoto, N | 1 |
| Yoshimoto, K | 1 |
| Okagawa, K | 1 |
| Kosaka, M | 1 |
| Saito, S | 1 |
| Chauffert, B | 1 |
| Lorcerie, B | 1 |
| André, F | 1 |
| Besancenot, JF | 1 |
| Martin, F | 1 |
| Noguchi, Y | 1 |
| Hasegawa, Y | 1 |
| Nakazawa, M | 1 |
| Yoda, Y | 1 |
| Abe, T | 1 |
| Mori, N | 1 |
| Hamoir, V | 1 |
| Binon, J | 1 |
| Pillai, GN | 1 |
| Suon, SZ | 1 |
| van Rijswijk, RE | 1 |
| de Meijer, AJ | 1 |
| Verbeek, J | 1 |
| Koza, I | 1 |
| Bohunický, L | 1 |
| Svancárová, L | 1 |
| Mardiak, J | 1 |
| Gyárfás, J | 1 |
| Madanat, FF | 1 |
| Culine, S | 1 |
| Diebold, J | 2 |
| Audebert, AA | 1 |
| Chomette, G | 1 |
| Prudhomme de Saint-Maur, P | 1 |
| Bernadou, A | 2 |
| Ohnoshi, T | 2 |
| Hayashi, K | 2 |
| Ueno, K | 1 |
| Tada, A | 1 |
| Murashima, M | 1 |
| Mizuta, J | 1 |
| Tagawa, S | 1 |
| Kimura, I | 1 |
| Pavlidis, N | 1 |
| Nikolaou, N | 1 |
| Tolis, C | 1 |
| Orfanos, S | 1 |
| Tolis, G | 1 |
| Takagi, T | 1 |
| Sawada, U | 1 |
| Kuraishi, Y | 1 |
| Kondo, M | 1 |
| Suzuki, H | 1 |
| Oyama, A | 1 |
| Mirimanoff, RO | 1 |
| Cionini, L | 1 |
| Mungai, V | 1 |
| Ponticelli, P | 1 |
| Meadows, LM | 1 |
| Rosse, WR | 1 |
| Moore, JO | 1 |
| Crawford, J | 1 |
| Laszlo, J | 1 |
| Kaufman, RE | 1 |
| Shaw, MT | 1 |
| Jacobs, SR | 1 |
| Ghouadni, R | 1 |
| Zouaoui-Benhadji, Z | 1 |
| Afiane, M | 1 |
| Kubisz, P | 2 |
| Belhadj-Merzoug, K | 1 |
| Krisch, C | 1 |
| Laugier, A | 1 |
| Druker, BJ | 1 |
| Malou, M | 1 |
| Zouaoui, Z | 1 |
| Abad, MT | 1 |
| Touhami, M | 1 |
| Faid, L | 1 |
| Cuzick, J | 1 |
| Bell, BA | 1 |
| Esseltine, DW | 1 |
| Freeman, CR | 1 |
| Smith, PJ | 1 |
| Toogood, I | 1 |
| Mauger, D | 1 |
| Takaue, Y | 1 |
| Ramirez, I | 1 |
| Cleary, KR | 1 |
| van Eys, J | 1 |
| Chao, N | 1 |
| Levine, J | 1 |
| Ahmed, R | 1 |
| Smith, D | 1 |
| Shalet, S | 1 |
| Sullivan-Halley, JA | 1 |
| Homeida, M | 1 |
| Mukhtar, ED | 1 |
| Daneshmend, T | 1 |
| Omer, A | 1 |
| St John, J | 1 |
| Morris, ID | 1 |
| Burger, HG | 1 |
| De Kretser, DM | 1 |
| Lynn, WA | 1 |
| Marcus, RE | 1 |
| Bennett, B | 1 |
| Moore, NR | 1 |
| Iurlo, A | 1 |
| Mecucci, C | 1 |
| Van Orshoven, A | 1 |
| Boogaerts, M | 1 |
| Van den Berghe, H | 1 |
| Gregory, WM | 1 |
| Schuler, D | 1 |
| Kardos, G | 1 |
| Révész, T | 1 |
| Friedlander, RJ | 1 |
| Powlis, WD | 1 |
| Goffman, T | 2 |
| De Vita, VT | 2 |
| Battegay, M | 1 |
| Obrist, R | 1 |
| Obrecht, JP | 1 |
| Zandecki, M | 1 |
| Dupriez, B | 1 |
| Laï, JL | 1 |
| Fenaux, P | 1 |
| Facon, T | 1 |
| Lepelley, P | 1 |
| Estienne, MH | 1 |
| Huart, JJ | 1 |
| Janjan, NA | 1 |
| Wilson, JF | 1 |
| Gillin, M | 1 |
| Schewe, K | 1 |
| Cold, S | 1 |
| Clausen, NT | 1 |
| Zaniboni, A | 1 |
| Simoncini, E | 1 |
| Marpicati, P | 1 |
| Montini, E | 1 |
| Marini, G | 2 |
| Willett, CG | 1 |
| Linggood, RM | 1 |
| Leong, JC | 1 |
| Miketic, LM | 1 |
| Stracher, MA | 1 |
| Skates, SJ | 1 |
| Kushner, DC | 1 |
| Boccaccio, P | 1 |
| Rosa, F | 1 |
| Casciaro, S | 1 |
| D'Elia, P | 1 |
| Romagnoli, M | 1 |
| Ghio, R | 1 |
| Kanaev, SV | 6 |
| Malinin, AP | 6 |
| Cruickshank, D | 1 |
| Worotniuk, V | 1 |
| Matthews, JP | 1 |
| España, P | 1 |
| Bonilla, F | 1 |
| Yebra, M | 1 |
| Diego, J | 1 |
| Alvarez de Mon, M | 1 |
| Marazuela, M | 1 |
| Durántez, A | 1 |
| Armitage, J | 1 |
| Moravec, D | 1 |
| Hutchins, M | 1 |
| Howe, D | 1 |
| Sorensen, S | 1 |
| Dowling, M | 1 |
| Okerbloom, J | 1 |
| Pevnick, W | 1 |
| Henkelmann, GC | 1 |
| van der Werf, SD | 1 |
| van Berge Henegouwen, GP | 1 |
| Bronkhorst, FB | 1 |
| Werre, JM | 1 |
| Wells, JD | 1 |
| Huskison, WT | 1 |
| Davenport, OL | 1 |
| de Gramont, A | 1 |
| Louvet, C | 1 |
| Krulik, M | 2 |
| Smadja, N | 1 |
| Donadio, D | 1 |
| Laporte, JP | 1 |
| Brissaud, P | 1 |
| Delâge, JM | 1 |
| Drolet, Y | 1 |
| Rioux, E | 1 |
| Rowland, KM | 1 |
| Murthy, A | 1 |
| Wesley, M | 1 |
| Tarbell, N | 1 |
| Skarin, A | 1 |
| Sans-Sabrafen, J | 1 |
| Pedro Olivé, C | 1 |
| Buxó Costa, J | 1 |
| Pardo Peret, P | 1 |
| Rodríguez Ferrera, JC | 1 |
| Woessner, S | 1 |
| Galofré, M | 1 |
| Rodríguez Méndez, F | 1 |
| Chikrizov, SI | 3 |
| Ryoo, MC | 1 |
| Kagan, AR | 1 |
| Wollin, M | 1 |
| Nussbaum, H | 1 |
| Chan, PY | 1 |
| Hintz, BL | 1 |
| Rao, AR | 1 |
| McMahon, J | 1 |
| Blaustein, JC | 1 |
| Lewkow, L | 1 |
| Crnkovich, MJ | 1 |
| Leopold, K | 1 |
| Sauer, MV | 1 |
| Macaso, TM | 1 |
| Ishida, EH | 1 |
| Giudice, L | 1 |
| Marshall, JR | 1 |
| Buster, JE | 1 |
| Ciocca Vasino, MA | 1 |
| Cametti, G | 1 |
| Urgesi, A | 1 |
| Bertini, M | 1 |
| Canta, M | 1 |
| Monetti, U | 1 |
| Bosio, C | 1 |
| Jayme, A | 1 |
| Lyding, JM | 1 |
| Tseng, A | 1 |
| Newman, A | 1 |
| Collins, S | 1 |
| Shea, W | 1 |
| Le Pors, P | 1 |
| Tschupp, MJ | 1 |
| de Queiroz, D | 1 |
| Grosbois, B | 1 |
| Lemoine, H | 1 |
| Schubert, B | 1 |
| Bazex, J | 1 |
| Gurney, HP | 1 |
| Phadke, K | 1 |
| Friedenberg, WR | 1 |
| Dirks, P | 1 |
| Beltaos, E | 1 |
| Mazza, JJ | 1 |
| Hoehn, JL | 1 |
| Greenlaw, RH | 1 |
| Russ, HH | 1 |
| Schloesser, LL | 1 |
| Griffiths, JD | 1 |
| Segal, GM | 1 |
| Duckert, LG | 1 |
| King, DJ | 1 |
| Bullock, I | 1 |
| Watt, JL | 1 |
| Carroll, WL | 1 |
| Berberich, FR | 1 |
| Glader, BE | 1 |
| Singh, AK | 1 |
| Kobayashi, T | 1 |
| Ohno, T | 1 |
| Hautekeete, ML | 1 |
| Berneman, ZN | 1 |
| Bieger, R | 1 |
| Stevens, WJ | 1 |
| Bridts, C | 1 |
| Buyssens, N | 1 |
| Peetermans, ME | 1 |
| Jochelson, MS | 1 |
| Weinstein, HJ | 1 |
| Haines, IE | 1 |
| Schwarz, MA | 1 |
| Dewit, L | 1 |
| Bartelink, H | 1 |
| Cirrincione, C | 1 |
| Redman, J | 1 |
| Cunningham, I | 1 |
| Baumgartner, G | 1 |
| Duschet, P | 1 |
| Schwarz, T | 1 |
| Partsch, H | 1 |
| Gschnait, F | 1 |
| Stacher, A | 2 |
| Bubman, I | 1 |
| Kirchhoff, LV | 1 |
| Morioka, H | 1 |
| deBellis, N | 1 |
| Bender, BL | 1 |
| Mayernik, DG | 1 |
| Edington, H | 1 |
| Salwitz, J | 1 |
| Roth, JA | 1 |
| Pass, H | 1 |
| Bourke, JP | 1 |
| Fennelly, JJ | 1 |
| Duggan, J | 1 |
| Boyle, E | 1 |
| McCabe, M | 1 |
| Warde, P | 1 |
| Conroy, R | 1 |
| Greenberg, P | 1 |
| Parker, RG | 1 |
| Northrop, MF | 1 |
| Simko, TG | 1 |
| Blayney, DW | 1 |
| Greene, MH | 1 |
| Postal, MG | 1 |
| Lanzillo, JH | 1 |
| Moylan, DJ | 1 |
| Mohiuddin, M | 1 |
| Kim, HC | 1 |
| Nosher, J | 1 |
| Haas, A | 1 |
| Sweeney, W | 1 |
| Lewis, R | 1 |
| Shetty, PA | 1 |
| Damle, SR | 1 |
| Shahane, AD | 1 |
| Schreiber, DP | 1 |
| Parlier, Y | 1 |
| Höffken, K | 1 |
| Ippisch, A | 1 |
| Pfeiffer, R | 1 |
| Becher, R | 1 |
| Perri, RT | 1 |
| Allen, JI | 1 |
| Limas, C | 1 |
| Kay, NE | 1 |
| Enriquez, R | 1 |
| Papac, R | 1 |
| Frau, A | 1 |
| Montalar, J | 1 |
| Slanina, J | 1 |
| Wannenmacher, M | 1 |
| Spratler, J | 1 |
| Blijham, GH | 1 |
| Vermeulen, A | 1 |
| Mendes de Leon, DE | 1 |
| Dinshaw, K | 1 |
| Pande, S | 1 |
| Advani, S | 1 |
| Ramakrishnan, G | 1 |
| Nair, C | 1 |
| Talvalkar, G | 1 |
| Rao, DN | 1 |
| Notani, P | 1 |
| Rao, R | 1 |
| Desai, P | 1 |
| Bo, YK | 1 |
| Hirose, J | 1 |
| Chohtoh, S | 1 |
| Nishijima, H | 1 |
| Kobayashi, A | 1 |
| Kamimura, R | 1 |
| Takashima, T | 1 |
| Yoshida, T | 1 |
| Musto, P | 1 |
| Lucchi, T | 1 |
| Barbieri, D | 1 |
| Ferraresi, P | 1 |
| Lanza, F | 1 |
| Moe, PJ | 1 |
| MacKenzie, R | 1 |
| Cooper, D | 1 |
| Cox, EB | 1 |
| Shakhtarina, SV | 1 |
| Behrens, BC | 1 |
| Vaughan Williams, CA | 1 |
| Leslie, NT | 1 |
| Ersbøll, J | 1 |
| Sørensen, HM | 1 |
| Keiding, N | 1 |
| Larsen, SO | 1 |
| Philip, P | 1 |
| Larsen, MS | 1 |
| Schultz, H | 1 |
| Flexner, JM | 1 |
| Schein, PS | 1 |
| Beretta, G | 1 |
| Fossati-Bellani, F | 1 |
| Goldsmith, MA | 1 |
| Carter, SK | 2 |
| Desser, RK | 1 |
| al-Mondhiry, H | 1 |
| Lacher, MJ | 1 |
| Connolly, CE | 1 |
| McLaren, JH | 1 |
| Mbidde, EK | 1 |
| Nkwocha, J | 1 |
| Hancock, PE | 1 |
| Ledlie, EM | 1 |
| Trepel, F | 1 |
| Stockhusen, G | 1 |
| Rastetter, J | 1 |
| Begemann, H | 1 |
| Huart, M | 1 |
| Anderson, CB | 1 |
| Philpott, GW | 1 |
| Ferguson, TB | 1 |
| Mannheimer, C | 1 |
| Sharer, LR | 1 |
| Barondess, JA | 1 |
| Gray, GF | 1 |
| Winokur, SH | 1 |
| Casirola, G | 1 |
| Ippoliti, G | 1 |
| Ferrari, E | 1 |
| Cridland, MD | 1 |
| Jardon-Jeghers, C | 1 |
| Schabel, FM | 1 |
| Goldin, A | 1 |
| Van Thiel, DH | 1 |
| Myers, GH | 1 |
| Lawhorn, TI | 1 |
| Stone, HH | 1 |
| Martin, JD | 1 |
| Wiltshaw, E | 2 |
| Millett, Y | 1 |
| Solomon, J | 1 |
| Jacobs, EM | 2 |
| Lukes, RJ | 1 |
| Weiner, JM | 1 |
| Donohue, DM | 1 |
| Rubin, P | 3 |
| Galvanek, EG | 1 |
| Brace, K | 1 |
| Serpick, AA | 3 |
| Block, JB | 2 |
| Arseneau, JC | 2 |
| Christensen, BE | 1 |
| Livingston, RB | 1 |
| DiBiasio, AG | 1 |
| Rubens, RD | 1 |
| Boesen, E | 1 |
| Galton, DA | 1 |
| Fairley, GH | 5 |
| William, LA | 2 |
| Panettiere, F | 1 |
| Luce, JK | 4 |
| Talley, R | 1 |
| Monto, RW | 2 |
| Lenhard, RE | 2 |
| Ibrahim, E | 1 |
| Steele, TH | 1 |
| Moore, MR | 1 |
| Bull, JM | 1 |
| Habib, MA | 1 |
| Donaldson, JC | 1 |
| Burningham, RA | 1 |
| Hunter, A | 1 |
| Smithers, DW | 1 |
| Constanzi, JJ | 1 |
| Talley, RW | 1 |
| Hewlett, JS | 1 |
| Delaney, FC | 1 |
| Johnson, RE | 1 |
| Ellman, L | 1 |
| Davis, J | 1 |
| Lichtenstein, NS | 1 |
| DeVitra, VT | 1 |
| DeWys, D | 1 |
| Grundmann, E | 1 |
| Fritzsche, R | 1 |
| Nison, DW | 1 |
| Kende, G | 1 |
| Peters, FC | 1 |
| Zippin, C | 1 |
| Lutz-Honders, M | 1 |
| Cleton, FJ | 1 |
| van Dongen, JA | 1 |
| Glazebrook, GA | 1 |
| el-Akkad, SM | 1 |
| Shakir, MA | 1 |
| Bethlenfalvay, NC | 1 |
| Bergin, JJ | 1 |
| Rana, C | 1 |
| Madigan, JP | 1 |
| Motteram, R | 1 |
| Maritz, JS | 1 |
| Turner, CN | 1 |
| Renzi, G | 1 |
| Lesage, R | 1 |
| DeConti, RC | 1 |
| Kaplan, SR | 1 |
| Calabresi, P | 1 |
| Greenberg, LH | 1 |
| Wong, S | 1 |
| Richardson, AP | 1 |
| Dollinger, MR | 1 |
| Tanaka, M | 1 |
| Kunii, A | 1 |
| Yamada, K | 1 |
| Pawlowski, J | 1 |
| Gaelen, LH | 1 |
| Levitan, S | 1 |
| Rywlin, AM | 1 |
| Recher, L | 1 |
| Hoffman, EP | 1 |
| Owens, AH | 1 |
| Alison, RE | 1 |
| Whitelaw, DM | 1 |
| Nicholson, WM | 1 |
| Beard, ME | 1 |
| Vartan, CP | 1 |
| Scott, RB | 1 |
| Wasastjerna, C | 1 |
| Kiely, JM | 1 |
| Harrison, EG | 1 |
| Cross, RM | 1 |
| Dixon, FW | 1 |
| Bishop, RC | 1 |
| Berkman, T | 1 |
| Stern, OS | 1 |
| Tulgan, H | 1 |
| Budnitz, J | 1 |
| Haidak, G | 1 |
| Gordon, HW | 1 |
| Wilson, WW | 1 |
| Beutler, E | 1 |
| Lefkowitz, ER | 1 |
| Silberman, HR | 1 |
| McGinn, TG | 1 |
| Kremer, WB | 1 |
| Poe, RH | 1 |
| Gable, CE | 1 |
| Jarrold, T | 1 |
| Pecchini, F | 1 |
| Dall'Aglio, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Phase III Trial of ABVD Versus Stanford V (+/-) Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease[NCT00003389] | Phase 3 | 854 participants (Actual) | Interventional | 1999-06-17 | Completed | ||
| Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden - a Register-based Retrospective Observational Study[NCT05029206] | 174 participants (Actual) | Observational | 2021-05-05 | Completed | |||
| "Prospective Non Randomized Study With Chemotherapy in Patients With Hodgkin's Disease and HIV Infection: Stanford V Regimen For Low Risk Patients, EBVP Regimen For High Risk Patients"[NCT00003262] | Phase 2 | 30 participants (Anticipated) | Interventional | 1997-05-31 | Active, not recruiting | ||
| Phase III Randomized Trial of Adjuvant Involved-Field Radiotherapy vs No Adjuvant Therapy Following Remission Induction With MOPP/ABV Hybrid Chemotherapy in Patients With Stage III/IV Hodgkin's Disease[NCT00002462] | Phase 3 | 615 participants (Actual) | Interventional | 1989-09-30 | Active, not recruiting | ||
| Protocol H8 for a Prospective Controlled Trial in Clinical Stage I-II Supradiaphragmatic Hodgkin's Disease. Evaluation of Treatment Efficacy and (Long Term) Toxicity in Three Different Prognostic Subgroups [H8 Trial][NCT00379041] | Phase 3 | 1,158 participants (Anticipated) | Interventional | 1993-09-01 | Active, not recruiting | ||
| A Phase II Pilot Study of Short Term (12 Week) Combination Chemotherapy (Stanford V) in Unfavorable Hodgkin's Disease[NCT00002715] | Phase 2 | 50 participants (Anticipated) | Interventional | 1989-04-30 | Completed | ||
| Optimization of the Primary Therapy for Patients With Hodgkin's Lymphoma and Evaluation of the Positron Emission Tomography (PET) as a Diagnostic Tool for Primary Staging and Assessment of the Effects of the Therapy[NCT00188149] | Phase 4 | 300 participants | Interventional | 2000-05-31 | Recruiting | ||
| Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis Or Treatment Regimen: A Study By The National Physicians Cooperative of the Oncofertility Consortium At Northwestern University[NCT00902720] | Phase 4 | 25 participants (Anticipated) | Interventional | 2009-05-31 | Recruiting | ||
| Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial[NCT00924131] | 157 participants (Anticipated) | Observational | 2009-04-17 | Completed | |||
| Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being[NCT02749474] | 400 participants (Anticipated) | Observational [Patient Registry] | 2003-07-31 | Recruiting | |||
| A Multicentric Randomized Trial Comparing the Bronchial Artery Embolization Combined With Medical Measures and the Medical Measures Alone in the Treatment of Non-severe Acute Hemoptysis of Mild-to-moderate Abundance[NCT01278199] | 73 participants (Actual) | Interventional | 2011-11-30 | Completed | |||
| Phase I/II Trial of Yttrium-90-labeled Daclizumab (Anti-CD25) Radioimmunotherapy With High-dose BEAM Chemotherapy and Autologous Hematopoietic Stem Cell Rescue in Recurrent and Refractory Hodgkin's Lymphoma[NCT01468311] | Phase 1/Phase 2 | 6 participants (Actual) | Interventional | 2011-10-11 | Terminated (stopped due to Poor enrollment and ability to radioconjugate Daclizumab. Neither Center for Cancer Research (CCR) or Nuclear Medicine/Radiology wanted to do the facilities upgrade and hire personnel needed to radioconjugate the drug at the Clinical Center.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Overall survival is defined as the time from randomization to death or last known alive. The 5-year survival rate is the probability a patient survives 5 years. (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5, and yearly for 5 years
| Intervention | Proportion of patients (Number) |
|---|---|
| Arm A (ABVD) | 0.88 |
| Arm B (Stanford V) | 0.88 |
"Failure-free survival is defined as the time from randomization to the earlier of progression/relapse or death. The 5-year failure-free survival is the probability a patient is failure-free and survives 5 years.~Progression is defined as an increase in size of 25% of the sum of the products of the pretreatment measurements or appearance of new lesions. Significant enlargement of the liver or spleen is evidence of progression. A significant increase in size is defined as > 2.0 cm in distance between costal margin and the inferior margin of either organ.~Relapse is defined as the re-appearance of any clinical evidence of Hodgkin's disease in a patient who has had a complete response. Relapse for partial responders is defined as progressive disease relative to disease status during the partial remission." (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5
| Intervention | Proportion of patients (Number) |
|---|---|
| Arm A (ABVD) | 0.74 |
| Arm B (Stanford V) | 0.71 |
Number of patients who developed second primary cancers (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5, and yearly for 5 years
| Intervention | participants (Number) |
|---|---|
| Arm A (ABVD) | 15 |
| Arm B (Stanford V) | 19 |
Complete response rate is defined as the time it takes a participant to achieve a complete response. Response is assessed by the Revised Response Criteria for Malignant Lymphoma. Complete response requires all of the following: complete disappearance of all detectable clinical evidence of disease and disease related symptoms if present before therapy. A post treatment residual mass is permitted as long as it is positron emission tomography (PET) negative. If a pretreatment PET scan was negative, all lymph nodes and nodal masses must have regressed on computed tomography (CT) to normal size (<1.5 cm in their greatest transverse diameter for nodes >1.5 cm before therapy); Previously involved nodes that were 1.1 to 1.5 cm in their long axis and more than 1.0 cm in their short axis before treatment must have decreased to <1.0 cm in their short axis after treatment. (NCT01468311)
Timeframe: 20 months post autologous stem cell transplant
| Intervention | months (Median) |
|---|---|
| Yttrium-90-labeled Daclizumab + Chemotherapy | 7.5 |
DFS is defined as the amount of time participants remain disease free. (NCT01468311)
Timeframe: DFS is evaluated at day 100 post autologous stem cell transplant, then 1-4 times yearly for 5 years
| Intervention | months (Median) |
|---|---|
| Yttrium-90-labeled Daclizumab + Chemotherapy | 36 |
Patients who develop either a Common Terminology Criteria in Adverse Events (CTCAE) v4.0 grade 3 or greater non-hematologic toxicity, with the exception of fatigue, of more than 5 days duration possibly, probably or definitely related to the infusion of 90Y-daclizumab prior to the start of Carmustine, Etoposide, Cytarabine, [Ara-C, Cytosine Arabinoside] and Melphalan (BEAM) chemotherapy (Day - 6) will have developed by definition a dose-limiting toxicity (DLT). (NCT01468311)
Timeframe: 30 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Yttrium-90-labeled Daclizumab + Chemotherapy | 0 |
Here is the number of participants with serious and non-serious adverse events assessed by the Common Terminology Criteria in Adverse Events (CTCAE v4.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. (NCT01468311)
Timeframe: 30 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Yttrium-90-labeled Daclizumab + Chemotherapy | 3 |
Overall survival is defined as the time from the date of registration to the date of death due to any cause or if no death occurs to the last documented information on the patient. (NCT01468311)
Timeframe: OS is evaluated at day 100 post autologous stem cell transplant, then 1-4 times yearly for 5 years
| Intervention | months (Median) |
|---|---|
| Yttrium-90-labeled Daclizumab + Chemotherapy | 36 |
103 reviews available for mechlorethamine and Granuloma, Hodgkin
| Article | Year |
|---|---|
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Da | 2022 |
[Treatment strategy of Hodgkin lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; B | 2014 |
Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Di | 2016 |
Treatment of Hodgkin lymphoma: the past, present, and future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cycl | 2008 |
Breast cancer after treatment of Hodgkin's lymphoma: general review.
Topics: Adolescent; Adult; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast N | 2008 |
Standard therapy of advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cy | 2009 |
Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 2012 |
[Dropped Head Syndrome after whiplash injury in a patient treated for a Hodgkin's lymphoma by mantle field radiotherapy].
Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cervical Plexus; Cerv | 2013 |
Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbaz | 2003 |
[Hodgkin's disease manifesting as paraneoplastic limbic encephalitis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Diagnosis, Differential; Doxorubi | 2003 |
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine | 2003 |
Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion; Child; Combined | 2005 |
[Primary treatment of advanced Hodgkin's disease].
Topics: Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophospha | 2005 |
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2007 |
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc | 1982 |
[The practice of chemotherapy with the DeVita protocol].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 1982 |
Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1982 |
[Recent developments in chemotherapy of malignant diseases].
Topics: Anthraquinones; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 1982 |
The cure of Hodgkin's disease with drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as | 1983 |
Chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1983 |
Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cobalt Radioisotopes; | 1984 |
Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1984 |
The reproductive potential of young men and women with Hodgkin's disease.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Congenital Abnormalities; Female; | 1984 |
Perspectives in cancer research Survival of patients with Hodgkin's disease.
Topics: Clinical Trials as Topic; Hodgkin Disease; Humans; Mechlorethamine; Random Allocation; Time Factors | 1980 |
Hodgkin's disease: biology, treatment, prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Giant Cell Tumors; | 1981 |
[Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1995 |
[Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1995 |
[Hodgkin's disease and pregnancy. 3 case reports and a review of the literature].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow Examination; C | 1993 |
Lymphomatoid papulosis and Hodgkin's disease: report of a case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin D | 1994 |
[Diffuse thymus hyperplasia following chemotherapy for nodular sclerosing Hodgkin lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Diagnosis, Differential; Doxorubic | 1994 |
Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomy | 1995 |
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyt | 1995 |
[Recent progress in the chemotherapy of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamid | 1995 |
[Chemotherapy of patients with Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1994 |
Modality treatment in adult stage I-II Hodgkin's disease with large mediastinal masses: study of 30 cases and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1993 |
The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1996 |
Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Hodgkin's disease: management of first relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
Treatment of Hodgkin's disease: the role of radio- and/or chemotherapy in advanced stages.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dr | 1996 |
[Malignant mesothelioma of the pleura following radiotherapy of Hodgkin disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Hodgkin Disease; Humans; | 1996 |
Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aorta; Aortic Aneurysm; Aortic Dissection; Ao | 1997 |
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined | 1998 |
[The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1998 |
Problems in Hodgkin's disease management.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1999 |
HIV-associated Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyt | 2000 |
Hodgkin's disease: clinical presentation and treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 2001 |
Treatment of advanced stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Doxo | 2001 |
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials, Phase III | 2000 |
The treatment of Hodgkin's disease: emphasizing programs at the Clinic Center, National Institutes of Health.
Topics: Adult; Bleomycin; Bone Marrow; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; H | 1977 |
Chemotherapy of Hodgkin's disease.
Topics: Bleomycin; Drug Therapy, Combination; Hodgkin Disease; Humans; Long-Term Care; Mechlorethamine; Pred | 1979 |
The action of antitumor agents: a double-edged sword?
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Burkitt Lymphoma; Choriocarcinoma; | 1977 |
The chemotherapy of Hodgkin's disease: past experiences and future directions.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; History, 19th Century; H | 1978 |
Issues of controversy in radiation therapy and combined modality approaches to Hodgkin's disease.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Neoplasm Staging; P | 1979 |
Human models of human diseases; breast cancer and the lymphomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; Drug Therapy, Combination; | 1979 |
Evaluation and treatment of Hodgkin's disease in the 70's.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Remission, Spontaneou | 1975 |
Chemotherapy-induced myocardial infarction in a young man with Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Hodgkin Disease; Huma | 1992 |
Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant; | 1992 |
Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin; | 1992 |
The management of Hodgkin's disease in relapse after primary radiation therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm S | 1992 |
Combined-modality therapy for the treatment of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1992 |
Combined chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1992 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality | 1992 |
Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1990 |
Chemotherapy of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1990 |
Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1990 |
Is there an effective salvage therapy for advanced Hodgkin's disease?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1991 |
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1991 |
[Treatment of relapses and failures in disseminated Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; | 1991 |
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine; | 1991 |
Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hod | 1991 |
Hodgkin's disease presenting in the skin: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Eczema; Hodgkin Disease; Humans; Male; Mechlorethami | 1990 |
Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1990 |
Pulmonary toxicity following MOPP chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dyspnea; Female; Hodgkin Disease; Humans; Lung | 1990 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast | 1986 |
Chemotherapy of malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance | 1985 |
[Drug therapy of malignant lymphoma].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1985 |
[Results of the treatment of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1986 |
Current approaches to the treatment of advanced-stage Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality The | 1986 |
[Rescue treatment in Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1987 |
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potential.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1987 |
[The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1988 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count | 1989 |
[A suggested program of combined treatment of Hodgkin's disease in children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarba | 1988 |
Recent issues in chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Sched | 1989 |
Current management and controversies. The chemotherapist's view.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Hodgkin Disease; Hu | 1989 |
[Current status of chemotherapy in the treatment of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1989 |
Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance; Hodgk | 1988 |
The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphoma; Mechlore | 1987 |
[Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1987 |
Hodgkin's disease: long-term effects of therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Brain; Female; Genitalia, Fem | 1986 |
Early-stage Hodgkin's disease: current approaches to treatment.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fem | 1985 |
[Current methods of treating patients with lymphogranulomatosis, stages I and II].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease; | 1985 |
Current management of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1985 |
Combination chemotherapy of advanced Hodgkin's disease. A review.
Topics: Bleomycin; Carmustine; Cyclohexanes; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; H | 1974 |
The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly.
Topics: Adrenal Cortex Hormones; Alopecia; Antineoplastic Agents; Bleomycin; Blood Platelet Disorders; Carmu | 1973 |
[Cytostatic chemotherapy in lymphogranulomatosis].
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Chlorambucil; Cyclohexanes; Cyclophosphamide; Doxorubi | 1973 |
Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Blood Sedimentation; Cyclophosphamide; Drug Therapy, Combination; Fema | 1973 |
Chemotherapy in solid tumors of childhood.
Topics: Abdominal Neoplasms; Adolescent; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Eye Neopla | 1972 |
Recently recognized complications of cancer chemotherapy.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Death, Sudden; Drug Therapy, Combination; | 1974 |
Single-agent therapy for Hodgkin's disease.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Carmustine; | 1973 |
Dilemmas in the treatment of Hodgkin's disease.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1971 |
Combination chemotherapy in malignant diseases.
Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosin | 1971 |
224 trials available for mechlorethamine and Granuloma, Hodgkin
| Article | Year |
|---|---|
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 2015 |
The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2009 |
Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazi | 2009 |
Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 2010 |
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 2011 |
Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2013 |
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2013 |
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dac | 2013 |
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2013 |
Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; | 2002 |
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-M | 2002 |
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; | 2003 |
Involved-field radiotherapy for advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2003 |
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distributio | 2003 |
Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival | 2004 |
Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2004 |
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Eto | 2004 |
Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2004 |
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2005 |
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Com | 2006 |
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 2006 |
[Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbaz | 2006 |
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Topics: Adolescent; Adult; Amenorrhea; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocol | 2007 |
Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodg | 2007 |
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Clinical Trials | 1984 |
The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.
Topics: Adolescent; Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration S | 1980 |
Combination chemotherapy for stage IV Hodgkin's disease (Report no 14).
Topics: Bleomycin; Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Neopla | 1981 |
A Southwest Oncology Group: chemotherapy versus chemotherapy plus radiotherapy in treatment of stage III Hodgkin's disease.
Topics: Bleomycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Follow | 1982 |
Alternating drug combinations in the treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Th | 1982 |
More than MOPP for advanced Hodgkin's disease?
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Therapy, | 1982 |
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc | 1982 |
Combined modality therapy for advanced Hodgkin's disease: long-term followup data.
Topics: Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female | 1982 |
Conclusions from clinical trials of the Southwest Oncology Group.
Topics: Antibiotics, Antineoplastic; Bleomycin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combina | 1982 |
Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
Topics: Adult; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Th | 1982 |
Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1983 |
Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Prot | 1983 |
The cure of Hodgkin's disease with drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as | 1983 |
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1984 |
Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topi | 1984 |
Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Top | 1983 |
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; C | 1984 |
The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combin | 1984 |
A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality T | 1984 |
Combined modality in Hodgkin's disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as T | 1984 |
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Hodgkin | 1983 |
The treatment of stage IIIA Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1983 |
Treatment of patients with stages I and II nonmediastinal Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Therapy, Combination; | 1982 |
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Follow-Up | 1980 |
Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Hodgkin Disease; | 1981 |
[Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Dru | 1982 |
A new combination chemotherapy for recurrent Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Therapy, Co | 1982 |
Perspectives in cancer research Survival of patients with Hodgkin's disease.
Topics: Clinical Trials as Topic; Hodgkin Disease; Humans; Mechlorethamine; Random Allocation; Time Factors | 1980 |
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA.
Topics: Adolescent; Adult; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Femal | 1980 |
[Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; D | 1981 |
Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, | 1982 |
Effect of age on therapeutic response and survival in advanced Hodgkin's disease.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination | 1982 |
Intergroup Hodgkin's disease in children study of stages I and II: a preliminary report.
Topics: Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgkin Disease; | 1982 |
Hodgkin's disease in children: treatment results with MOPP and low-dose, extended-field irradiation.
Topics: Adolescent; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgk | 1982 |
Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymph Nodes; Mechloretham | 1982 |
Radiotherapy versus combined modality treatment of stage I and II Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm S | 1982 |
Radiotherapy or chemotherapy as the initial treatment for stage IIIA Hodgkin's disease (Report no 13).
Topics: Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Neopl | 1981 |
The management of stage IIIA Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di | 1980 |
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemat | 1980 |
Hodgkin's disease in the very young.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 1994 |
Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Combined Modality | 1994 |
A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie cont
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1994 |
Early intensive therapy with autotransplantation for high-risk Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1993 |
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-Curie.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1994 |
ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Coho | 1994 |
Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1994 |
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1994 |
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality | 1994 |
Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Di | 1995 |
Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomy | 1995 |
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bo | 1995 |
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubici | 1995 |
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free | 1995 |
Optimal treatment of early-stage Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1993 |
Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
Chemotherapy dose and survival in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response Relatio | 1993 |
Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 1993 |
Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Doxorub | 1995 |
Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1994 |
Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide | 1993 |
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1996 |
Fixed versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease. A prospective randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1995 |
ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1996 |
Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 1996 |
Treatment of Hodgkin's disease: the Swedish National Care Programme experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1996 |
Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined | 1996 |
Chemotherapy in Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1996 |
Treatment of childhood Hodgkin's disease without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1997 |
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Co
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorub | 1997 |
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Ca | 1997 |
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child | 1997 |
A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1997 |
Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 1997 |
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modali | 1997 |
[A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes].
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 1997 |
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dis | 1998 |
Inhibin A concentrations in the sera of young women during and after chemotherapy for lymphoma: correlation with ovarian toxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1998 |
MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1998 |
Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemotherapy, | 1998 |
Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxor | 1998 |
MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1999 |
Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1999 |
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Filgrastim; Granulocyte C | 1999 |
Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease-Free Survival; | 1999 |
Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1999 |
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2000 |
[Results of a prospective protocol for the treatment of adult Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; D | 1999 |
Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2000 |
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2000 |
Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Etop | 2000 |
Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Citrates; | 2000 |
Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; Doxorubicin; | 2001 |
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diseas | 2002 |
ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Daca | 2002 |
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
Topics: Adolescent; Adult; Bleomycin; Child; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; | 1975 |
Initial treatment of stage IIIA Hodgkin's disease. Comparison of radiotherapy with combined chemotherapy. British National Lymphoma Investigation.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; La | 1976 |
Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin D | 1976 |
The treatment of Hodgkin's disease: emphasizing programs at the Clinic Center, National Institutes of Health.
Topics: Adult; Bleomycin; Bone Marrow; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; H | 1977 |
Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Bleomycin; Child; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug | 1977 |
ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
Topics: Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combin | 1978 |
Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; D | 1979 |
Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluatio | 1978 |
The chemotherapy of Hodgkin's disease: past experiences and future directions.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; History, 19th Century; H | 1978 |
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.
Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Femal | 1979 |
Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Drug Therapy, Combi | 1979 |
The chemotherapy--radiotherapy sequence in the management of Hodgkin's disease. Results of a clinical trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination | 1979 |
Combined modality treatment of Hodgkin's disease confined to lymph nodes. Results eight years later.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Cobalt Radioisotopes; Dru | 1979 |
The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
Topics: Abdomen; Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymph | 1977 |
New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patients.
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; Hum | 1977 |
Randomised trial of two-drug and four-drug maintenance chemotherapy in advanced or recurrent Hodgkin's disease. Medical Research Council's working party on lymphomas.
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore | 1979 |
Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease: a Cancer and Acute Leukemia Group B study.
Topics: Adult; Aged; Antineoplastic Agents; Blood Cell Count; Blood Platelets; Bone Marrow; Drug Administrat | 1979 |
delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
Topics: Adult; Antiemetics; Antineoplastic Agents; Double-Blind Method; Dronabinol; Drug Therapy, Combinatio | 1979 |
The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.
Topics: Drug Therapy, Combination; Evaluation Studies as Topic; Hodgkin Disease; Humans; Mechlorethamine; Pr | 1975 |
[Treatment of Hodgkin's disease stages I, II, and III].
Topics: Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Prednisone; Procarbazine; Splenectomy; Time Fa | 1977 |
Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
Topics: Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechl | 1975 |
A combined modality approach to the treatment of Hodgkin's disease. Preliminary results of a prospectively randomized clinical trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Cobalt Radioisotopes; Drug Therapy, Combination; Ev | 1975 |
[Polychemotherapy of Hodgkin's disease (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Ma | 1975 |
A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
Topics: Drug Evaluation; Drug Therapy, Combination; Follow-Up Studies; Hodgkin Disease; Humans; Mechloretham | 1975 |
Combined modality therapy for localized Hodgkin's disease. A seven-year update of an early study.
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Hum | 1975 |
Role of additional radiotherapy in advanced stages of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami | 1992 |
Four cycles of chemotherapy and regional radiation therapy for clinical early-stage and intermediate-stage Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1992 |
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Ch | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm | 1992 |
Hodgkin's disease, clinical stages I, II A-B and IIIA. Results of brief chemotherapy followed by irradiation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1992 |
A prospective randomized study of two alternating, non cross-resistant chemotherapies for advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Dacarbazine; Doxorubic | 1992 |
Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD.
Topics: Adaptation, Psychological; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarba | 1992 |
Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: evidence of a more difficult rescue for patients relapsed after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1992 |
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality | 1992 |
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1990 |
Chemotherapy of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; | 1990 |
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1991 |
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; | 1991 |
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dose-Re | 1991 |
Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1991 |
Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; | 1992 |
Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Dose- | 1992 |
[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; H | 1991 |
Will doxorubicin-containing regimens replace MOPP and its variants?
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamin | 1991 |
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1991 |
British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Follow-Up S | 1991 |
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; | 1991 |
A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1991 |
Chemotherapy alone for the treatment of early-stage Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethami | 1990 |
The intergroup Hodgkin's disease in children. A study of stages I and II.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgki | 1990 |
A note on the Wilcoxon-Mann-Whitney test for 2 X kappa ordered tables.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biometry; Bleomycin; Clinical Trials as Topic; Dacar | 1985 |
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1985 |
Autologous bone marrow transplantation in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1985 |
Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1986 |
Long-term follow-up of cardiac function in patients with Hodgkin's disease treated with mediastinal irradiation and combination chemotherapy including doxorubicin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Pressure; Clinical Trials as | 1986 |
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1986 |
MOPP/ABVD chemotherapy for advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbaz | 1986 |
Evaluation of therapeutic modalities in the control of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modali | 1986 |
[Treatment of Hodgkin's disease in children. Results of the Polish Group for the Treatment of Leukemia and Neoplastic Diseases in Children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin | 1986 |
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1987 |
[Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1987 |
Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1988 |
Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease: results of a joint cooperative study by the French Society of Pediatric Oncology (SFOP) and Hôpital Saint-Louis, Paris.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1988 |
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1989 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1989 |
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1989 |
Hodgkin's disease in children: adaptation of treatment to risk factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin | 1989 |
[Controversy regarding the treatment of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Clinical Trials as Topic; C | 1989 |
Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin | 1989 |
Current management and controversies. The chemotherapist's view.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Hodgkin Disease; Hu | 1989 |
Relationship of histological subtypes to prognosis in early stage Hodgkin's disease: a review of 312 cases in a controlled clinical trial. The Groupe Pierre et Marie Curie.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; C | 1989 |
[Chemotherapy of stage III-IV Hodgkin's disease. A retrospective analysis of the 53 cases collected from 9 institutions in Japan].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1989 |
MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1989 |
Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; C | 1988 |
Failure to preserve fertility in patients with Hodgkin's disease.
Topics: Amenorrhea; Animals; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Dogs; Female; Follic | 1987 |
The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Follow-Up Studies; Hodgkin | 1988 |
Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Clinica | 1988 |
Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Tr
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1988 |
Twenty years of MOPP therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as T | 1986 |
Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Trials as | 1986 |
Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1986 |
Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1985 |
The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combine | 1985 |
Treatment selection for stage IIIA Hodgkin's disease patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality T | 1985 |
Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Tria | 1985 |
Maintenance chemotherapy for advanced Hodgkin's disease in remission.
Topics: Blood Cell Count; Blood Platelets; Hodgkin Disease; Humans; Lymphocytes; Mechlorethamine; Nitrosoure | 1973 |
Treatment of early Hodgkin's disease.
Topics: Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine | 1967 |
Combination chemotherapy and survival in advanced Hodgkin's disease.
Topics: Antineoplastic Agents; Benzoates; Clinical Trials as Topic; Evaluation Studies as Topic; Follow-Up S | 1973 |
Chemotherapy of lymphoma with mechlorethamine and vinblastine.
Topics: Adult; Blood Cell Count; Blood Platelet Disorders; Clinical Trials as Topic; Evaluation Studies as T | 1973 |
Combination radiotherapy and chemotherapy in the treatment of early Hodgkin's disease.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Cobalt Radioisotopes; Drug Therapy, Combination; | 1973 |
International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
Topics: Biopsy; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Gold Colloid, Radioa | 1973 |
Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
Topics: Antineoplastic Agents; Carmustine; Chlorambucil; Evaluation Studies as Topic; Hodgkin Disease; Human | 1973 |
Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
Topics: Adult; Age Factors; Antineoplastic Agents; Benzoates; Blood Cell Count; Bone Marrow; Evaluation Stud | 1973 |
Combination chemotherapy-radiotherapy for stage 3 Hodgkin's disease. An acute leukemia group B study.
Topics: Adult; Age Factors; Blood Cell Count; Blood Platelets; Bone Marrow; Evaluation Studies as Topic; Fem | 1973 |
Multiple chemotherapeutic agents for Hodgkin disease. Comparison of three routines: a cooperative study by acute leukemia group B.
Topics: Adult; Age Factors; Benzoates; Drug Synergism; Female; Hodgkin Disease; Humans; Leukocytes; Male; Me | 1973 |
Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Age | 1973 |
Mechlorethamine HCl and cyclophosphamide in the treatment of Hodgkin's disease and the lymphomas.
Topics: Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Dosage Forms; Follow-Up Studies; Hodgkin D | 1968 |
Chemotherapeutic implications of staging in Hodgkin's disease.
Topics: Animals; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Drug Combinations; Follow-Up Stud | 1971 |
908 other studies available for mechlorethamine and Granuloma, Hodgkin
| Article | Year |
|---|---|
Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Child; Doxorubicin; Hodg | 2023 |
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2020 |
Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Modality Therapy in the Stanford V Trials (the G4 and G5 Studies).
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Cyclophospham | 2021 |
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colon; Colo | 2017 |
[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2013 |
Treatment of Hodgkin lymphoma: a 50-year perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Clinical Trials as Top | 2014 |
Thyroid malignancies in survivors of Hodgkin lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2014 |
Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Colitis, Ulcerative; Hodgkin Dis | 2014 |
Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Combined Mod | 2014 |
Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2015 |
Fifty years from Paris: the remarkable story of the lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Congresses as Topic; History, 19th Century; History, | 2015 |
[The effectiveness and toxicity of therapy in primary Hodgkin's lymphoma with extranodal lesions].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleo | 2015 |
[Effect of brentuximab vedotin combined with chlormethine hydrochloride on the treatment of 6 patients with relapsed and refractory Hodgkin lymphoma].
Topics: Antineoplastic Agents, Alkylating; Brentuximab Vedotin; Hodgkin Disease; Humans; Immunoconjugates; M | 2015 |
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Clinical T | 2015 |
Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 2016 |
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Bleomycin; C | 2016 |
McFarland W, Granville NB, Dameshek W. Autologous bone marrow infusion as an adjunct in therapy of malignant disease. Blood. 1959;14(5):503-521.
Topics: Antineoplastic Agents; Bone Marrow Transplantation; Combined Modality Therapy; History, 20th Century | 2016 |
Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2017 |
[Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2008 |
Prognostic factors in children with Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethamine; Pre | 2008 |
The treatment of lymphogranulomatosis with nitrogen mustard gas
Topics: Hodgkin Disease; Mechlorethamine | 1948 |
Studies in Hodgkin's syndrome; nitrogen mustard therapy.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Syndrome | 1948 |
Six cases of Paltauf-Sternberg lymphogranulomatosis and two analogous conditions treated by nitrogen mustard, a derivative of mustarditis.
Topics: Hodgkin Disease; Mechlorethamine | 1948 |
Nitrogen-mustard therapy for Hodgkin's disease, lymphosarcoma, the leukemias, and other disorders.
Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mustard Plant; Nitrogen | 1948 |
Nitrogen mustards in the treatment of Hodgkin's disease and lymphosarcoma.
Topics: Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Sarco | 1948 |
Nitrogen mustard in the treatment of Hodgkin's disease; a case report with discussion.
Topics: Ethylamines; Hodgkin Disease; Mechlorethamine | 1948 |
Six cases of Paltauf-Sternberg lymphogranulomatosis and two analogous conditions treated with nitrogen mustard, a derivative of hyperperitis.
Topics: Hodgkin Disease; Mechlorethamine | 1948 |
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbaz | 2009 |
[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2008 |
Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cholestasis; Combined Modality The | 2008 |
[Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; | 2009 |
[Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Pr | 2008 |
Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Compo | 2009 |
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Com | 2009 |
Acute promyelocytic leukemia after Stanford V plus radiotherapy for advanced Hodgkin lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin | 2009 |
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2010 |
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cohort Studies; Combine | 2009 |
[Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Heart; | 2009 |
Long-term follow-up of survival in Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Follow-Up Studi | 2009 |
A case of Hodgkin's disease treated with nitrogen mustard.
Topics: Ethylamines; Hodgkin Disease; Mechlorethamine | 1947 |
Nitrogen mustards in Hodgkin's disease; report on 21 cases and four of other reticuloses.
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Peptide Nucleic Acids | 1947 |
Nitrogen mustard as a therapeutic agent for Hodgkin's disease, lymphosarcoma and leukemia.
Topics: Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine | 1947 |
Clinical experiences with nitrogen mustard in Hodgkin's disease.
Topics: Ethylamines; Hodgkin Disease; Mechlorethamine | 1947 |
Hodgkin's lymphoma: Richter's transformation of chronic lymphocytic leukemia involving the liver.
Topics: Antineoplastic Agents, Alkylating; Female; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, | 2010 |
Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.
Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Chondrosarcoma | 2010 |
Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
Topics: Amines; Gas Poisoning; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechloret | 1946 |
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Com | 2010 |
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms | 2012 |
Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Congenital | 2012 |
Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors.
Topics: Adult; Aneuploidy; Case-Control Studies; Chromosomal Instability; Chromosome Aberrations; Chromosome | 2012 |
Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomy | 2012 |
[Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study].
Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiomyopa | 2012 |
[Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 2012 |
The impact of drug shortages on children with cancer--the example of mechlorethamine.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Disease-Fr | 2012 |
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
Topics: Academic Medical Centers; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Californ | 2013 |
Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Croatia; Dacarba | 2002 |
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bioma | 2002 |
Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 2002 |
Analysis of treatment results in advanced Hodgkin's disease: the case for adjuvant radiotherapy.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleom | 2003 |
Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chemotherapy, Adjuvant; | 2003 |
[Nitrogen mustard therapy of various cases of malignant lymphogranuloma and lymphosarcoma].
Topics: Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds | 1952 |
[Treatment of malignant granuloma with nitrogen mustard].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1952 |
Combined nitrogen mustard and single dose irradiation treatment of lymphomata and other malignant tumors.
Topics: Hodgkin Disease; Humans; Lymphoma; Mechlorethamine; Neoplasms; Radiotherapy Dosage | 1952 |
New therapy for leukemia, polycythemia, and lymphoma.
Topics: Aminopterin; Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Multiple | 1953 |
[Effect of x-rays and nitrogen mustard in the therapy of Hodgkin's disease].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy; X-Rays | 1952 |
[Role of nitrogen mustard in the therapy of malignant lymphogranulomatosis].
Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy | 1952 |
Use of nitrogen mustards during acute hepatitis.
Topics: Acute Disease; Hepatitis; Hepatitis A; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1953 |
[Diagnosis and therapy of Hodgkin's disease; study of 110 cases].
Topics: Cortisone; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy; Triethyleneme | 1952 |
[Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
Topics: Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymp | 1953 |
[Therapeutic effect of small doses of chloroethylaminohydrochloride associated with roentgenotherapy in blastomatosis].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy; X-Ray Therapy | 1953 |
The use of nitrogen mustard in the management of two pregnant lymphoma patients.
Topics: Disease Management; Fetus; Hodgkin Disease; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; P | 1953 |
[Treatment of symptomatic hemolytic anemias].
Topics: Anemia, Hemolytic; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; | 1953 |
HODGKIN'S disease: diagnosis and treatment.
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Triethylenemelamine | 1953 |
[Effect of x-rays and nitrogen mustards in the treatment of Hodgkin's disease].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy; X-Rays | 1953 |
[Role of nitrogen mustard in the treatment of malignant lymphogranuloma].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1953 |
[Pulmonary Hodgkin's disease; treatment and evolution with nitrogen mustards].
Topics: Hodgkin Disease; Lung Neoplasms; Mechlorethamine; Nitrogen Mustard Compounds | 1953 |
[The treatment of Hodgkin's diseases].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy | 1953 |
[Histopathological aspect of the lymph nodes in Hodgkin's disease treated with nitrogen mustards].
Topics: Hodgkin Disease; Lymph Nodes; Mechlorethamine; Nitrogen Mustard Compounds | 1953 |
[Considerations on therapeutic effect of chloramine and colchicine in Hodgkin's disease].
Topics: Chloramines; Colchicine; Hodgkin Disease; Mechlorethamine | 1953 |
Treatment of Hodgkin's disease and the lymphosarcomas.
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compound | 1954 |
[Histopathological aspect of the lymph nodes in Hodgkin's disease treated with nitrogen mustards].
Topics: Blood; Hodgkin Disease; Lymph Nodes; Mechlorethamine; Nitrogen Mustard Compounds | 1953 |
[Nitrogen mustard and Hodgkin's disease; case report].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1953 |
[Treatment of Hodgkin's disease with nitrogen mustards].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1954 |
[Efficacy of nitrogen mustard on iridocyclitis in Hodgkin's disease].
Topics: Hodgkin Disease; Iridocyclitis; Mechlorethamine; Nitrogen Mustard Compounds | 1953 |
[Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions].
Topics: Ethylamines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, | 1953 |
[Malignant lymphogranulomatosis (Hodgkin's diseases) with cutaneous initiation: total remission under combined treatment with radio-therapy and nitrogen mustard].
Topics: Combined Modality Therapy; Hodgkin Disease; Manipulation, Osteopathic; Mechlorethamine; Nitrogen Mus | 1954 |
Biological actions and therapeutic applications of nitrogen mustard.
Topics: Hodgkin Disease; Leukemia; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitr | 1954 |
[Treatment of malignant lymphogranulomatosis with intraarterial injections of nitrogen mustards and chloramphenicol].
Topics: Chloramphenicol; Hodgkin Disease; Humans; Injections, Intra-Arterial; Mechlorethamine; Nitrogen Must | 1954 |
[Experimental and clinical studies on the toxic and therapeutic effect of both nitrogen mustard compounds, trichlortriethylamine and dichloro-diethylamine].
Topics: Biomedical Research; Diethylamines; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1953 |
Beta-Naphthyl-di-chloroethylamine in the treatment of malignant diseases, particularly Hodgkin's disease.
Topics: Hodgkin Disease; Hydrocarbons, Aromatic; Mechlorethamine; Naphthalenes; Neoplasms; Nitrogen Mustard | 1954 |
Treatment of the resistant stages of Hodgkin's disease and lymphoblastic diseases.
Topics: Cortisone; Hodgkin Disease; Lymphocytes; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen | 1954 |
[Beta-Naphthyl-di-chlorethylamine therapy of malignant conditions, especially Hodgkin's disease].
Topics: Hodgkin Disease; Mechlorethamine; Naphthalenes; Neoplasms; Nitrogen Mustard Compounds | 1954 |
[Therapeutic use of embichin].
Topics: Hodgkin Disease; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds | 1954 |
[Treatment of Hodgkin's disease in children].
Topics: Child; Hodgkin Disease; Infant; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy | 1954 |
[Triethylene melamine treatment of leukemia and lymphogranulomatosis].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis; Triethylenemela | 1954 |
[The combination of radiotherapy and N-lost therapy].
Topics: Hodgkin Disease; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Radiotherapy | 1955 |
Indication of the use of beta-naphthyl-di-2-chloroethylamine, in Hodgkin's disease and Leukemia.
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1955 |
[Our experiences in treatment with nitrogen mustard].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1954 |
Immediate and remote results of chloroethylamine treatment of Hodgkin's disease.
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1956 |
[Malignant lymphogranuloma (Hodgkin's disease) and leprosy concomitant in the same patient; treatment with nitrogen mustard].
Topics: Hodgkin Disease; Leprosy; Mechlorethamine; Nitrogen Mustard Compounds | 1955 |
[Remarquable results with yperite nitrate in two cases of Hodgkin's disease].
Topics: Hodgkin Disease; Mechlorethamine; Mustard Gas; Nitrates; Nitrogen Mustard Compounds; Nitrogen Oxides | 1956 |
Evaluation of CB 1348 in Hodgkin's disease and allied disorders.
Topics: Arylsulfonates; Chlorambucil; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1956 |
Clinical trial of a new nitrogen-mustard compound.
Topics: Hodgkin Disease; Leukemia; Lung Neoplasms; Mechlorethamine; Nitrogen; Nitrogen Mustard Compounds | 1956 |
[Changes of phosphorus metabolism in the lymph nodes in lymphogranulomatosis by means of radioactive phosphorus in the treatment with embichin].
Topics: Hodgkin Disease; Lymph Nodes; Mechlorethamine; Phosphorus | 1956 |
[Changes of phosphorus metabolism in the lymph nodes in lymphogranulomatosis by means of radioactive phosphorus in the treatment with embichin].
Topics: Hodgkin Disease; Lymph Nodes; Mechlorethamine; Phosphorus | 1956 |
[Changes of phosphorus metabolism in the lymph nodes in lymphogranulomatosis by means of radioactive phosphorus in the treatment with embichin].
Topics: Hodgkin Disease; Lymph Nodes; Mechlorethamine; Phosphorus | 1956 |
[Changes of phosphorus metabolism in the lymph nodes in lymphogranulomatosis by means of radioactive phosphorus in the treatment with embichin].
Topics: Hodgkin Disease; Lymph Nodes; Mechlorethamine; Phosphorus | 1956 |
[Trials of treatment by p-(di-2-chloroethylamino)phenylbutyric acid in Hodgkin's disease, chronic lymphoid leukemia and different sarcomas of lymphatic tissue; study of one hundred cases].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoid Tiss | 1956 |
[Use of sanamycin and triethylenemelanine or of nitrogranulogen in malignant granuloma].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Dermatologic Agents; Hodgkin Disease; Mechloreth | 1956 |
[Treatment of hematologic neoplasms with nitrogen oxide mustards].
Topics: Hematologic Neoplasms; Hodgkin Disease; Leukemia; Lymphoma; Mechlorethamine; Mustard Plant; Nitrogen | 1957 |
[Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit | 1957 |
[Apparent cure of iridocyclitis of Hodgkin's disease obtained with nitrogen mustard & maintained for 3 1/2 years].
Topics: Hodgkin Disease; Iridocyclitis; Mechlorethamine; Nitrogen Mustard Compounds | 1957 |
Therapeutic results in treatment of Hodgkin's disease with CB 1348 and R-48.
Topics: Chlorambucil; Hodgkin Disease; Mechlorethamine; Naphthalenes; Nitrogen Mustard Compounds | 1957 |
[Action of cytotoxic drugs in Hodgkin-Sternberg malignant granuloma; electrophoretic changes in blood].
Topics: Antineoplastic Agents; Electrophoresis; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1957 |
[Therapeutic use of embikhin in lymphogranulomatosis].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1955 |
Hodgkin's disease: a revised clinical classification and an approach to the treatment of its localized form.
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy | 1957 |
[Clinical experiences with a new drug, chlorambucil (CB 1348), in malignant lymphogranuloma].
Topics: Chlorambucil; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1957 |
[Chronic hodgkinian pericarditis with large effusion; favorable effect of nitrogen mustard by intrapericardial route].
Topics: Heart Neoplasms; Hodgkin Disease; Mechlorethamine; Medical Records; Neoplasms; Nitrogen Mustard Comp | 1957 |
[Preliminary data on application of dopamine lymphogranulomatosis].
Topics: Dopamine; Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds; Uracil | 1957 |
Intermittent obstructive jaundice in Hodgkin's disease: report of a case.
Topics: Hodgkin Disease; Humans; Jaundice; Jaundice, Obstructive; Mechlorethamine; Nitrogen Mustard Compound | 1958 |
[Diagnosis ex juvantibus with azoiprite of Hodgkin's disease].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1957 |
[Therapy of Hodgkin's disease (lymphogranulomatosis)].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis | 1958 |
[Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustar | 1958 |
[P-bis-(beta-chloroethyl) aminophenylalanine (sarcolysin) in antiblastic chemotherapy with special reference to lymphatic blood diseases].
Topics: Hodgkin Disease; Humans; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechloret | 1958 |
[Late results in the chemotherapy of lymphogranulomatosis].
Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds | 1958 |
[Trial therapy of leukoses, lymphogranulomas & malignant tumors with urethane, chloroethylamine & other clinical compounds].
Topics: Antineoplastic Agents; Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compo | 1957 |
Changes in the urinary excretion of metabolites during treatment with nitrogen mustard and triethylenemelamine.
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Triethylenemelamine | 1958 |
[Use of embichin in lymphogranulomatosis in children].
Topics: Child; Hodgkin Disease; Humans; Infant; Mechlorethamine; Sarcoidosis | 1958 |
A CLINICAL study of the comparative effect of nitrogen mustard and DON in patients with bronchogenic carcinoma, Hodgkin's disease, lymphosarcoma, and melanoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Hodgkin Disease; Humans; Leucine; Lymphoma; Lymphoma | 1959 |
The histopathological changes induced by the nitrogen mustards in the lymphomas: a brief review of the literature.
Topics: Hodgkin Disease; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1959 |
Radiotherapy for advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; H | 2003 |
[The treatment of Hodgkin's disease by short cures with nitrogen mustards. Apropos of 15 cases].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1961 |
Massive nitrogen mustard therapy in Hodgkin's disease with protection of bone marrow by tourniquets.
Topics: Bone Marrow; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Tourniquets | 1960 |
Combined radiation and nitrogen mustrad therapy in Hodgkin's disease as compared with radiation therapy alone.
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen; Nitrogen Mustard Compounds | 1959 |
A comparative study of the effectiveness of HN2 and cyclophosphamide in bronchogenic carcinoma, Hodgkin's disease and lymphosarcoma.
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Cyclophosphamide; Hodgkin Disease; Lung Neoplasms; L | 1962 |
[Data on the therapy of lymphogranulomatosis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Dermatologic Agents; Hodgkin Disease; Mannomusti | 1962 |
Nitrogen mustards in the management of Hodgkin's disease and the leukemias. IX. Further clinical reports, 1960-1962.
Topics: Disease Management; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1963 |
Nitrogen mustards in the management of Hodgkin's disease and the leukemias. VII. Clinical reports, 1959-62.
Topics: Disease Management; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1962 |
The effect of nitrogen mustard and maintenance chlorambucil in the treatment of advanced Hodgkin's disease.
Topics: Chlorambucil; Hodgkin Disease; Humans; Mechlorethamine | 1963 |
THE MALIGNANT LYMPHOMAS.
Topics: Adrenal Cortex Hormones; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma | 1963 |
SUBACUTE CEREBELLAR DEGENERATION WITH HODGKIN'S DISEASE.
Topics: Ataxia; Cerebellar Diseases; Hodgkin Disease; Humans; Mechlorethamine; Mediastinal Neoplasms; Nerve | 1963 |
[EVALUATION OF THE CURRENT THERAPEUTIC TRENDS IN HODGKIN'S DISEASE. CRITICAL REVIEW AND CASUISTIC CONTRIBUTION].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Aziridines; Bone Marrow Trans | 1963 |
HODGKIN'S DISEASE IN PREGNANCY.
Topics: Female; Hodgkin Disease; Mechlorethamine; Neoplasms; Pregnancy; Pregnancy Complications; Triethylene | 1963 |
ROLE OF CHEMOTHERAPY IN THE MANAGEMENT OF EARLY HODGKIN'S DISEASE.
Topics: Bone Marrow Examination; Chlorambucil; Disease Management; Histological Techniques; Histology; Hodgk | 1963 |
FURTHER COMPARATIVE TRIAL OF TRIETHYLENE THIOPHOSPHORAMIDE AND MECHLORETHAMINE IN PATIENTS WITH MELANOMA AND HODGKIN'S DISEASE.
Topics: District of Columbia; Hodgkin Disease; Mechlorethamine; Melanoma; New York; Thiotepa; Toxicology | 1964 |
A STUDY OF THE MECHANISMS OF GRANULOCYTOPENIA.
Topics: Agranulocytosis; Anemia; Anemia, Macrocytic; Carcinoma; Carcinoma, Bronchogenic; Child; Hodgkin Dise | 1964 |
HODGKIN'S DISEASE AND SALMONELLA TYPHIMURIUM INFECTION.
Topics: Chloramphenicol; Cyclophosphamide; Hodgkin Disease; Humans; Mechlorethamine; Neoplasms; Salmonella I | 1964 |
[EARLY DIAGNOSIS AND MEDICAL THERAPY OF MALIGNANT TUMORS].
Topics: Antineoplastic Agents; Busulfan; Colchicine; Early Diagnosis; Hodgkin Disease; Mechlorethamine; Merc | 1963 |
EXCRETION OF TRYPTOPHAN METABOLITES IN DIFFERENT FORMS OF HAEMOBLASTOSIS.
Topics: Cortisone; Cyclophosphamide; Genetic Diseases, X-Linked; Hodgkin Disease; Humans; Kynurenic Acid; Ky | 1964 |
RETINOPATHY OF OBSCURE (TOXIC?) ORIGIN IN HODGKIN'S DISEASE.
Topics: Anemia; Chloramphenicol; Chlorpromazine; Eye; Glutethimide; Herpes Zoster; Herpes Zoster Ophthalmicu | 1964 |
[ANTINEOPLASTIC PREPARATIONS USED AS A MEANS OF PROTECTION AGAINST THE FREE ELEMENTS IN THE BLOOD AND CONTAMINATION BY NEOPLASTIC CELLS, IN OPERATIVE INTERVENTIONS].
Topics: Antineoplastic Agents; Carcinoma; Cyclophosphamide; Hodgkin Disease; Humans; Mechlorethamine; Melano | 1963 |
COMPRESSION OF THE SPINAL CORD IN PATIENTS WITH MALIGNANT LYMPHOMA.
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechloret | 1964 |
THE EFFECT OF NITROGEN MUSTARD ON THE DISTRIBUTION OF RADIOIRON IN MAN.
Topics: Bone Marrow; Breast Neoplasms; Erythropoiesis; Hodgkin Disease; Humans; Iron; Iron Isotopes; Liver; | 1964 |
[THERAPEUTIC RESULTS IN MALIGNANT GRANULOMA].
Topics: Child; Hodgkin Disease; Humans; Infant; Mechlorethamine; Neoplasms | 1964 |
[DATA ON THE MECHANISM OF ACTION OF DEGRANOL].
Topics: Breast Neoplasms; Erythrocytes; Female; Hodgkin Disease; Humans; Mannomustine; Mechlorethamine; Phot | 1964 |
[HISTOPATHOLOGICAL EFFECTS OF ANTINEOPLASTIC AGENTS ON MALIGNANT LYMPHOMA].
Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Geriatrics; Hodgkin Dise | 1964 |
HODGKIN'S DISEASE OF THE LUNG WITH CAVITATION.
Topics: Antineoplastic Agents; Chlorambucil; Diagnosis, Differential; Hodgkin Disease; Lung Neoplasms; Mechl | 1964 |
[HODGKIN'S DISEASE; LACRIMAL LOCALIZATION].
Topics: Hodgkin Disease; Lacrimal Apparatus; Mechlorethamine; Neoplasms; Pathology; Surgical Procedures, Ope | 1964 |
PATHOGENESIS OF AMYLOIDOSIS.
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Agammaglobulinemia; Amyloid; Amyloidosis; Arthritis; Ar | 1964 |
LONG TERM RESULTS ACHIEVED WITH THE USE OF ALKYLATING AGENTS IN MALIGNANT LYMPHOMA AND HODGKIN'S DISEASE.
Topics: Alkylating Agents; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Larg | 1964 |
ABDOMINAL PERFUSION FOR CANCER CHEMOTHERAPY USING HYPOTHERMIA AND HYPERTHERMIA.
Topics: Abdomen; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Colonic Neoplasms; Cycloph | 1964 |
LYMPHANGIOGRAPHY FOR MALIGNANT DISEASES IN CHILDREN.
Topics: Adolescent; Child; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Myeloid; Lymph Nodes; Lympha | 1964 |
PNEUMOCYSTIS CARINII PNEUMONIA. CASE STUDIES WITH ELECTRON MICROSCOPY.
Topics: Chlorambucil; Chloramphenicol; Cytomegalovirus Infections; Diagnosis, Differential; Digoxin; Electro | 1964 |
NONSURGICAL TREATMENT OF PULMONARY CANCER.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agen | 1964 |
ENDOREDUPLICATION IN LEUCOCYTE CHROMOSOMES. PRELIMINARY REPORT OF ITS RELATION TO CANCER AND WHOLE-BODY IRRADIATION.
Topics: Breast Neoplasms; Chromosome Aberrations; Chromosome Disorders; Chromosomes; Cobalt Isotopes; Coloni | 1964 |
THE MANAGEMENT OF LEUKEMIA AND LYMPHOMA.
Topics: Adrenal Cortex Hormones; Busulfan; Chlorambucil; Cortisone; Cyclophosphamide; Hodgkin Disease; Human | 1964 |
NECROTIZING TOXOPLASMIC ENCEPHALITIS AND HERPETIC PNEUMONIA COMPLICATING TREATED HODGKIN'S DISEASE. REPORT OF A CASE.
Topics: Alkylating Agents; Antineoplastic Agents; Cyclophosphamide; Encephalitis; Herpesviridae Infections; | 1965 |
CYTOTOXIC DRUGS IN BRONCHIAL CARCINOMA.
Topics: Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Bronchogenic; Drug Therapy; Hodgkin Disease; | 1964 |
[CONTRIBUTION TO THE CYTOSTATIC TREATMENT OF LYMPHOGRANULOMATOSIS].
Topics: Cytostatic Agents; Hodgkin Disease; Humans; Mannomustine; Mechlorethamine; Quinine; Radiography; Sar | 1964 |
ASSOCIATION OF HERPES ZOSTER WITH LEUKEMIA AND LYMPHOMA IN CHILDREN.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Child; Cyclophosphamide; Drug Therapy; Herpes Zoster; Ho | 1965 |
LONG-TERM RESULTS OF X-RAY TREATMENT IN MALIGNANT DISEASE OF THE LYMPHO-RETICULAR SYSTEM.
Topics: Classification; England; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodg | 1964 |
RADIATION AND DRUG INDUCED HYALINIZATION OF THE STOMACH.
Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Drug Therapy; Ganglioneuroma; Gastroin | 1965 |
ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
Topics: Alkylating Agents; Aminopterin; Busulfan; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leu | 1965 |
LOW BACK PAIN: AN UNUSUAL CAUSE OF A COMMON COMPLAINT.
Topics: Back Pain; Drug Therapy; Hodgkin Disease; Humans; Low Back Pain; Lumbosacral Region; Mechlorethamine | 1965 |
[Histological picture in treated cases of malignant lymphogranuloma].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1954 |
[Symptomatic psychosis in nitrogen-mustard treatment of a lymphogranulomatosis].
Topics: Hodgkin Disease; Humans; Mechlorethamine; Mental Disorders; Mustard Plant; Nitrogen; Nitrogen Mustar | 1955 |
[Combination of microdosage of chloralkylamines with roentgen irradiation in the treatment of hemoblastoses and hemoblastomas].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphatic Vessels; Mechlorethamine | 1952 |
About Combined N-Lost Urethane Therapy for Chronic Myeloses.
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Urethane | 1955 |
Hodgkin's disease treated with nitrogen mustard and radiation, complicated by osteomyelitis of the mandible.
Topics: Disease; Hodgkin Disease; Mandible; Mandibular Diseases; Mechlorethamine; Nitrogen Mustard Compounds | 1960 |
Treatment of malignant lymphomas and lymphadenoses with leukeran.
Topics: Chlorambucil; Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Mechlorethamine; Nitrogen Mus | 1959 |
[A severe case of lymphographylomatosis successfully treated with dopan].
Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds; Uracil; Uracil Mustard | 1959 |
[The use of nitrogen mustard in the treatment of lymphatic diseases of a malignant type].
Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, | 1959 |
New nitrogen mustards in the management of Hodgkin's disease.
Topics: Disease Management; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1960 |
Clinical evaluation of the effect of degranol.
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphocytes; Mannitol; Mannomustine; Mechlorethamine; | 1959 |
[Results obtained with the use of chlorambucil in the treatment of malignant lymphopathies].
Topics: Chlorambucil; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodg | 1961 |
[Evaluation of immediate results in the treatment of lymphogranulomatosis with dopan and degranol].
Topics: Antineoplastic Agents; Hodgkin Disease; Mannomustine; Mechlorethamine; Nitrogen Mustard Compounds; U | 1962 |
Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard).
Topics: Disease Management; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; | 1962 |
Revascularization for acute coronary occlusion in a young woman following radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Coronar | 2003 |
[Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do | 2003 |
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2003 |
Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2004 |
Nitrogen mustards in the treatment of neoplastic disease.
Topics: Hodgkin Disease; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis | 1950 |
Hodgkin's disease.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds | 1950 |
[Case of very severe lymphogranuloma treated with nitrogen mustard].
Topics: Hodgkin Disease; Mechlorethamine | 1950 |
[Efficacy and limitations of karyoklastic therapy of leukosis, lymphogranulomatosis, and malignant tumors in childhood].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoidosis; Uret | 1950 |
[Nitrogen mustard therapy of lymphogranulomatosis].
Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis | 1950 |
[Nitrogen mustard therapy of malignant tumors].
Topics: Carcinoma; Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1950 |
The partition of radio-phosphorus (P32) in blood, urine and tumor tissue in patients with Hodgkin's disease and lymphosarcoma before and after treatment with nitrogen mustard [methyl bis (beta-chloroethyl) amine].
Topics: Amines; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Phosph | 1950 |
Trial of beta-naphthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders.
Topics: Arylsulfonates; Ethylamines; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
[Treatment of Hodgkin's disease by deep radiotherapy and nitrogen mustard].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy | 1950 |
[Modern means in the diagnosis and therapy of Hodgkin's disease].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy | 1951 |
[Therapy of malignant lymphogranuloma of Hodgkin; personal contribution on the effect of the methyl and naphtyl derivatives of nitrogen mustard].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
[Chloronaphthylamine in the treatment of malignant lymphogranuloma and chronic leukemia].
Topics: Chronic Disease; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1950 |
[Effect of methyl-bis (beta-chloroethyl)amine hydrochloride on Hodgkin's disease, lymphosarcoma, leukemia and neoplasms].
Topics: Amines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplas | 1951 |
Nitrogen mustard and radium therapy in Hodgkin's disease. [Hebrew text; English summary].
Topics: Ethnicity; Hodgkin Disease; Humans; Language; Mechlorethamine; Nitrogen Mustard Compounds; Radium | 1951 |
[Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases].
Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compou | 1951 |
Trisethylene-imino-s-triazine (triethylene melamine or TEM) in the treatment of neoplastic diseases.
Topics: Animals; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma; Mechlorethamine; Mice; Neoplasms; Nitrog | 1951 |
[Naphthyl-chloroethylamine therapy of Hodgkin's disease and allied forms].
Topics: Cystitis; Hodgkin Disease; Lymphogranuloma Venereum; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplas | 1950 |
The principles of radiation therapy of lymphoblastoma.
Topics: Hodgkin Disease; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Sarco | 1951 |
Clinical experience with nitrogen mustard in Hodgkin's disease.
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
The treatment of Hodgkin's disease.
Topics: Arsenic; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radioisotopes | 1951 |
A quantitative evaluation of the contribution of nitrogen mustard to the therapeutic management of Hodgkin's disease.
Topics: Disease Management; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit | 1951 |
[Nitrogen mustard therapy of malignant granuloma, leukemia and neoplasms].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1951 |
[Treatment of malignant lymphogranuloma and chronic leukemia with chloroethylnaphthylamine].
Topics: Chronic Disease; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
[Pathologic anatomy and physiology of Hodgkin's disease treated with nitrogen mustard].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
[Treatment of Hodgkin's disease with naphthyl amine compounds].
Topics: Amines; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1952 |
Toxic psychosis following nitrogen mustard therapy.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds; Psychotic Disorders | 1952 |
[Therapeutic results with nitrogen mustards].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
[Immunity, blood proteins and leucocyte picture in malignant granuloma; effect of nitrogen mustards therapy].
Topics: Blood Proteins; Hodgkin Disease; Leukocytes; Mechlorethamine; Nitrogen Mustard Compounds | 1952 |
[Chloronaphthyne in the treatment of malignant granuloma; advantage of rectal therapy].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
[Nitrogen mustards in the treatment of children].
Topics: Disease; Hodgkin Disease; Lymph Nodes; Lymphatic Diseases; Mechlorethamine; Nitrogen Mustard Compoun | 1952 |
Therapeutic options in patients with lymphoma and severe liver dysfunction.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antibodies, Monoclona | 2004 |
Pediatric Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 2004 |
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera | 2004 |
[Therapy with nitrogen mustard compounds in some cases of malignant lymphogranulomatosis].
Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
[Cases of malignant lymphogranuloma treated with methilbis-beta-chloroethyl-amine chlorhydrate].
Topics: Amines; Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
[A case of lymphogranuloma treated with a nitrogen mustard compound (chloramine)].
Topics: Chloramines; Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
[Immediate results of chlorethylamine therapy in a case of Hodgkin's disease].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
[Action of chloramine in two cases of leukemic myelosis and in a case of malignant lymphogranuloma].
Topics: Chloramines; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
[Three cases of Hodgkin lymphogranuloma, treated with azoto-iprite].
Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases.
Topics: Arylsulfonates; Ethylamines; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; | 1950 |
[Nitrogen mustard therapy in several cases of anaplasia].
Topics: Anaplasia; Hodgkin Disease; Liver; Mechlorethamine; Mediastinum; Neoplasms; Nitrogen Mustard Compoun | 1950 |
[Critical observations on the treatment of lymphogranulomatosis with nitrogen mustards].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis | 1950 |
The role of nitrogen mustard therapy in the treatment of lymphomas and leukemias.
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoma | 1950 |
Haematological results of nitrogen mustard therapy in case of abnormal Hodgkin's disease.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds | 1950 |
[Deep radiotherapy associated with nitrogen mustard in the treatment of malignant lymphogranulomatosis].
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; X-Ray Therapy | 1950 |
Treatment of Hodgkin's disease with roentgen irradiation and nitrogen mustards.
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1950 |
Nitrogen mustards in the treatment of malignant disease.
Topics: Hodgkin Disease; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1950 |
[Roentgen resistant lymphogranulomatosis treated with trichlorotriethylamine hydrochloride, with special reference to following modifications in the hemopoietic system].
Topics: Hematopoietic System; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis | 1950 |
[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child | 2004 |
Acquisition of a Ph chromosome with minor BCR/ABL fusion in treatment-related myelodysplastic syndrome with chromosome 7 abnormalities in a patient treated for Hodgkin disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Chromosome | 2005 |
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Dacarbazine; Disea | 2005 |
Secondary transitional cell carcinoma and nitrogen mustard treatment.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; Hodgkin Disease; Humans | 2005 |
Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; H | 2005 |
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 2005 |
Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidin | 2005 |
Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1989 |
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combin | 2005 |
[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2006 |
Hodgkin's lymphoma in adolescents.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Chem | 2006 |
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr | 2006 |
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 2006 |
Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 2006 |
Malignant fibrous histiocytoma following radiation therapy and chemotherapy for Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adju | 2007 |
[Our experiences in treating patients with Hodgkin disease in the last decade].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad | 2007 |
Hodgkin lymphoma among patients infected with HIV in post-HAART era.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomy | 2007 |
Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; Doxorubicin; | 2007 |
Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Anti-Mullerian Hormone; Antineoplastic Combined Chemot | 2007 |
Treatment-related risk factors for premature menopause following Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 2008 |
Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Child; Dacarbazine; Do | 2007 |
[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 2007 |
Nitrogen mustard therapy; the use of methyl bis (B chloroethyl) amine hydrochloride in Hodgkin's disease, leukemia, lymphosarcoma and cancer of the lung.
Topics: Amines; Ethylamines; Hodgkin Disease; Humans; Leukemia; Lung Diseases; Lung Neoplasms; Lymphoma; Lym | 1949 |
The use of nitrogen mustard in Hodgkin's disease and lymphosarcoma.
Topics: Ethylamines; Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Sarcoma | 1949 |
Histopathologic observations in cases of Hodgkin's disease treated with nitrogen mustard.
Topics: Ethylamines; Hodgkin Disease; Mechlorethamine | 1949 |
Nitrogen mustard therapy in Hodgkin's disease; analysis of 50 consecutive cases.
Topics: Hodgkin Disease; Mechlorethamine | 1949 |
The clinical effect of nitrogen mustard on Hodgkin's disease.
Topics: Ethylamines; Hodgkin Disease; Mechlorethamine | 1949 |
Nitrogen mustards; Treatment of hodgkin's disease and related conditions.
Topics: Hodgkin Disease; Humans; Mechlorethamine | 1948 |
Methyl-bis (beta-chloroethyl)amine in large doses in the treatment of neoplastic diseases.
Topics: Amines; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms; Nitrogen Mus | 1949 |
Nitrogen mustard therapy with special reference to Hodgkin's disease.
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
Nitrogen mustard treatment of Hodgkin's disease.
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
Treatment of lymphogranuloma malignum and related conditions with methyl bis-chloroethylamine (nitrogen mustard).
Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 2008 |
Systemic chemotherapy for cancer: from weapon to treatment.
Topics: Antineoplastic Agents, Alkylating; Chemical Warfare Agents; Female; History, 20th Century; Hodgkin D | 2008 |
Hypersensitivity to nitrogen mustards in the form of erythema multiforme. A unique adverse reaction.
Topics: Chlorambucil; Drug Hypersensitivity; Erythema Multiforme; Hodgkin Disease; Humans; Male; Mechloretha | 1967 |
Action of elatericin A on human leukemic and normal lymphocytes.
Topics: Aminopterin; Animals; Antineoplastic Agents; Azirines; Cathartics; Cell Nucleus; Chlorambucil; Cyclo | 1967 |
[Treatment of Hodgkin's disease by polychemotherapy combining nitrogen mustard, vincristine, methylhydrazine and prednisone].
Topics: Hodgkin Disease; Humans; Hydrazines; Mechlorethamine; Prednisone; Vincristine | 1967 |
Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Castration; Dacarbazin | 1984 |
[Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Dacarbazine; Daunorubi | 1984 |
Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administra | 1980 |
Chemotherapy of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Chlorambucil; Drug Administration Schedule; Drug Therapy, Combinat | 1980 |
Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Drug Therapy, Co | 1980 |
The treatment of advanced hodgkin's disease.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechl | 1981 |
Treatment failures and severe complications in children with Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin | 1981 |
Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1982 |
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Bleomycin; Child; Child, Preschool; Daca | 1982 |
[Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
Alternating drug combinations for advanced Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1982 |
Lasting Hb F reactivation and Hb A2 reduction induced by the treatment of Hodgkin's disease in a woman heterozygous for beta-thalassemia and the Swiss type of the heterocellular hereditary persistence of Hb F.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fetal Hemoglobin; Globins; Hemoglobin | 1982 |
Twelve years of experience with cytotoxic therapy in malignant tumors of the neck and head.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
Factors affecting relapse following chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dru | 1982 |
Hodgkin's disease in renal transplant recipients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Therapy, Combination; Hodgkin Diseas | 1983 |
Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1982 |
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; H | 1983 |
Treatment of 49 unrandomized patients with advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1983 |
MOPP treatment of resistant Hodgkin's disease following ABVD failure.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do | 1983 |
Bone and soft tissue sarcomas in the follow-up of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child, | 1983 |
Adriamycin combinations as salvage therapy in advanced MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Resi | 1983 |
Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Res | 1983 |
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1984 |
[Hodgkin's disease: analysis of a reduction of chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1983 |
Subacute sensory neuropathy with remission: an association with lymphoma.
Topics: Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Hypesthesia; Mechlorethamine; Middle Age | 1982 |
Burkitt cell leukemia following treatment of Hodgkin's disease: report of a case and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Hodgkin Disease; Humans; Leuke | 1984 |
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
Topics: History, 20th Century; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Ne | 1984 |
The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chorionic | 1983 |
Ovarian function in young women in long-term remission after treatment for Hodgkin's disease stage I or II.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Estrad | 1984 |
Acute graft-versus-host disease resulting from normal donor blood transfusions.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Graft vs Host Disease; Histocompatibi | 1984 |
Hodgkin's disease in children. A ten-year experience in South Africa.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Follow- | 1984 |
[Treatment of recurrences of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1984 |
A decision-analysis methodology for consideration of morbidity factors in clinical decision-making.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Decision Making; Hodgkin Disease; Huma | 1984 |
Comparison of treatments for symptomatic Hodgkin's lymphoma employing decision analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Decision Making; Health Service | 1984 |
[Aseptic necrosis of the femur head as a complication of intensive cytostatic, glucocorticoid and radiation therapy of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Femur Head Necrosis; Gluc | 1984 |
[Various disputable problems of ambulatory treatment of tumors of the blood system].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Hodgkin | 1984 |
Antibody-dependent cellular cytotoxicity in some lymphoreticular diseases.
Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami | 1984 |
Autoimmune neutropenia, hemolytic anemia, and reticulocytopenia in Hodgkin's disease.
Topics: Adult; Agranulocytosis; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocol | 1984 |
Hodgkin's disease in children. Results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined M | 1984 |
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1984 |
Composite lymphoma: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma | 1984 |
[CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hum | 1984 |
[Second tumor following Hodgkin's disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Presc | 1984 |
[Treatment of Hodgkin's disease including the staging laparotomy].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1984 |
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Dis | 1984 |
[Experience with the management of patients with therapy-resistant Hodgkin's disease].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Comb | 1984 |
The management of stage II supradiaphragmatic Hodgkin's disease at St. Bartholomew's Hospital. A retrospective review of 114 previously untreated patients over 14 years.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1984 |
Acute allergic reaction due to vincristine sulfate. A case report.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Hyperse | 1984 |
[Effect of splenectomy on the leukocyte count during the treatment of children with Hodgkin's disease].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Hodgkin Disease | 1984 |
Transient optic neuropathy secondary to MOPP chemotherapy in Hodgkin's disease: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Disease; Humans; Mechloretham | 1984 |
MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children: long-term results.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1984 |
Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined Modality Therapy; Drug Resistanc | 1984 |
[Prognostic value of the results of short-term polychemotherapy by the MOPP program of Hodgkin's disease stages III and IV].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; | 1984 |
An evaluation of long-term survival and treatment complications in children with Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Therapy, Combination; Evalua | 1983 |
[Chemotherapy of Hodgkin disease with modified MOPP].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Res | 1983 |
[Acute leukemias and solid tumors in the course of Hodgkin disease].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 1983 |
Diagnosis and management of Hodgkin's disease in the adult.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1983 |
Simultaneous occurrence of mycosis fungoides and Hodgkin disease: clinical and histologic correlations in three cases with ultrastructural studies in two.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymph | 1983 |
Stage I-II Hodgkin's disease: current therapeutic options and recommendations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine | 1983 |
Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Thera | 1983 |
Early response to chemotherapy as a prognostic factor in Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1983 |
Second malignancy complicating Hodgkin's disease.
Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cycloph | 1983 |
[Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Mediastina | 1983 |
[Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
Topics: Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophos | 1983 |
Acute nonlymphocytic leukemia after treatment for Hodgkin's disease.
Topics: Acute Disease; Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 1983 |
Primary Hodgkin's disease of the lung. Case report and review of the literature.
Topics: Adult; Alcohol Drinking; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lu | 1983 |
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1983 |
Osteonecrosis of the femoral head following treatment for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Femur Head | 1983 |
Prognostic significance of large mediastinal involvement in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1983 |
Hodgkin disease clinical stages I, II, and III (A, B): results of radiotherapy with or without chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cesi | 1983 |
Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Growth | 1983 |
[Recurrences in lymphogranulomatosis].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Fe | 1983 |
[Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamin | 1983 |
Treatment of early stage Hodgkin's disease with radiation therapy plus short-cycle (3 MOPP) adjuvant chemotherapy.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Evaluation S | 1983 |
A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Dose-Response Relationship, Drug | 1983 |
Chemotherapy-radiotherapy versus chemotherapy in Hodgkin's disease with bone marrow involvement. Retrospective analysis of 32 cases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child | 1981 |
[Hodgkin's disease in children: long-term therapeutic results (author's transl)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin | 1981 |
Acute erythroblastic leukemia terminating a very long-lasting (27 years) Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Leukemia, Er | 1982 |
[Radiotherapy of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1982 |
[Chemotherapy of Hodgkin disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1982 |
Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy.
Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Therapy, | 1982 |
[Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Drug | 1982 |
The effective use of combined modality therapy for the treatment of patients with Hodgkin's disease who relapsed following radiotherapy.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Recur | 1983 |
Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr | 1983 |
Pretreatment nausea in cancer chemotherapy: a conditioned response?
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Conditioning, Psycholo | 1980 |
Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Surface Area; Bon | 1980 |
Irradiation in the treatment of Hodgkin disease: a follow-up report.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 1981 |
[Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Dise | 1981 |
[Combined therapy of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Drug The | 1981 |
Survival in Hodgkin's disease: the role of immunocompetence and other major risk factors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Hodgkin Di | 1982 |
Reasons for failure of MOPP to cure Hodgkin's disease: The importance of dose and schedule.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relati | 1982 |
[10 years of DeVita protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1982 |
Microbicidal activity of peripheral blood monocytes from patients with Hodgkin's disease for Toxoplasma gondii.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Chlorambucil; Hodgkin Disease; Huma | 1982 |
[Hodgkin's disease in childhood: long term results].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Therapy, C | 1982 |
[Treatment of lymphogranulomatosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1982 |
[Pregnancies and offspring after MOPP therapy].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fertility; Fetus; Hodgkin | 1982 |
Hodgkin's disease and acute promyelocytic leukaemia. A case report.
Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechloret | 1980 |
Hodgkin's disease; tracheoesophageal fistula during MOPP chemotherapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mechloreth | 1981 |
Erythroleukaemia following treatment of Hodgkin's disease.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combinati | 1982 |
[Chemotherapy of malignant lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; | 1982 |
Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Erythrocytes; Hodgkin Disease; Humans | 1980 |
[Drug therapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1981 |
The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymph No | 1982 |
Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female | 1982 |
Gonadal function after combination chemotherapy for Hodgkin's disease in childhood.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgk | 1982 |
Supradiaphragmatic Hodgkin's disease: is there a role for MOPP chemotherapy in patients with bulky mediastinal disease?
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Mediastinal Neoplasms; Predniso | 1980 |
[Possibilities of treatment of reduction in Hodgkin's disease. III. Can polychemotherapy when combined with radiotherapy of localised stages be reduced? (author's transl)].
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Age | 1981 |
Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Femur Head Necrosis; Hodgkin Diseas | 1981 |
Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Contraceptives, Oral; Female; Hodgkin Disease; Humans; Mechlorethamine; Menstruat | 1981 |
Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Agents; Female; Follow-Up Studies; Hodgkin Disease; Ho | 1981 |
[The current state of curability of Hodgkin's disease].
Topics: Chromosome Aberrations; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Mechlorethamin | 1981 |
Evaluation of the significance of prognostic factors in stage III Hodgkin's disease treated with MOPP and radiotherapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hepati | 1980 |
Lactic acidosis associated with Hodgkin's disease: response to chemotherapy.
Topics: Acidosis; Adult; Dexamethasone; Hodgkin Disease; Humans; Lactates; Male; Mechlorethamine; Vincristin | 1980 |
The cure of disseminated Hodgkin's disease: prospects and problems.
Topics: Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Hodgkin Disease; Hum | 1980 |
Skin infiltration in Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procar | 1980 |
Osteonecrosis in patients with Hodgkin disease following combination chemotherapy.
Topics: Adult; Drug Therapy, Combination; Female; Femur Head Necrosis; Hodgkin Disease; Humans; Mechloretham | 1980 |
[Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans | 1980 |
Hodgkin's disease in South African children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Follo | 1981 |
Diagnosis, staging, and treatment of the malignant lymphomas.
Topics: Biopsy; Cyclophosphamide; Drug Combinations; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Mechlor | 1980 |
[Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Ep | 1995 |
Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD3 Complex; Dacarbazine; Doxorubicin; Et | 1995 |
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Tr | 1993 |
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combin | 1994 |
Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Sedimentation; B | 1994 |
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1994 |
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1994 |
Lymphocyte predominant Hodgkin's disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; B-L | 1995 |
Primary Hodgkin's disease of the bone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Doxorubicin; Femal | 1995 |
[Lung fibrosis after bleomycin therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Hodgkin Disease; Humans | 1994 |
Spontaneous fracture of the outlet catheter of a totally implanted catheter system (Port-A-Cath).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheterization, Central Veno | 1994 |
Autologous stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin's disease in first complete remission after MOPP/ABVD.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1995 |
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1995 |
Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Transfusion; Combined Modality | 1995 |
Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequ | 1995 |
[Hodgkin disease and amyloidosis].
Topics: Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubi | 1994 |
Body wars: effect of friendly fire (cancer therapy)
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Hodgkin | 1995 |
[Analysis of prognostic factors of Hodgkin's disease with Cox model].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 1994 |
MOPP, ABVD, or both to treat Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1993 |
MOPP, ABVD, or both to treat Hodgkin's disease.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor | 1993 |
C-MOPP/ABV yields good results in a public hospital population with Hodgkin disease in Brazil.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Cyclophosphami | 1993 |
Hodgkin's disease associated with central pontine myelinolysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Demyelinating Disease | 1993 |
Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1993 |
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool | 1993 |
Pediatric stage IV Hodgkin disease. Long-term survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther | 1993 |
Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dexametha | 1993 |
Thymic hyperplasia in adults following chemotherapy for malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin | 1993 |
[Effectiveness of chemotherapy and radiotherapy in 60 cases of Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cobalt Ra | 1993 |
Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1993 |
[Breast cancer after treatment of Hodgkin's disease].
Topics: Adenocarcinoma; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 1995 |
Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphocytes; Lymphoma, B-Ce | 1995 |
Pregnancy after autologous bone marrow transplantation for malignant lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cyt | 1994 |
Meningioma-like cerebral relapse of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fatal Outcome; Female; Ho | 1994 |
Myelodysplastic syndrome after autologous transplant for lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Hodgkin Dis | 1994 |
Curative radiotherapy is the best single treatment modality for the favorable early stage Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease; | 1994 |
Second malignant neoplasms in patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Moda | 1994 |
Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 1994 |
Reduced bone mineral density in men following chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Etoposide; Follicle Stimulating | 1994 |
Comparative dosimetry of O6-methylguanine in humans and rodents treated with procarbazine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; DNA; Guanine; Hodgkin Disease; Humans; Leuk | 1994 |
Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1994 |
Malignant schwannoma following treatment for Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female | 1994 |
Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy.
Topics: Adolescent; Adult; Aneuploidy; Animals; Antineoplastic Combined Chemotherapy Protocols; Chromosome A | 1994 |
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Case-Co | 1994 |
Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 1994 |
The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd | 1994 |
Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Female; Follow-Up St | 1993 |
A technique using parallel-opposed high energy electron beams for reirradiation of tumors near the spinal cord.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1993 |
Ethical decision-making processes used by health care providers.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Decision Making; Decision Theory; Ethical Ana | 1993 |
Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1993 |
Breast cancer developing after therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intr | 1993 |
Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1993 |
[Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymphoma, No | 1995 |
Second malignant tumours in childhood Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Protocols; Cohort | 1996 |
Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1996 |
Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1995 |
[Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1996 |
Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholestas | 1996 |
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1996 |
Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Follicle Stimulating Hormone; Fol | 1996 |
Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 1997 |
[Hodgkin's disease in the very young child. Apropos of 11 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1996 |
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; An | 1997 |
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; | 1997 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Ch | 1997 |
A blood stem cell transplant in a person with concomitant Hodgkin disease and testicular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Germinoma; Hematopoietic | 1997 |
Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 1997 |
[A case of Hodgkin's disease with an uncommon clinical course. Predominant localization in the liver].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Female; Hodgkin Disease; Huma | 1996 |
Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1997 |
[Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, P | 1996 |
Resolution of paraneoplastic bile duct paucity following successful treatment of Hodgkin's disease.
Topics: Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Diseases; Bil | 1997 |
Gonadal function following ABVD therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkyla | 1997 |
G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antine | 1997 |
Salvage radiotherapy for Hodgkin's disease following chemotherapy failure.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Di | 1997 |
A cure model with time-changing risk factor: an application to the analysis of secondary leukaemia. A report from the International Database on Hodgkin's Disease.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Fr | 1998 |
Should MOPP-ABVD alone be standard for childhood Hodgkin's?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin | 1998 |
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomyci | 1998 |
Hodgkin's disease in children in southern Africa: epidemiological characteristics, morbidity and long-term outcome.
Topics: Adolescent; Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Chil | 1997 |
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherap | 1997 |
Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
Topics: Adolescent; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Co | 1998 |
Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hematopoietic Stem | 1998 |
Second cancer among long-term survivors from Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleom | 1998 |
Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1998 |
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con
Topics: Abdomen; Actuarial Analysis; Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; | 1998 |
[Hodgkin's disease in two children of mother treated with nitrogranulogen].
Topics: Alkylating Agents; Child; Female; Hodgkin Disease; Humans; Male; Maternal Welfare; Mechlorethamine; | 1998 |
[Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome].
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineop | 1998 |
Unilateral proptosis in an immunocompetent man as the initial clinical manifestation of systemic Hodgkin disease.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Exophthalmos; | 1999 |
Advanced stage and unfavorable Hodgkin's disease in the Chinese-a 20-year experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca | 1999 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; | 1999 |
Gemcitabine is active in relapsed Hodgkin's disease.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; D | 1999 |
In vivo expansion of reinfused autologous peripheral blood stem cells after a myeloablative regimen, as an alternative to ex vivo expansion pretransplantation: an intriguing observation in apatient autografted twice.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Cyclophosphamide; Doxoru | 1999 |
Association between alopecia and response to aggressive chemotherapy in patients with Hodgkin's disease.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin | 1999 |
Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 1999 |
Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
Topics: Adult; Antigen-Antibody Complex; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; | 2000 |
Follow-up of sperm concentration and motility in patients with lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cryopreservation; Daca | 2000 |
[Diagnostic problems due to alternative medicine].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast N | 2000 |
Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined | 2000 |
Efficacy of standard treatment in patients with Hodgkin's disease--a single center experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2000 |
[Thyroid lymphoma. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Follow-Up Studies; | 2000 |
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Ther | 2000 |
Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2000 |
[Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Child; Cycl | 2000 |
[Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Hodgkin Disease; Humans; Lam | 2000 |
Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Combined Modality Therapy; | 2001 |
Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report.
Topics: Alveolar Bone Loss; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Dacarb | 2001 |
Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Female; Hodgkin D | 2001 |
The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hosp
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; F | 2001 |
[The chemotherapeutic treatment of advanced Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2001 |
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modali | 2001 |
The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomyci | 2001 |
Subdiaphragmatic Hodgkin's disease: the University of Florida experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Di | 2002 |
[Treatment of advanced Hodgkin's disease: an analysis of 128 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CCAAT-Enhancer-Binding Prot | 2000 |
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 2001 |
Pulmonary toxicity secondary to procarbazine.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male | 2002 |
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbaz | 2002 |
[Criteria for choice of therapeutic procedures in lymphomas].
Topics: Antineoplastic Agents; Bleomycin; Cobalt Radioisotopes; Doxorubicin; Drug Therapy, Combination; Hodg | 1975 |
[Current problems in therapy of evolutive malignant granuloma. Our experience with a new scheme of polychemotherapy].
Topics: Antineoplastic Agents; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Hodgkin | 1975 |
Progress in the chemotherapy of hematologic diseases.
Topics: Antineoplastic Agents; Bleomycin; Daunorubicin; DNA Replication; Doxorubicin; Drug Therapy, Combinat | 1975 |
Palliation in malignant pleural effusion.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Drainage; Female; Hodgkin Disease; Humans; Lung Neopl | 1975 |
Pituitary function in patients receiving intermittent cytotoxic and corticosteroid therapy for malignant lymphoma.
Topics: Adult; Antineoplastic Agents; Circadian Rhythm; Doxorubicin; Drug Therapy, Combination; Female; Hodg | 1976 |
[Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hod | 1976 |
New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease.
Topics: Adult; Aged; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combin | 1976 |
Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
Topics: Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Huma | 1977 |
[Effect of combined chemotherapy on the prognosis of Hodgkin's disease: retrospective study of 74 cases from 1959-1973].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Cyclophosphamide; Dacarbazine; Dac | 1977 |
Long term experience with combination chemotherapy in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; | 1977 |
[Cytostatic chemotherapy of lymphogranulomatosis].
Topics: Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combinat | 1978 |
Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
Topics: Adolescent; Adult; Bleomycin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgk | 1978 |
Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; | 1978 |
Pregnancy after chemotherapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Drug Administration Schedule; Drug Therapy, Combina | 1979 |
Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP).
Topics: Adolescent; Adult; Alopecia; Antineoplastic Agents; Bleomycin; Child; Doxorubicin; Drug Administrati | 1979 |
Combination chemotherapy in stages I or II Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Di | 1979 |
[Hodgkin's disease: classification, staging, therapy].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparoscopy; Life Expectancy; Mechlorethamine; N | 1978 |
Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
Topics: Antibodies, Viral; Antigens, Viral; Burkitt Lymphoma; Child; Herpesvirus 4, Human; Hodgkin Disease; | 1975 |
People with Hodgkin disease: the nursing challenge.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Hodgkin Disease; Humans; Male; Mechlorethamine; | 1978 |
Acute myelogenous leukemia as a late complication of the multimodality therapy for Hodgkin's disease.
Topics: Adult; Biopsy; Bone Marrow; Cytarabine; Daunorubicin; Hodgkin Disease; Humans; Leukemia, Myeloid, Ac | 1977 |
Fulminant sepsis after the successful treatment of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Female; Haemophilus Infections; Hodgkin Disease; Humans; M | 1977 |
Stages I--III Hodgkin's disease in children: results of staging and treatment.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lym | 1977 |
Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment.
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlore | 1977 |
Management of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lympha | 1979 |
Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse.
Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans | 1979 |
Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Glom | 1979 |
An evaluation of total nodal irradiation as treatment for stage III A Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combinat | 1979 |
Extrapyramidal tract syndrome following intensive MOPP therapy for stage IV-B Hodgkin's disease in childhood.
Topics: Antineoplastic Agents; Basal Ganglia Diseases; Child; Drug Therapy, Combination; Hodgkin Disease; Hu | 1979 |
Hodgkin's disease in children: treatment with low dose radiation and MOPP without staging laparotomy: a preliminary report.
Topics: Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1979 |
Hodgkin's disease: combination chemotherapy for relapse following radical radiotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Disease; | 1979 |
The role of combined modality therapy in the treatment of stage IIIA Hodgkin's disease.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Predniso | 1979 |
[Results of the combined chemotherapy of stage III and IV lymphogranulomatosis].
Topics: Drug Evaluation; Drug Therapy, Combination; Female; Hematopoiesis; Hodgkin Disease; Humans; Male; Me | 1979 |
Feasibility of different combinations of chemotherapy (6 MOPP) plus radiotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; | 1979 |
Hodgkin's disease: results of treatment with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Me | 1977 |
Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease?
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1978 |
MVPP chemotherapy regimen for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Femal | 1978 |
Impact of salvage treatment on initial relapses in patients with Hodgkin disease, stages I-III.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr | 1978 |
Hemorrhagic cystitis with MOPP therapy.
Topics: Child; Cyclophosphamide; Cystitis; Drug Therapy, Combination; Hematuria; Hodgkin Disease; Humans; Ma | 1978 |
Relapse of Hodgkin disease after extended-field radiotherapy.
Topics: Adolescent; Adult; Aged; Bone Marrow; Child; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lym | 1978 |
Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; | 1978 |
[MVPP multiple drug therapy combined with conventional radiotherapy in children with Hodgkin's disease].
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mal | 1978 |
[Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech | 1978 |
Childhood Hodgkin's disease in Uganda: a ten year experience.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gynec | 1978 |
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di | 1978 |
The place of radiation therapy in the treatment of Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Myocardial | 1978 |
[Polychemotherapy of lymphomas. Results of a selection of 32 cases diagnosed in stage III and stage IV and not previously treated].
Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine | 1978 |
[MOPP chemotherapy of generalized Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; | 1978 |
Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment.
Topics: Adolescent; Adult; Child; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neopl | 1978 |
[Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphom | 1976 |
Recent advances and controversies in the management of Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Lymphography; Mechlorethamine | 1975 |
[Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine | 1975 |
The therapy of Hodgkin's disease in Nigeria: a five year study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Ther | 1976 |
Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.
Topics: Adult; Biopsy; Drug Hypersensitivity; Female; Hodgkin Disease; Humans; Lung Diseases; Mechlorethamin | 1977 |
[Combined cyclic treatment of generalized Hodgkin's disease by the MOPP program. Preliminary results and observed complications].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd | 1977 |
[Initial treatment of Hodgkin's disease with polychemotherapy. Long-term results in 226 cases (1- to 10-year follow-up)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Evaluation; Drug Therapy, Combination; F | 1977 |
Comparative Bayesian and traditional inference for gamma-modeled survival data.
Topics: Bayes Theorem; Hodgkin Disease; Humans; Mechlorethamine; Statistics as Topic; Therapeutics | 1977 |
[The results of radiotherapy managements in Hodgkin's disease (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Me | 1977 |
[81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Retro | 1977 |
The effect of quadruple chemotherapy on the peripheral blood lymphocyte populations in Hodgkin's disease.
Topics: Adult; Depression, Chemical; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukocyte Count; Ly | 1977 |
[Recent progress in the treatment of Hodgkin's disease].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinbl | 1977 |
Hematologic neoplasia in patients treated for Hodgkin's disease.
Topics: Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia; Male; Mechloreth | 1977 |
[Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Prednisone; Procarb | 1977 |
[Polychemotherapy of Hodgkin's disease. Long-term results in 226 cases].
Topics: Drug Therapy, Combination; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; | 1977 |
[Laparotomy in the therapy of Hodgkin's disease].
Topics: Cobalt Radioisotopes; Diaphragm; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mec | 1977 |
Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
Topics: Adolescent; Adult; Age Factors; Aged; Alopecia; Antineoplastic Agents; Cyclophosphamide; Drug Therap | 1976 |
Long term remissions with combined modality therapy for advanced Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Age | 1976 |
Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment.
Topics: Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Metastasis; Neoplasm Recurrence, Lo | 1976 |
Effects of nitrogen mustard and splenectomy on mouse bone marrow colony formation in vitro.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cell Division; Clone Cells; Hodgkin Disease; Male; Mechlore | 1976 |
[Long-term remission in advanced stages of lymphogranulomatosis following combined chemotherapy using a modified de Vita system].
Topics: Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Hodgkin Disease; Humans; Mechloretha | 1976 |
Combination chemotherapy of Hodgkin's disease in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combinat | 1976 |
Hypertrophic pulmonary osteoarthropathy in Hodgkin's disease: reversal with chemotherapy.
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lung Diseases; Mal | 1976 |
[Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
Topics: Agranulocytosis; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Life | 1976 |
Patterns of changes in peripheral blood composition in the course of combination chemotherapy of cancer.
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Hematopoies | 1976 |
The effect of nitrogen mustard on human mononuclear blood cells.
Topics: Adult; Cell Survival; Cells, Cultured; Hodgkin Disease; Humans; Lymphocytes; Male; Mechlorethamine; | 1976 |
Prednisone in MOPP chemotherapy for Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone | 1976 |
Staging laparotomy and splenectomy: treatment and complications of Hodgkin's disease in children.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Di | 1976 |
Hodgkin disease with acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Daunorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemi | 1975 |
Management of Hodgkin's and non-Hodgkin's lymphomas.
Topics: Administration, Oral; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Injectio | 1975 |
Fetal renal malformation following treatment of Hodgkin's disease during pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Adult; Autopsy; Female; Fetus; Hodgkin Disease; Huma | 1975 |
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechloret | 1975 |
Combination chemotherapy in Hodgkin's disease: relation to radiotherapy.
Topics: Drug Therapy, Combination; Evaluation Studies as Topic; Hodgkin Disease; Humans; Mechlorethamine; Pr | 1975 |
Towards curative treatment of advanced Hodgkin's disease.
Topics: Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Proca | 1975 |
[Experiences with combined cyclic chemotherapy (COPP type) in advanced lymphogranulomatosis].
Topics: Adult; Aged; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodg | 1975 |
Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up).
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore | 1975 |
[Polychemotherapy without prednisone in Hodgkin's disease].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd | 1975 |
Combination chemotherapy in Hodgkin's disease at advanced stages.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechloret | 1975 |
[Chemotherapy of advanced stages (IIIB and IV) of Hodgkin's disease].
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlore | 1975 |
Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.
Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine; Pos | 1976 |
Testicular function after combination chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Cell Count; Cyclophosphamide; Drug Therapy, Combination; Follicle Stim | 1976 |
Unusual cardiac reaction to chemotherapy following mediastinal irradiation in a patient with Hodgkin's disease.
Topics: Adult; Drug Therapy, Combination; Heart; Hodgkin Disease; Humans; Male; Mechlorethamine; Mediastinal | 1976 |
Spinal cord compression in malignant lymphoma. Treatment and results.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Hodgkin Disease; Humans; Infant; Mechlorethamine; | 1976 |
[Combined chemotherapy in Hodgkin's disease].
Topics: Antineoplastic Agents; Blood Cell Count; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlor | 1976 |
Non-Hodgkin's lymphoma in children.
Topics: Adolescent; Central Nervous System; Child; Diagnosis, Differential; Hodgkin Disease; Humans; Lymphom | 1976 |
The Second International Symposium on Hodgkin's Disease. Workshop III: Recommendations for future clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modali | 1992 |
[Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Administra | 1992 |
[Cancer of the testis after Hodgkin's disease. Apropos of 2 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Dysgermi | 1992 |
Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols | 1992 |
[Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 1992 |
Hodgkin's disease and acute leukemia. Is it a true association?
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil | 1992 |
Bilateral aseptic necrosis of the humeral head following combined therapy for Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1992 |
Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic | 1992 |
Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy.
Topics: Adult; Alopecia Areata; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomyc | 1992 |
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1992 |
ABEP as primary chemotherapy for Hodgkin's disease.
Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabin | 1992 |
[Radiotherapy vs. chemotherapy in early-stage Hodgkin's disease: a justified approach?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Decision Making; Hodgkin D | 1992 |
Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
Topics: Adolescent; Adult; Alkylating Agents; Child; Chlorambucil; Cohort Studies; Female; Follow-Up Studies | 1992 |
Remission of scleroderma during chemotherapy for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1992 |
The frequency of translocations after treatment for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 4; Combined Modality Therap | 1992 |
Selective metaphasic arrest of erythroblasts by vincristine in patients receiving high doses of recombinant human erythropoietin for myelosuppressive anemia.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Erythroblasts; Erythropoietin; Hodgkin Disea | 1992 |
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1992 |
Residual mediastinal mass after treatment of Hodgkin's disease: a decision analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Decision Trees; Hodgkin D | 1992 |
Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microgl | 1992 |
[Hodgkin's disease. Our 9-year experience with the 1980 protocol].
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy | 1992 |
Late cardiopulmonary toxicity after treatment for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Exerci | 1992 |
Radiation therapy is better than chemotherapy in early-stage Hodgkin's disease? Not so fast.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1992 |
Chromosome aberrations following cytotoxic therapy in patients in complete remission from lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cells, Cultured; Chromosome Aberrations | 1992 |
Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Chromosomes; Dacarbazi | 1990 |
Treatment of Hodgkin's disease with MOPP chemotherapy: effect of dose and schedule modification on treatment outcome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response R | 1990 |
Secondary uncommon solid neoplasms in cured Hodgkin's disease and follow-up of the original B-DOPA chemotherapy patient group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Dacarbaz | 1990 |
Development of pulmonary histiocytosis X after chemotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fem | 1990 |
The impact of breakthrough clinical trials on survival in population based tumor registries.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Hodg | 1991 |
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Et | 1990 |
Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Dacarbazine; Doxorubi | 1991 |
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 1991 |
Development of effective salvage treatment programs for Hodgkin's disease: an ongoing clinical challenge.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1991 |
Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1991 |
MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1991 |
Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 1991 |
Haematological toxicity compromises MOPP/ABVD chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1991 |
Serum antithrombin III and alpha-2-antiplasmin concentrations in patients with Hodgkin's disease in the course of chemotherapy.
Topics: Adult; Aged; alpha-Macroglobulins; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; | 1991 |
In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols | 1991 |
Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 1991 |
[Hodgkin's disease during pregnancy. Study of late effects in the newborn infants].
Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chrom | 1991 |
Chemotherapy combined with involved-field radiotherapy for 177 children with Hodgkin's disease treated in 1983-1987.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child | 1991 |
[Treatment of Hodgkin's disease. National Protocol of Antineoplastic Drugs: preliminary report].
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1991 |
Maternal and foetal outcome following Hodgkin's disease in pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Birth Weight; Case-Control Studies; Cesarean | 1992 |
An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Discriminant Analy | 1991 |
Mechlorethamine, vinblastine, procarbazine and prednisolone (MVPP) for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1991 |
Transient reversal of bone marrow aplasia associated with lymphocyte depleted Hodgkin's disease after combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Female; Hodgkin Disease; | 1991 |
Hodgkin's disease of the liver; prognosis and possible indications for radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Protocols; Hodgkin Disease; H | 1991 |
Sister chromatid exchange frequency in Hodgkin's disease patients with elevated in vivo hprt mutant frequencies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera | 1991 |
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1991 |
In vitro fertilization techniques with frozen-thawed sperm: a method for preserving the progenitive potential of Hodgkin patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cryopreservation; Embryo Transfer; Female; Fe | 1991 |
Treatment of childhood Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Hodgkin Disease; Humans; Me | 1991 |
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1991 |
Early-stage Hodgkin's disease: a choice of treatments or a treatment of choice?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1991 |
Influence of age and duration of follow-up on lung function after combined chemotherapy for Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Femal | 1990 |
Thoracic irradiation in Hodgkin's disease: disease control and long-term complications.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1990 |
Active oxygen radicals produced by leukocytes of malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Electron Spin Resonan | 1990 |
Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1990 |
Acute nonlymphocytic leukemia after radiation and MOPP chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1990 |
Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1990 |
MOPP dose intensity and survival: flawed analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1990 |
Delayed life-threatening pneumonitis secondary to procarbazine.
Topics: Adult; Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Di | 1990 |
Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therap | 1990 |
Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1990 |
Luteinizing hormone pulsatility in men with damage to the germinal epithelium.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Hodgkin Disease; Humans; Ley | 1990 |
The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cohort Studies; Colo | 1990 |
Laparotomy and splenectomy in Hodgkin's disease: a reappraisal after twenty years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1985 |
MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1985 |
Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1985 |
[Malignant lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 1985 |
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodg | 1986 |
Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1985 |
[Laparotomy with splenectomy in the evaluation of the results of cytostatic treatment of patients with advanced Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 1986 |
ABVD versus MOPP: which is better?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1987 |
Prognostic value of response after three MOPP cycles in Hodgkin's disease--stage III and IV.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance | 1987 |
Hodgkin's disease (HD): a historical perspective.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba | 1986 |
Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Composition; Elec | 1987 |
Treatment of Hodgkin's disease in children with or without radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 1987 |
[Controversial aspects in the current treatment of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1987 |
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Dru | 1987 |
[The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1987 |
Serum lysozyme activity in patients with Hodgkin's disease undergoing chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1987 |
Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Follow-Up Stu | 1988 |
[Hodgkin's disease in children. Current therapeutic strategies].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1988 |
Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1988 |
Is first salvage chemotherapy the last-line chemotherapy in children with Hodgkin's disease? A tentative answer based on long observation of two patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Combined Modal | 1987 |
[Improved survival rates in Hodgkin's disease].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; D | 1988 |
An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; D | 1988 |
[Hodgkin's disease and AIDS. Presentation of 5 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 1988 |
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1988 |
Procarbazine hypersensitivity manifested as a fixed drug eruption.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Eru | 1988 |
Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb | 1989 |
[Femoral osteonecrosis in patients treated with radiochemotherapy of Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cobalt Radioisotopes; Combined Mod | 1989 |
[Function of the lungs in patients with Hodgkin's disease after chemotherapy and radiotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cobalt Radioisotopes; | 1988 |
Allogeneic marrow transplantation for refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1989 |
Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi | 1989 |
Conventional salvage therapy for Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod | 1989 |
Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 1989 |
Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1989 |
[Radiotherapy with neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Doxorub | 1989 |
[A case of Hodgkin's disease exhibiting erythrodermia probably due to allergic reaction to vinca alkaloids].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dermatitis, Exfoliative; Drug Eruptions; Hodgkin Dis | 1989 |
[Recurrent paralysis induced by vincristine during the treatment of Hodgkin's disease].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamine | 1989 |
[Hodgkin's disease diagnosed from the numerous Reed-Sternberg cells in the bone marrow].
Topics: Antigens, Differentiation; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone | 1989 |
Pediatric Hodgkin's disease. Later results and toxicity--the Toronto experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Follow | 1989 |
Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Comb | 1985 |
Prognostic factors for Stage IV Hodgkin's disease treated with MOPP, with or without bleomycin.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Hodgkin Disease; | 1985 |
Third-line salvage chemotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox | 1985 |
[Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D | 1985 |
How much MOPP?
Topics: Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Hodgkin Disease; H | 1989 |
Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Discriminant Analysis; Dose-Res | 1989 |
[Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1989 |
Two cycles of MOPP and definitive radiotherapy for stage IIIA and IIIB Hodgkin's disease.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fert | 1989 |
Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1989 |
MOPP therapy in children with Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin Disease; Hu | 1989 |
Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Hodgkin Dis | 1989 |
Ten-year nodular sclerosis Hodgkin's disease and second malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1989 |
Hodgkin's disease presenting as myelofibrosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Diagnosis, Differential; Female; | 1989 |
Cutaneous Hodgkin's disease in a patient with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; H | 1989 |
MOPP chemotherapy alone: a suitable treatment for early stages of Hodgkin's disease?
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Dise | 1985 |
Advanced Hodgkin disease (clinical stages IIIB and IV): low relapse rate after brief chemotherapy followed by high-dose total lymphoid irradiation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1989 |
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Chlorambucil; Female; Hodg | 1989 |
[Treatment of Hodgkin's disease by chemotherapy with MOPP alone. Long-term results].
Topics: Adolescent; Adult; Algeria; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Follow-Up | 1986 |
A method for analysing case-control studies with ordinal exposure variables.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biometry; Burkitt Lymphoma; Cl | 1985 |
Hodgkin's disease following Wilms' tumor: a case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgk | 1987 |
Second malignant neoplasm in treated Hodgkin's disease. Report of a patient and scope of the problem.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Combined Modality Therapy; G | 1986 |
Retroperitoneal fibrosis following treatment for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1987 |
Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Follow-Up Studies | 1987 |
Case report: multiagent chemotherapy of Hodgkin's disease associated with red cell aplasia, acquired ichthyosis and anhidrosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Hypohidrosis; Ichthyosis; M | 1987 |
The pituitary-Leydig cell axis in men with severe damage to the germinal epithelium.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Follicle Stimulating Hormone; Hod | 1987 |
Plasma inhibin levels in men with chemotherapy-induced severe damage to the seminiferous epithelium.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Follicle Stimulating Hormone; Hod | 1988 |
Glomerulonephritis preceding late relapse of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Glomerulonephritis; Glomerulosclerosis, Foca | 1988 |
The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Damage; Doxorubicin; Hodgkin D | 1988 |
The karyotype in secondary hematologic disorders after treatment for Hodgkin's disease. A study of 19 patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Female; Hodgkin Disea | 1988 |
Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Leukoc | 1988 |
Dibromdulcitol containing chemotherapeutic regimen in the treatment of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin | 1988 |
Treatment of patients with "minimal" stage IIIA Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1987 |
[10 years' therapy of Hodgkin's disease in the Oncology Department of the Basel Canton Hospital: a retrospective study].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1987 |
Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Female; Hodgkin | 1988 |
Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Combined Modality Therapy; Fema | 1988 |
Severe delayed neurotoxicity after accidental high-dose nitrogen mustard.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechlorethamine; Me | 1988 |
Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relationship | 1988 |
[Acute leukemia in patients treated for Hodgkin's disease].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Human | 1988 |
[Comparative evaluation of the efficacy of chemotherapy and chemoradiotherapy of stage IIIB Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1988 |
Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in Hodgkin's disease. An analysis of long-term follow-up.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Child; Fema | 1988 |
[Prognostic factors in the chemoradiation treatment of III-stage lymphogranulomatosis].
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 1988 |
[Second tumors in patients treated for Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modali | 1988 |
ChlVPP--an effective and well-tolerated alternative to MOPP therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Hodgk | 1988 |
Two cycles of MOPP and radiotherapy for stage III1A and stage III1B Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedul | 1988 |
Chemotherapy responsive collagenous colitis in a patient with Hodgkin's disease: a possible paraneoplastic phenomenon.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Basement Membrane; Colitis; Collagen Diseases; | 1987 |
Gallium citrate Ga 67 accumulation in pulmonary lesions after chemotherapy (MOPP).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Gallium Radioisotopes; Hodgkin Diseas | 1986 |
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Erythrocyte Indices; Hodgkin Disease; Humans; Leukem | 1987 |
Plasma and leukocytic bactericidal activity in the course of chemotherapy of Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Bactericidal Activity | 1987 |
Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child, Presch | 1987 |
[Hodgkin's disease. Study of 100 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1987 |
Nitroblue tetrazolium test in patients with Hodgkin's disease in the course of chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Granulocytes; Hodgk | 1987 |
Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1987 |
[Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1987 |
[Role of radiotherapy in the treatment of stage IIIB Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1987 |
Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 1987 |
Recurrent "syncytial variant" of Hodgkin's disease: an immunohistologic diagnosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hodgkin Disease; Hu | 1987 |
Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1987 |
Pregnancy following nonsurgical donor ovum transfer to a functionally agonadal woman.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Embryo Transfer; Estradiol; Female; Hodgkin D | 1987 |
Predictive value of the early response to chemotherapy in high-risk stages II and III Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1987 |
Intramedullary spinal cord metastasis in Hodgkin's disease. Rapid diagnosis and treatment resulting in neurologic recovery.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di | 1987 |
[Twin pregnancy after iatrogenic menopause].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Estrogens; Female; Hodgkin Disease; Humans; I | 1987 |
Hodgkins disease: a personal account.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1987 |
[Photochemotherapy of eyelid lesions].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Eyelid Diseases; Female; Hodgkin Disease; Huma | 1987 |
Hodgkin's disease presenting with central nervous system involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Hodgkin Disease; Humans; Mal | 1987 |
Improved survival in the treatment of advanced Hodgkin's disease at a nonuniversity institution (1970-1979).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hu | 1986 |
Mallory-Weiss tear and cytotoxic-induced emesis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mallory-Weiss | 1986 |
Reversible mechlorethamine-associated hearing loss in a patient with Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Audiometry; Auditory Threshold; Cyclophospham | 1986 |
Variation of SCE frequency in lymphocyte cultures from patients with Hodgkin's disease before, during, and after treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Hodgkin Disease; Human | 1986 |
Pancytopenia with myelofibrosis. An unusual presentation of childhood Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Female; Hodgkin Disease; Humans; | 1986 |
Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Celiac Disease; Hodgkin Disease; Humans; Immun | 1986 |
[Clinical features and treatment of Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Immunity, Cellular; | 1986 |
Purpura fulminans in pneumococcal sepsis.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Fema | 1986 |
Unusual thoracic radiographic findings in children treated for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1986 |
A rare opportunity to observe aspects of the natural history of untreated Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymph Nodes; | 1986 |
[Hodgkin's disease in children; treatment results with or without radiotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Mediastina | 1986 |
[Hodgkin's disease in children; treatment results with or without radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethamine; Pre | 1986 |
Lymphomatoid papulosis: remission following intravenously administered acyclovir.
Topics: Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Injections, Intr | 1986 |
[The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
MOPP after two decades.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1986 |
Treatment of Hodgkin's disease stages I and II with chemotherapy alone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Disease; H | 1986 |
Hodgkin's disease presenting with isolated craniospinal involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; D | 1986 |
Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Hodgkin Disease | 1986 |
[The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1986 |
Chemotherapy treated Hodgkins disease--a fifteen year review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Follow-Up Studies; Hodg | 1986 |
Treatment of pathologically staged IIIA Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease; | 1986 |
MOPP after two decades.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1987 |
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy; | 1987 |
Radiotherapy of stage I and II Hodgkin disease with inguinal presentation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1985 |
Cystic degeneration of thymic Hodgkin's disease following radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cysts; Diagnosis, Differential; Hodgkin Disea | 1985 |
Clinical significance of heat labile Regan isoenzyme variant in Hodgkin's disease.
Topics: Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; GPI-Linked Proteins; Ho | 1985 |
The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Tolerance; Female; Hod | 1985 |
Hodgkin's disease in adults: the challenge.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Laparotomy; Mechlore | 1985 |
[Chemotherapy of advanced lymphogranulomatosis. Results of MOPP/COPP treatment at the West German Tumor Center, Essen].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hu | 1985 |
Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1985 |
Hodgkin's disease, intracranial involvement. Report of a case and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Hodgkin Disease; Humans; Mal | 1985 |
Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; | 1985 |
[MOPP therapy of Hodgkin's disease previously treated with MOPP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone | 1985 |
[Pregnancy and fetal development after therapy of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Embryonic and Fetal Develop | 1985 |
Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Hodgkin Disease; Humans; Mechlore | 1985 |
Osteonecrosis of sternum and rib in a patient treated for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1985 |
Pediatric Hodgkin's disease in India.
Topics: Actuarial Analysis; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; | 1985 |
[Primary gastric Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H | 1985 |
[The role of radiotherapy in the treatment of Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th | 1985 |
[Acute lymphoblastic leukemia L3 in Hodgkin's disease in remission: primary or secondary leukosis?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Karyotyping; Leukemia, Lymp | 1985 |
Varicella in immunodepressed children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Child; Female; Hodgkin Disease; Humans; | 1985 |
Reduction of fatal complications from combined modality therapy in Hodgkin's disease.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Pro | 1985 |
Current status and new vistas in combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgkin Disease; H | 1985 |
Pregnancy after chemotherapy induced ovarian failure.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1985 |
Stage IA to IIB supradiaphragmatic Hodgkin's disease. Long-term survival and relapse frequency.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presch | 1985 |
The management of stage II Hodgkin's disease with a large mediastinal mass: a prospective program emphasizing irradiation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1985 |
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
Topics: Acute Disease; Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Prot | 1985 |
Management of malignant lymphomas: a practical and philosophical approach.
Topics: Bleomycin; Cyclophosphamide; Hodgkin Disease; Hospitals, Special; Humans; Laparotomy; Lymphoma; Mech | 1973 |
Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Doxorubicin; Drug Therapy, Combina | 1973 |
International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Hodgkin Diseas | 1973 |
Acute leukemia in Hodgkin's disease.
Topics: Adult; Bleomycin; Carmustine; Chlorambucil; Drug Therapy, Combination; Female; Hodgkin Disease; Huma | 1974 |
Prognosis and survival with extranodal Hodgkin's disease.
Topics: Adult; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Human | 1974 |
[Chemotherapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Bleomycin; Drug Hypersensitivity; Drug Therapy, Combination; Hodgkin Disease; | 1974 |
Letter: Chemotherapy of Hodgkin's disease.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin D | 1974 |
[Cytostatic effects on nucleic acid- and protein synthesis of benign and malignant lymphomas].
Topics: Amides; Antineoplastic Agents; Dactinomycin; DNA, Neoplasm; Hodgkin Disease; Humans; Hydralazine; In | 1967 |
[Hodgkin's disease in the practice of general medicine. Problems posed by the diagnosis, surveillance of treatments and social rehabilitation of patients].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Biopsy; Chlorambucil; Cyclophosphamide; Hodgkin | 1974 |
Amyloidosis: origin from fixed periodic acid-Schiff positive reticuloendothelial cells in loco and basic factors in pathogenesis.
Topics: Adrenocorticotropic Hormone; Agammaglobulinemia; Amyloidosis; Animals; Arthritis, Rheumatoid; Cortis | 1966 |
The treatment of malignant pleural effusions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamou | 1974 |
[Confusion of uncertain etiology in Hodgkin's disease].
Topics: Aged; Cognition Disorders; Female; Herpes Zoster; Hodgkin Disease; Humans; Mechlorethamine; Predniso | 1974 |
Association of Hodgkin disease and Gaucher disease.
Topics: Adult; Autopsy; Biopsy; Gaucher Disease; Hodgkin Disease; Humans; Liver; Lymph Nodes; Lymphocytes; M | 1974 |
Letter: Chemotherapy of Hodgkin's disease.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Remis | 1974 |
[Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
Topics: Antineoplastic Agents; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlore | 1974 |
Hodgkin's disease of the spleen: some clinical aspects and problems.
Topics: Adrenal Cortex Hormones; Adult; Cyclophosphamide; Endoscopy; Female; Hodgkin Disease; Humans; Kerato | 1974 |
Chemotherapy of Hodgkin's disease.
Topics: Adrenal Cortex Hormones; Aged; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; | 1974 |
[Hodgkin's disease complicated by myeloblastic leukosis].
Topics: Adult; Biopsy; Hodgkin Disease; Humans; Hydrazines; Leukemia, Myeloid, Acute; Lymph Nodes; Male; Mec | 1973 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
Evidence for a specific seminiferous tubular factor affecting follicle-stimulating hormone secretion in man.
Topics: Adult; Biopsy; Cell Count; Clomiphene; Cyclophosphamide; Follicle Stimulating Hormone; Hodgkin Disea | 1972 |
The place of chemotherapy in Hodgkin's disease and allied disorders.
Topics: Blood Cell Count; Hodgkin Disease; Humans; Laparotomy; Liver Function Tests; Lymphoma, Large B-Cell, | 1972 |
Management of patients with non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Lymphography; Ly | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Comment: the non-Hodgkin's lymphomas.
Topics: Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-C | 1973 |
Nephrosis of Hodgkin disease. An immune complex-induced lesion.
Topics: Antigen-Antibody Complex; Basement Membrane; Biopsy; Blood Urea Nitrogen; Body Weight; Capillaries; | 1973 |
Updated Hodgkin's disease: B. Curability of localized disease. Comment: The mantle failure: The transdiaphragmatic extension.
Topics: Diaphragm; Hodgkin Disease; Humans; Lymph Nodes; Lymphography; Mechlorethamine; Methods; Procarbazin | 1973 |
Treatment of Hodgkin's disease. Results obtained by individualized treatment using radiotherapy and cytostatics.
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Female; Hodgkin Disease; Humans; Male; Mechloretha | 1972 |
The MOPP controversy.
Topics: Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1972 |
Multiple-drug therapy in Hodgkin's disease.
Topics: Antiemetics; Drug Synergism; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Pro | 1972 |
The treatment of Hodgkin's disease.
Topics: Agranulocytosis; Antineoplastic Agents; Bone Marrow Diseases; Chlorambucil; Drug Combinations; Hodgk | 1972 |
Treatment of Hodgkin's disease.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Medicine; Prednisone; Procarbazine; Referral and Consultat | 1972 |
Combination chemotherapy of acute leukemia and Hodgkin's disease.
Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Predni | 1972 |
Hodgkin's disease therapeutic program.
Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Proc | 1972 |
Splenectomy effects on chemotherapy in Hodgkin's disease.
Topics: Antineoplastic Agents; Benzoates; Blood Cell Count; Blood Platelets; Evaluation Studies as Topic; Ho | 1973 |
Eastern cooperative oncology group studies.
Topics: Antineoplastic Agents; Blood Cell Count; Carmustine; Cyclophosphamide; Hodgkin Disease; Humans; Mech | 1973 |
Combined chemotherapy radiotherapy management of stage 3 Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Benzoates; Blood Cell Count; Blood Platelets; Cyclophosphamide; Evalua | 1973 |
Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Hodgkin Disease; Humans; Male; Mechlorethami | 1973 |
Antidiuretic response to cyclophosphamide in man.
Topics: Adult; Aged; Cyclophosphamide; Diuresis; Female; Glomerular Filtration Rate; Hodgkin Disease; Humans | 1973 |
MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Benzoates; Evaluation Studies as Topic; | 1973 |
Chemotherapy in Hodgkin's disease (lymphadenoma).
Topics: Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinca Alkaloi | 1973 |
[Non-leukemic hematosarcomas. Hodgkin's disease. Current therapeutic ideas. Personal experience with multiple drug therapy].
Topics: Drug Synergism; Hodgkin Disease; Humans; Mechlorethamine; Methylprednisolone; Procarbazine; Vincrist | 1973 |
Hodgkin's disease of the colon.
Topics: Adult; Biopsy; Colonic Neoplasms; Female; Hodgkin Disease; Humans; Lymph Nodes; Mechlorethamine; Pre | 1973 |
Status and perspectives in chemotherapy of Hodgkin's disease.
Topics: Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cyt | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Management with combination therapy.
Topics: Antineoplastic Agents; Benzoates; Carmustine; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; | 1973 |
Updated Hodgkins' disease. C. Advanced disease and special problems. Advances in chemotherapy.
Topics: Antineoplastic Agents; Benzoates; Cyclophosphamide; Evaluation Studies as Topic; Hodgkin Disease; Hu | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program.
Topics: Antineoplastic Agents; Benzoates; Cyclophosphamide; Evaluation Studies as Topic; Hodgkin Disease; Hu | 1973 |
Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
Topics: Adult; Age Factors; Antineoplastic Agents; Biopsy; Carmustine; Chlorambucil; Cyclophosphamide; Dacti | 1973 |
Combination chemotherapy in advanced and recurrent Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; | 1973 |
Intensive chemotherapy for Hodgkin's disease: long-term complications.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; E | 1973 |
The use of different drugs and combinations in the treatment of Hodgkin's disease.
Topics: Administration, Oral; Anemia; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; I | 1973 |
Hodgkin's disease in childhood.
Topics: Adolescent; Antineoplastic Agents; Child; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Pr | 1973 |
Uremia due to occult lymphomatous infiltration of the kidneys.
Topics: Biopsy; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Kidney Neoplasms; Mechlorethamin | 1974 |
Letter: Therapy for Hodgkin's disease.
Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr | 1974 |
[Pathology of treated Hodgkin's disease. A retrospective study (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Autopsy; Child; Child, Preschool; Drug Therapy, Combination; D | 1974 |
Protection from chemotherapeutic epilation by prior irradiation.
Topics: Adolescent; Alopecia; Antineoplastic Agents; Child; Cyclophosphamide; Drug Therapy, Combination; Fem | 1974 |
Combination chemotherapy of Hodgkin's disease.
Topics: Age Factors; Bone Marrow; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies; | 1974 |
[Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
Topics: Adolescent; Adult; Child; Child, Preschool; Disseminated Intravascular Coagulation; Drug Therapy, Co | 1974 |
Combination chemotherapy.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Chemical Phenomena; Chemistry; Daunorubicin; | 1974 |
Combined chemotherapy and radiotherapy for advanced Hodgkin's disease and reticulum cell sarcoma: a preliminary report.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lympho | 1971 |
Combination chemotherapy in malignant disease.
Topics: Administration, Oral; Blood Cell Count; Breast Neoplasms; Bronchial Neoplasms; Child, Preschool; Fem | 1971 |
Severe cerebral toxicity after intravenous nitrogen mustard therapy.
Topics: Adult; Brain Diseases; Coma; Dexamethasone; Diuresis; Fever; Hodgkin Disease; Humans; Hydrocephalus; | 1972 |
Combination chemotherapy (MOPP) in the management of advanced Hodgkin's disease. A progress report on 55 patients.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Benzoates; Bone and Bones; Drug Combinations; Female; Ho | 1972 |
Endobronchial Hodgkin's disease and bronchoesophageal fistula.
Topics: Adult; Biopsy; Bronchial Fistula; Bronchial Neoplasms; Bronchopneumonia; Esophageal Fistula; Female; | 1972 |
Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents.
Topics: Agranulocytosis; Alkylating Agents; Bone Marrow Cells; Bone Marrow Examination; Cyclophosphamide; En | 1972 |
Combination chemotherapy of Hodgkin's disease in private practice.
Topics: Adolescent; Adult; Aged; Anemia; Biopsy; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mid | 1972 |
Treatment of Hodgkin's disease in private practice.
Topics: Hodgkin Disease; Humans; Mechlorethamine; Medicine; Prednisone; Private Practice; Procarbazine; Refe | 1972 |
[Hodgkin's disease].
Topics: Adolescent; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Chlorambucil; Cyclophosphamide; Fema | 1971 |
Hodgkin's disease of the bone marrow.
Topics: Alkaline Phosphatase; Blood Platelets; Bone Marrow; Drug Combinations; Hematocrit; Hodgkin Disease; | 1971 |
[Results of treatment of Hodgkin's disease with large doses of nitrogranulogen and glucocorticoids].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Synergism; Female; Glucocorticoids; Hodgkin Dis | 1971 |
Solitary intracranial metastasis by Hodgkin's disease.
Topics: Adult; Brain Neoplasms; Cerebral Angiography; Cerebral Ventriculography; Dura Mater; Female; Hodgkin | 1967 |
Lymphoma-like presentation of Kaposi's sarcoma. Three cases without characteristic skin lesions.
Topics: Aged; Blood; Blood Protein Electrophoresis; Diagnosis, Differential; Female; Hodgkin Disease; Humans | 1966 |
Recent advances in chemotherapy of lymphoma.
Topics: Alkylating Agents; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Larg | 1967 |
A comparison of nitrogen mustard and vinblastine sulfate in the treatment of patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Vinbla | 1970 |
Chemotherapy of the lymphomas.
Topics: Antimetabolites; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydrazines; Lymphoma; Mechloreth | 1970 |
Combination chemotherapy in generalized Hodgkin's disease.
Topics: Antimetabolites; Bone Marrow; Drug Synergism; Hodgkin Disease; Humans; Hydrazines; Mechlorethamine; | 1970 |
[Chemotherapy of malignant lymphomas].
Topics: Adrenal Cortex Hormones; Amines; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Hydrazines | 1970 |
Long-term remission in Hodgkin's disease after nitrogen mustard therapy.
Topics: Adolescent; Biopsy; Hodgkin Disease; Humans; Male; Mechlorethamine; Prognosis | 1970 |
Procarbazine hydrochloride (Matulane) for Hodgkin's disease.
Topics: Antineoplastic Agents; Benzoates; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Vincristine | 1970 |
Treatment of Hodgkin's disease: with what and by whom?
Topics: Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine | 1970 |
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Child; Cyclophosphamide; Drug Synerg | 1970 |
A combined clinical and histological assessment of survival of patients with Hodgkin's disease.
Topics: Biopsy; Follow-Up Studies; Hodgkin Disease; Humans; Lymph Nodes; Mechlorethamine; Prognosis | 1971 |
Chemotherapy of Hodgkin's disease, lymphoma, and leukemia.
Topics: Adult; Antineoplastic Agents; Busulfan; Chlorambucil; Hodgkin Disease; Humans; Leukemia; Lymphoma; M | 1968 |
[Hodgkin's disease in children. Study of 72 personal cases].
Topics: Adolescent; Child; Child, Preschool; Female; Hodgkin Disease; Humans; Hydrazines; Male; Mechloretham | 1968 |
[The phenomenon of nitrogen mustard aggravation].
Topics: Adolescent; Adult; Aged; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Paraplegia; Sp | 1968 |
Endobronchial presentation of malignant lymphoma.
Topics: Bone Neoplasms; Bronchial Neoplasms; Bronchoscopy; Chlorambucil; Hodgkin Disease; Humans; Male; Mech | 1968 |
Response of the fever of Hodgkin's disease to nitrogen mustard (NSC-762): an evaluation of its significance.
Topics: Adolescent; Adult; Aged; Female; Fever; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged | 1969 |
Perforation of transverse colon in a patient with Hodgkin's disease.
Topics: Adolescent; Colonic Neoplasms; Cyclophosphamide; Female; Hodgkin Disease; Humans; In Vitro Technique | 1965 |
Control of fever in Hodgkin's disease by indomethacin.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Aspirin; Female; Fever | 1965 |
Advanced Hodgkin's disease. Management with chemotherapeutic agents.
Topics: Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Hydrazines; Mechlorethamine; Prednisone; Vi | 1965 |
Hypogammaglobulinemia in Hodgkin's disease treated with nitrogen mustard.
Topics: Adult; Agammaglobulinemia; Hodgkin Disease; Humans; Liver Neoplasms; Male; Mechlorethamine | 1966 |
[On the genesis of amyloidosis during Hodgkin's granuloma. (Considerations on therapeutic treatment].
Topics: Adrenal Cortex Hormones; Adult; Amyloidosis; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; | 1966 |